







Staphylococcus infection dynamics. 
By 








Department of Molecular Biology and Biotechnology, The University of 









Staphylococcus aureus is a clinically significant human pathogen which poses an increasing 
healthcare threat due to the spread of antibiotic resistance. To better understand the 
process of S. aureus pathogenesis, a vertebrate model for infection, using zebrafish 
embryos, was previously pioneered at The University of Sheffield. 
  
In this study I have utilised this systemic embryonic model of S. aureus infection in 
combination with a recently developed fluorescence microscopy technique – light sheet 
fluorescence microscopy, in order to investigate the real-time dynamics of S. 
aureus infection within a living host. 
 
The first aim of this project was to develop methodology that enables the imaging of 
infected, living transgenic embryos, over extended time scales. Having established 
mounting and imaging parameters, infection progression was followed using fluorescent S. 
aureus reporter strains and fluorescently labelled host phagocytes.  
 
The 4D imaging of these interactions identified macrophages as the host-niche in which 
bacterial expansion, followed by phagocyte escape, occurs. Furthermore, by using bacterial 
population studies it was confirmed that depletion of macrophages abolishes the immune 
bottleneck which proceeds clonal, population expansion of S. aureus.  
 
When imaging embryos in the terminal stages of infection it was apparent that the large 
bacterial aggregates which form within the host, have biofilm-like characteristics. As such, 
the role of staphylococcal proteins involved in biofilm formation, during infection 
progression was investigated using fluorescent reporters for gene expression. It was 
determined that S. aureus nuclease is produced both inside of host phagocytes and later by 
bacteria associated with large aggregates. Nuclease was also identified as a novel virulence 
factor in the zebrafish embryo model of S. aureus infection. 
 
Light sheet fluorescence microscopy has proven a useful tool to gain further insight into the 
temporal and spatial dynamics of S. aureus pathogenesis and to dissect real-time host-
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 Staphylococcus aureus 
Staphylococcus aureus is a non-motile, gram-positive, oblate spheroid bacterium which replicates 
by binary fission in three perpendicular planes (Amako and Umeda, 1979), giving rise to its 
eponymous, three-dimensional clusters that resemble a ‘bunch of grapes’ - staphlye or ‘berries’ - 
kokkus in Greek and the distinctive golden colour of the bacteria gives rise to the name aureus  
(Kloos and Bannerman, 1994).  It is one of 47 species within the Staphylococcus genus (which are 
described as facultative anaerobes) and is the most characterized within the genus, having been 
studied for over a century (Becker et al., 2014). 
Like other staphylococcal species, S. aureus preferentially colonises the mammalian body, in 
particular the skin glands and mucous membranes (Archer, 1998). Whilst other staphylococci are 
capable of causing disease, S. aureus has evolved as a well-armed pathogen. Traditionally it was 
characterised by its coagulase protein (Coa) (Becker et al., 2014), which has the ability to clot blood 
plasma (Archer, 1998). Coagulase was previously believed to be unique to S. aureus within the 
genus and was used as a clinical indicator to discriminate between S. aureus infection and other 
staphylococci; however other coagulase positive staphylococci have been discovered more recently 
(Becker et al., 2014; Kloos and Bannerman, 1994). 
As a facultative anaerobe, it can generate adenosine tri-phosphate (ATP) by fermentation in low 
oxygen environments. It grows optimally at temperatures 30-37 °C; however it has the ability to 
survive at temperatures from 6.5 – 46 °C and can withstand a wide range of pH (4.2 – 9.3) 
 Clinical significance of S. aureus 
The anterior nares of around 20 % of the population are permanently colonised by S. aureus and 
another 60 % are transient carriers of the bacteria (Kluytmans et al., 1997) and although carriage 
can be harmless, it often precedes infection by this opportunistic pathogen (Huang and Platt, 2003).  
S. aureus is the most common pathogen causative of nosocomial infections, colonising wound sites 
and in-dwelling devices such as catheters (Chatterjee et al., 2014; Kloos and Bannerman, 1994). 
Patients are often infected with a strain they were carrying prior to admission but colonised 
healthcare workers are also responsible for the spread the bacteria among patients (Huang and 
Platt, 2003; Lowy, 1998). S. aureus is causative of many forms of infection including (but not 
exclusively) scalded skin syndrome (SSS), cellulitis, impetigo, surgical wound infection and more 
seriously Toxic Shock syndrome (TSS), bacteremia, and acute endocarditis (Archer, 1998).  
For a long time, S. aureus infections seemed to be acquired mostly in the hospital setting, however, 





occurring worldwide and are epidemic in the USA (Kobayashi and DeLeo, 2009). These community 
acquired strains are hypervirulent, commonly causing skin and soft tissue infections (SSTIs); 
however they are also capable of causing serious invasive  infections such as fatal sepsis, 
nectrotising pneumonia, and necrotising faciitis (Kobayashi and DeLeo, 2009; Liu, 2009). CA 
infections often occur in people with pre-disposing risk-factors such as intravenous drug use, poor 
personal hygiene or diabetic foot ulcers (Dunyach-Remy et al., 2016; Kobayashi and DeLeo, 2009), 
but more worryingly there are an increasing number CA infections in healthy individuals that have 
not come into contact with healthcare and lack identifiable risk factors (David and Daum, 2010).  
The life threatening TSS infections caused by the protein toxic-shock syndrome toxin-1 (TSST-1) 
(Dinges et al., 2000) were first reported in 1978, gaining attention in the 1980s with occurrence in 
healthy individuals, mostly concurrent with menstruation (Davis et al., 1980) but also TSS also 
occurs in post-operative patients, patients with respiratory infections and post-partum women 
(Zaghloul, 2015). 
In both the hospital and community setting, 65-77 % of reported infections are the milder, SSTIs 
(Kobayashi and DeLeo, 2009). These can develop into far more serious infections as S. aureus has a 
propensity to gain access to the blood causing bacteremia, sepsis and spread to distant tissues 
(Archer, 1998; David and Daum, 2010; Kluytmans et al., 1997; Kobayashi and DeLeo, 2009).  
1.2.1 Treatment of S. aureus infections 
One of the first antibiotics, penicillin, was initially described by Alexander Fleming, subsequently 
purified and researched by Howard Florey and Ernst Chain (all three were awarded the Nobel prize 
in Physiology or Medicine in 1945 for their work), was first used in patients in 1942 and 
revolutionised the treatment of bacterial infections (Chain et al., 2005). Penicillin was widely used 
to combat S. aureus infection, but by the end of the same decade, most hospital isolates identified 
were resistant to penicillin (Wilson and Cockcroft, 1952). This resistance to killing by penicillin was 
conferred by the production of the enzyme β-lactamase which degrades penicillin by hydrolysing 
the β-lactam ring. As a result of resistance the semi-synthetic penicillins, such as methicillin, which 
were resistant to β-lactamase were developed. Soon after the introduction of these, S. aureus 
acquired resistance to methicillin (Barber, 1961). This new form of resistance was mediated via a 
novel penicillin binding protein (PBP2a) which has low-affinity for methicillin and therefore 
provides resistance to all available β-lactams (Hartman and Tomasz, 1984). PB2a is encoded by the 
mecA gene which is on a mobile genetic element, the SCCmec cassette (Katayama et al., 2000). 
The emergence of S. aureus strains resistant to β-lactam antibiotics – termed Methicillin Resistant 
Staphylococcus Aureus (MRSA), in both the community and hospital settings has created an 





2015). This widespread resistance greatly increases the threat posed by staphyloccal infections, 
exacerbating the ability of a mild infection developing into a life-threatening illness.  
A class of antibiotics, glycopeptides, which include the drug vancomycin have become the mainstay 
in combating MRSA infections. Vancomycin works by binding D-ala-D-ala residues involved in 
peptidoglycan synthesis, blocking cell wall production – this mechanism is unperturbed by 
production of both β-lactamase and PBP2a (Lowy, 2003). Strains more insensitive to vancomycin, 
termed Vancomycin Intermediate-resistant S. Aureus (VISA) were first identified in 1997, with 
many more reported since (Liu and Chambers, 2003). Vancomycin Resistant S. Aureus (VRSA) were 
first reported in the USA in 2002, with resistance acquired by a conjugal transfer of the vancomycin 
resistant enterococci (VRE) plasmid from Enterococcus faecalis. Among others, this plasmid 
contains the genes vanA, vanH, and vanX which are essential for the vancomycin resistant 
phenotype. Together VanA and VanH synthesise D-Ala-D-Lac and VanX is a D-D dipeptidase that 
hydrolyses the D-alanyl-D-alanine ester bond, preventing competition of D-Ala-D-Lac with the 
peptidoglycan precursor UDP-linked tripeptide. Incorporation of D-Ala-D-Lac into the 
peptidoglycan produces a cell wall whose synthesis is not susceptible to vancomycin (McGuinness 
et al., 2017). 
 The emergence of VRSA strains further escalates the severity that S. aureus poses as a ‘super-bug’, 
threatening a throwback to the pre-antibiotic era in terms of combating S. aureus infections. 
1.2.2 Prevention of S. aureus infection 
Mandatory surveillance of bacteraemia caused by MRSA since 2005 has revealed that screening and 
decolonising asymptomatic carriers of MRSA upon admission to hospital has resulted in the 
decrease in incidence of MRSA-caused bacteraemia in hospitals (Pearson et al., 2009). Public Health 
England have reported a 41 % reduction in the proportion of cases of bacteremia caused by MRSA 
from 2011/12 (11.3 %) – 2017/18 (6.6 %); this is the period in which reporting of bacteraemia 
caused by MSSA has also been compulsory. There has however been an increase in the total 
number of bacteraemia cases reported over this period, evidencing there has not been a reduction 
in incidence of bacteraemia caused by MSSA (Simor, 2011) (Public Health England, 2018).  This is 
due to screening strategies which currently target resistant strains and patients are not routinely 
screened for carriage of sensitive strains (Wyllie et al., 2011). There are an increasing number of 
strategies for decolonisation of high-risk patients, carrying MSSA prior to elective surgery which 
have been attempted with varied success (Simor, 2011). 
Due to the ever-increasing spread of resistance and rapid evolution of S. aureus, a vaccine against 
the pathogen would be very valuable, especially in high-risk groups, for example, prior to elective 





ability to adapt to multiple hosts (Richardson et al., 2018), and the myriad of proteins it produces to 
survive within the host and subvert the immune response (Buchan et al., 2019) makes finding a 
vaccine target difficult. Although there are many successful vaccines targeting a single component 
of other pathogens such as well-conserved toxins and capsular polysaccharide (for example the 
tetanus toxoid and pneumococcal conjugate vaccines), attempts to confer immunity with vaccines 
targeting a single S. aureus antigen have all failed. The StaphVAX vaccine (a capsular polysaccharide 
conjugate) did reach phase III trials, and a 57 % decrease in bacteremia incidence was observed, 
with protection lasting 40 weeks post vaccination was observed, but it failed in a subsequent larger 
trial where no significant protection was found (Scully et al., 2014). 
As a result of the failure of many single-antigen vaccines a multi-antigen approach is now being 
widely adopted. Several multi-antigen vaccine candidates have made it to phase II clinical trials 
(Giersing et al., 2016). 
The Pfizer vaccine candidate, S4Ag, was the most advanced of these, reaching phase IIb trials after 
receiving fast-track approval from the FDA (Giersing et al., 2016) with its 4 antigen vaccine 
comprised of the adhesin clumping factor A (ClfA), manganese transporter (MntC), and the capsular 
polysaccharides 5 and 8 (CP5 and CP8). This aimed to elicit a broad humoral and cellular immune 
response targeting multiple virulence mechanism involved in establishing and maintaining 
infection (Anderson et al., 2012). However, it was announced in December 2018, that the 
‘STtaphylococcus aureus suRgical Inpatient Vaccine Efficacy’ (STRIVE) trial of the vaccine PF-
06290510 in patients undergoing elective spinal fusion surgery, was discontinued due to futility - 
the low statistical probability of the study to meet its primary objectives (Pfizer investor press 
release, December 2018). A vaccine developed by Glaxo Smith Kline (GSK) contained 3 of the same 
antigens (ClfA, CP5 and CP8) in a candidate that contained 5 antigens; however this vaccine failed 
in phase I trials (Giersing et al., 2016). Other multi-antigens are being tested in earlier phases but 
many of these target toxins such as TSST-1, Panton-Valentine leukocidin (PVL) and staphylococcal 
enterotoxin (SEB) which are only present in a subset of strains (Scully et al., 2014). 
A passive immunisation strategy, using monocolonal antibodies (mAb) raised against α hemolysin 
(Hla), MEDI4893, is currently undergoing phase II clinical trials looking at the safety, efficacy, and 
dosing in mechanically ventilated patients (who have a high-risk of contracting pneumonia) 
(ClinicalTrials.gov NCT02296320). The producer of the vaccine, MedImmune, have since reported 
increased efficacy using a combination of mAbs (MEDI4893 and H110 raised against ClfA) than 
with a bi-specific antibodies (BiSAbs) in murine models (Tkaczyk et al., 2017). This recent approach 






 Staphylococcal virulence determinants involved in host-binding and 
immune evasion 
S. aureus produces a vast repertoire of proteins, both membrane bound and secreted, which are 
involved in binding host proteins for colonisation and modulation of the host immune response.  
1.3.1 The surface proteins of S. aureus 
At the earliest stages of infection S. aureus must colonise the host. Attachment of the bacteria to 
host tissues via binding the extracellular matrix (ECM) is mediated by cell wall anchored adhesins 
(CWA). Among these are the microbial surface components recognising adhesive matrix molecules 
(MSCRAMMs) which often have two adjacent domains with IgG like folds (Deivanayagam et al., 
2002) and a‘dock, lock, and latch’ model for binding of some of these surface proteins to their host 
substrates has been proposed (Ponnuraj et al., 2003). There is redundancy in the targets of 
MSCRAMMS with clumping factor A (ClfA), clumping factor B (ClfB) and bone sialo-binding protein 
(Bbp) all binding the plasma glycoprotein fibrinogen (Fg), two fibronectin binding proteins, 
fibronectin binding protein A & B (FnBPA & FnBPB) which also bind Fg, and two which bind 
desquamated epithelial cells, serine-aspartate repeat protein C & D (SdrC & SdrD)  (Foster et al., 
2014). 
The MSCRAMM, collagen-binding protein (Cna), is involved in binding collagen rich tissues (Zong et 
al., 2005) such as the cornea (Rhem et al., 2000) and cartilage has a role in septic arthritis induced 
by S. aureus in a murine model (Xu et al., 2004).  FnBPA promotes adherence to and internalisation 
by epithelial cells (Massey et al., 2001). However the region of the Cna protein responsible for 
adherence to keratinocytes is distinct from the fibronectin binding region (Edwards et al., 2011).  
 The main Fg binding protein, ClfA is a 96.4 kDa protein, a major virulence factor (O’Connell et al., 
1998) and is found in 100 % of clinically isolated strains(Ghasemian et al., 2015). ClfA is involved in 
the process of agglutination, binding fibrin fibrils undergoing agglutination in the blood of the host. 
The N-terminal of ClfA contains a ~500 residue domain which binds the C-terminal of γ chain of Fg, 
preventing subsequent binding of additional fibrin subunits to the agglutinated fibrils (Geoghegan 
et al., 2010). Through this binding event, the bacteria are masked by the fibrils enabling evasion of 
phagocytosis within the host blood (Flick et al., 2013). ClfA protects S. aureus from murine 
macrophages- in a fibrinogen dependent process (Josefsson et al., 2001). Agglutination of these 
infectious thrombi in S. aureus sepsis is implicated in systemic dissemination in the host and is 
essential to its lethal outcome in mouse models (McAdow et al., 2011). ClfA is also essential in 
murine staphylococcal arthritis models (Palmqvist et al., 2005), and rat and rabbit models for 
endocarditis (Entenza et al., 2005; Siboo et al., 2001; Sullam et al., 1996). As a result of its vital role 





and both active and passive immunization with a combination of ClfA FnBPA & FnBPB is protective 
in mice (Arrecubieta et al., 2008). However, recent use of ClfA in the vaccine Veronate© failed in 
phase III testing (Schaffer and Lee, 2008). 
In addition to MSCRAMMs, the near iron transporter (NEAT) motif family of CWA contains the 
proteins iron-regulated surface proteins A and B (IsdA & IsdB) which facilitate adhesion to 
desquamated epithelial (Clarke et al., 2006) and non-phagocytic cells (Zapotoczna et al., 2013) in 
addition to their roles in iron acquisition.Another adhesin, extracellular adherance protein (Eap) 
binds Fg, Fn, and prothrombin and promotes internalization to fibroblasts, reducing detectability 








Figure 1.1 The secreted proteins of S. aureus and their roles in immune-evasion 
Adapted from (Buchan et al., 2019). Schematic of a phagocytic cell demonstrating host-targets of S. 
aureus secreted virulence factors. Virulence factors are shown in orange: chemotaxis inhibitory 
protein of staphylococcus CHIPs, staphylococcal superantigen like protein 3, 5, 13 SSL3, SSL5, 
SSL13, staphylococcal kinase SAK, extracellular adhesion protein Eap, phenyl soluble modulins 







1.3.2 The secreted proteins of S. aureus 
S. aureus has evolved to produce an arsenal of factors which interfere with the host immune 
response, many of these are secreted proteins working on different aspects of the innate immune 
response to the pathogen, (Figure 1.1). The first line of defense against infection are host barrier 
tissues, which produce antimicrobial peptides (AMPs) to combat invading pathogens, often via 
insertion into the plasma membrane bacteria. Staphylococcal kinase (SAK) is produced by S. aureus 
to inactivate one of the most abundant AMPs, α-defensin. SAK acts by directly binding and 
inactivating α-defensin, but also activates plasminogen – which degrades blood plasma proteins (Jin 
et al., 2004). Another defense against innate defences is the production of O-acetyltransferase 
(OatA) (Bera et al., 2005). OatA leads to a modification of the cell wall peptidoglycan, blocking 
activity of the host enzyme lysozyme (found in saliva, plasma and sweat) which acts by cleaving 
bonds between N-acetyl-muramic acid and N-acetylglucosamine in the peptidoglycan (Bera et al., 
2005). 
The complement pathways are biochemical cascades which are an integral part of the innate 
immune system, derived from more than 30 proteins present in the serum, tissue fluids and cell 
surfaces (Walport, 2001a). Complement is involved in clearing pathogens and the distinguishing 
between self and non-self targets during an immune response (Serruto et al., 2010). There are three 
types of complement pathway, classical, alternative and lectin pathways. The classical pathways is 
reliant on antibody recognition of a microbial target and suqbsequent binding of complement 
protein C1 (Walport, 2001b). The alternative pathway is continuously active at a basal level and 
relies upon host cell-surface proteins to inactivate components of the cascade. The lectin pathway is 
dependent on the recognition of specific patterns comprised of saccharides and related molecules. 
All three pathways converge upon the activation of the complement protein C3. The formation of 
membrane attack complex (MAC) – comprised of five complement proteins, results in the direct 
killing of gram negative bacteria by creating a pore in the bacterial membrane. However, gram 
positive bacteria are protected from formation of MAC and clearance of bacteria is reliant on 
phagocytosis stimulated by complement proteins C3b and C5a. Figure 1.2 depicts the three 










Figure 1.2 The complement pathways 
Adapted from (Serruto et al., 2010). Activation of the complement cascade in response to 
pathogens. The classical and lectin pathways begin with humoral proteins binding bacterial 
antigens. The alternative pathway is constitutively active, but host cells prevent activation of bound 
C3 through expression of Factor H. The complement protein C3 is the pinnacle of the complement 
cascade and is activated by C3 convertases C3bBb and C4b2a. It’s activated form, C3a is a key 
mediator of phagocytosis. Additionally, complement C5a is also a pro-phagocytic signal of the 
cascade involved in the clearance of pathogens. The proteins C5b, C6, C7, C8, and C9 for the 
membrane attack complex (MAC) which can directly kill gram negative bacteria by creating a pore 
















The pathogen also produces many proteins which disrupt the ‘complement’ cascade, one of these 
secretory products of S. aureus is Chemotaxis Inhibitory Protein of Staphylococcus (CHIPS) can bind 
receptors for C5a (C5aR1) (Postma et al., 2005) and formyl-peptide receptor (FPR1) on neutrophils 
(Haas et al., 2004). Two distinct regions of CHIPS bind these two receptors, blocking C5a and N-
formylated tripeptide N-formylmethionyl-leucyl-phenylalanine (fMLF) binding C5aR1 and FPR1 
respectively.  Through this action CHIPS interferes with neutrophil chemotaxis and extravasion 
(Foster, 2005). 
  A key aspect of the complement system is C3, which is the crux of all three complement pathways 
(Serruto et al., 2010). This is cleaved by C3 convertase to form C3a (a potent chemoattractant) and 
C3b (involved in opsonisation, by covalently binding the cell wall of the pathogen and promoting 
phagocytosis) (Lambris et al., 2008). S. aureus interferes with C3 activity in a number of ways; by 
activating plasmin, SAK can degrade C3b. The bacteria produce extracellular fibrinogen-binding 
protein (Efb), which in addition to binding fibrinogen, binds a region of C3, preventing cleavage 
hence blocking the classical and alternative complement pathways, obstructing C3b deposition and 
also formation of C3 convertase (Lee et al., 2004). Besides this, Efb interferes with the adaptive 
immune response by preventing recognition of C3b by B-cells (Ricklin et al., 2008). The 
extracellular complement binding protein (Ecb) also disrupts opsonisation by binding C3b (Amdahl 
et al., 2013). A protein conserved by 90 % of S. aureus strains, staphylococcal complement inhibitor 
(SCIN) disrupts the complement cascade by binding to and stabilising the C3 convertases, C4b2a 
and C3bBb, thus disrupting all complement pathways. Through this activity, SCIN is probably the 
most potent modulator of the humoural immune response (Rooijakkers et al., 2005).  
As well as its role in internalisation, Eap also targets intracellular adhesion molecule-1 (ICAM-1) on 
the surface of host endothelial cells. Through Eap binding ICAM-1 the intended ligand, lymphocyte-
function-associated antigen (IFA-1), expressed on the surface of neutrophils, is blocked, preventing 
neutrophil adhesion, diapedesis, and extravasion (Haggar et al., 2004). Furthermore it inhibits the 
neutrophil serine proteases (NSPs) neutrophil elastase (NE), cathepsin G and proteinase 3, 
produced after phagocytosis to aid killing of internalised bacteria, by binding the catalytic clefts of 
the NSPs (Stapels et al., 2014). 
Recently the protein ‘Staphylococcal peroxide inhibitor’ (SPIN) has been identified and 
characterised; it works by binding and inhibiting myeloperoxidase (MPO) (Jong et al., 2017). MPO is 
involved in the oxidative burst which occurs within neutrophils in response to intracellular 
bacteria, it catalyses the production of hypochlorous acid (HOCl) within the phagosome, from 
hydrogen peroxide (H2O2) and chloride ions. HOCl is the most potent oxidative product within the 
phagosome (Klebanoff et al., 2013). By occluding the active site of MPO, SPIN enables S. aureus to 





Protein A (SpA) is a 42 kDa protein produced by S. aureus that has been very well characterized; it 
can be both localized to the cell surface or secreted into the extracellular milieu (Lambris et al., 
2008). Once secreted it can bind the antigen binding fragment (Fab) regions of the B-cell receptor, 
resulting in apoptosis of B-cells, hindering the adaptive immune response (Kobayashi and DeLeo, 
2013). When associated with the bacterial cell surface, SpA binds the constant region (Fc) of an 
antibody (Ab), sequestering antibodies and inhibiting antibody binding to the hexameric 
complement component, C1q which stimulates the classical complement cascade (Lambris et al., 
2008). More recently it has been shown that SpA also binds von Willebrand factor, promoting 
surface adhesion of S. aureus to the epithelium (Hartleib et al., 2000) and the tumour necrosis 
factor receptor 1 (TNFR1) of epithelial cells, resulting in the epithelium shedding the receptor and 
neutralising available tumour necrosis factor α (TNF- α) and it has been shown that SpA binding 
TNFR1 is essential for S. aureus induced pneumonia (Gómez et al., 2004).   
A crucial part of the host innate-immune response is the activation of phagocytes after the 
recognition of pathogen associated molecular patterns (PAMPs) by pattern recognition receptors 
(PRRs). The two main classes of PRRs are the Toll-like receptors (TLRs) localized on the host cell 
surface and NOD-like receptors (NLRs) are cytosolic host receptors (Franchi et al., 2009; Kawai and 
Akira, 2010). Activation of PRRs leads to the production of cytokines (immune signaling proteins), 
chemokines (which recruit phagocytes) and stimulation of an inflammatory response. During this 
innate immune response, key cytokines CXCL1, CXCL2, CXCL7, and IL-8 are produced that all bind a 
target receptor CXCR2, a key chemotactic receptor found on the membrane of neutrophils (Hato 
and Dagher, 2015). S. aureus disrupts binding of these key immune modulators by production of, 
staphopain A (ScpA), a cysteine protease which cleaves the N-terminus of CXCR2 destroying the 
functionality of the receptor and abolishing neutrophilic response to CXCL1 and CXCL7 (Laarman et 
al., 2012).  In addition, TLR2 (which is activated by both gram-positive and gram-negative 
lipoproteins) is also targeted by S. aureus by production of staphylococcal superantigen-like protein 
3 (SSL3). SSL3 binds to the extracellular domain of TLR2, preventing heterodimerisation of TLR2/6 
and TLR2/1 and as a consequence prevents the production of IL-8, disrupting neutrophil 
recruitment (Bardoel et al., 2012).  
Another class of secreted staphylococcal proteins are the phenyl-soluble modulins (PSMs) which 
are ‘surfactant toxins’ (Peschel and Otto, 2013). These also indirectly target TLR2 by shedding 
lipoproteins from the bacterial membrane, leading to activation of downstream inflammatory 
pathways via production of TLR2 dependent chemokines (Hanzelmann et al., 2016). Although TLR2 
plays an important role in clearing PSM producing  S. aureus strains, high levels of PSMs are 
produced by highly pathogenic CA-MRSA strains and PSM production is essential for sepsis in 





staphylococci, however it has been shown that TLR2 activity in response to lipoprotein shedding of 
skin commensals S. aureus and Staphylococcus epidermidis (S. epidermidis) is ten times lower than 
TLR2 activity in response to lipoproteins of the non-commensal species Staphylococcus carnosus (S. 
carnosus) and this is due to the position of acylation of the long-chain fatty acids. The position of the 
acyl groups on the lipoproteins from S. aureus and S. epidermidis result in lipoproteins binding the 
TLR2/1 complex whereas the lipoproteins of S. carnosus binds the TLR2/6 complex. By binding 
TLR2/1 S. aureus and S. epidermidis lipoproteins silence innate and adaptive immune responses, 
suggesting immunomodulation by S. aureus that may underpin infection (Nguyen et al., 2017). 
There are seven PSMs, all of which are produced by most strains of S. aureus, these are small 
peptides 20-45 αα in length, that have a cytolytic effect on leukocytes and erythrocytes (Peschel 
and Otto, 2013). Importantly these are cytolytic against human neutrophils (Surewaard et al., 2013; 
Wang et al., 2007), and unlike the bi-component toxins, PSMs do not have cell specificity (Cheung et 
al., 2012). Neutrophil killing by PSMs has been shown to occur subsequent to phagocytosis of the 
cells (Surewaard et al., 2013) and it is likely that the intracellular production of PSMs is triggered 
by the stringent response (Geiger et al., 2012). The ability to cause cytolysis of host cells is key to 
pathogenesis of S. aureus and deletion of the PSMs from the core genome of the hypervirulent CA-
MRSA strains, USA300 and USA400, reduces cytolytic capacity to that of strain 252, a HA-MRSA, in a 
human neutrophil model (Wang et al., 2007).  
The surfactant PSMs have likely evolved as a mechanism of creating channels within S. aureus 
biofilms, these channels give the biofilms their characteristic ‘spongey’ texture and provide access 
to required nutrients. The expression of PSMs in this instance is controlled by quorum-sensing in 
the post-exponential growth phase (Periasamy et al., 2012). 
1.3.2.1 The pore-forming toxins of S. aureus 
By secreting leukocytic toxins, S. aureus can trigger phagocyte cell death before bacterial killing has 
been accomplished. The mechanism of these toxins is to form a pore in the phagocyte membrane, 
causing leakage and inevitably lysis of cells. The alpha-toxin (also known as alpha-hemolysin, Hla) 
is the major cytotoxic agent produced, the protein forms a heptamer in the membrane, producing a 
β-barrel pore (Dalla Serra et al., 2005). 
 S. aureus also produces many bi-component leukotoxins, five of which are specific to human 
infection, Panton-Valentine leukocidin (PVL), leukocidin AB and ED (LukAB and LukED), and γ-
haemolysin AB and CD (HlgAB and HlgCD)(Dalla Serra et al., 2005; Seilie and Wardenburg, 2017). 
The two subunits of the toxins are secreted separately, forming hexameric or heptameric 
complexes, producing pores in the leukocyte membrane (Kaneko et al., 1997). The most prominent 





both erythrocytes and leukocytes. However, PVL is only found in around 3 % of strains isolated 
from nares of healthy individuals (Shukla et al., 2010), but is expressed in 77-100 % of CA-MRSA 
strains and is associated with the SCCmec cassette types IV and V, commonly found in CA-MRSA 
strains (Vandenesch et al., 2003). Presence of PVL correlates with severe contagious skin infection 
and severe pneumonia in healthy individuals (Foster, 2005).  
LukAB is the most recently discovered bi-component toxin and is the most genetically distant from 
the other leukocidins (Ventura et al., 2010). It targets monocytes, macrophages, and dendritic cells 
(DuMont et al., 2011), and has been shown to cause extracellular killing of neutrophils (DuMont et 
al., 2013). There is cross-over in the roles of the different pore-forming toxins as LukED is also 
cytotoxic to dendritic cells, macrophages, and T-Cells, targeting the chemokine receptors CXCR1 
and CXCR2 (Reyes-Robles et al., 2013). 
Another defense against the immune response is the distinctive golden colour of S. aureus, which 
arises from production of staphyloxanthin, a carotenoid which works as an anti-oxidant to 
counteract oxidative stress encountered from reactive oxygen species (ROS) produced by the host 
immune response (Clauditz et al., 2006). 
 Regulation of virulence determinant production 
Expression of S. aureus virulence factors are controlled by two-component regulatory systems 
(TCS) of which 16 have been identified within the genome and DNA binding proteins. These 
respond to environmental cues such as pH, CO2 and bacterial density (Bronner et al., 2004a). The 
TCS are histidine-kinase complexes, localised in the cell-membrane, with an extra-cellular sensing 
domain and an intracellular response regulator. 
1.4.1 Regulation of S. aureus exoprotein expression 
The S. aureus exoprotein expression (sae) locus contains the co-transcribed saeRS TCS comprised of 
the sensor protein SaeS and the response regulator SaeR (Liu et al., 2016). SaeS consists of an N- 
terminal transmembrane domain followed by a 10 αα extracellular loop, which responds to 
environmental signals connected to a second transmembrane domain leading to an intracellular 
histidine kinase (HK) (Geiger et al., 2008). SaeR has a N-terminal receiver domain, which requires 
phosphorylation by the HK of SaeS. Phosphorylation of this domain is essential for SaeR binding 
target DNA; a 16 nucleotide consensus sequence which has been identified in 26 genes encoding 
exoproteins including the virulence factors Coa, Hla, emp, efb, SCIN, Eap, TSST-1 , FnbA/B, LukE/A, 
HlgC, Nuc, Sak, and Aur (Liu et al., 2016). Transcription of the sae operon (including the ancillary 
genes saeP & saeQ) is maximal in the post-exponential growth phase, however there is constitutive 
basal transcription of saeRS from a secondary promoter, producing enough SaeRS for sensing and 





 It has been shown that SaeRS is activated in response to molecules of the innate immune response. 
The antimicrobial peptides, human neutrophil peptide 1, 2, and 3 (HNP1-3, also known as α-
defensins) are produced by neutrophils, found in the azurophilic granules, and are the main source 
of bacterial killing in the phagolysosome. HNP1-3 activate SaeRS at subinhibitory concentrations 
(Geiger et al., 2008) and unsurprisingly saeRS is activated within human neutrophils, however not 
all SaeR/S regulated virulence factors are upregulated in response to HNP1-3 (Zurek et al., 2014). 
Another stimulant of SaeRS is calprotectin, a member of the EF-hand calcium binding protein 
family, comprising 50 % of the neutrophilic cytosolic protein and is also found in high 
concentrations in abscesses, where it sequesters Zn and Mn, nutrient metal ions required for 
staphylococcal growth (Cho et al., 2015). Inhibitory concentrations of H2O2 (found within 
neutrophils, a constituent of ROS production) have also been shown to activate SaeRS (Geiger et al., 
2008). It is not yet known how the differential expression of SaeRS controlled virulence factors is 
regulated. 
1.4.2 The accessory genome regulator of S. aureus 
A major regulator of S. aureus is the accessory gene regulator (Agr) which is involved in the 
regulation of gene expression in the post-exponential growth phase. This system is responsible for 
quorum sensing of S. aureus, which plays an important role in biofilm development, and the 
regulation and modulation of proteins involved in chronic infection (Boles and Horswill, 2008; 
Bronner et al., 2004b; Moormeier and Bayles, 2017a; Periasamy et al., 2012). Agr is both a 
transcriptional and translational regulator, a schematic of the activation of this regulatory system is 
shown in Figure 1.3.  The agr locus contains two divergent promoters, P2 and P3, which direct 
expression of RNAII and RNAIII transcripts (Recsei et al., 1986). The first (RNAII) encodes proteins 
AgrB, AgrD, AgrC, and AgrA which are required for agr-mediated virulence factor regulation (Peng 
et al., 1988). AgrB is a membrane-associated protease which is involved in the digestion of AgrD to 
generate and secrete auto-inducing peptide (AIP), an octopeptide, quorum sensing molecule (Zhang 
et al., 2002). Accumulation of extracellular AIP leads to activation of AgrA and AgrC – a TCS. The 
binding of AIP to the transmembrane sensor kinase protein AgrC, causes homdimerisation of AgrC. 
Subsequently AgrC phosphorylates AgrA – the cytoplasmic response regulator Phosphorylation of 
AgrA leads to transcription of RNAIII which activates transcription of secreted proteins including 
Hla, Hlg, PVL, and TSST-1 and simultaneously represses surface bound virulence factors. (Dunman 








Figure 1.3 Schematic to show transcriptional and translational regulation by agr 
The agr locus contains two divergent promoters P2 and P3. Translation of RNAII results in the 
expression of proteins AgrB, AgrD, AgrC, and AgrA. The protein AgrD interacts with and is 
modified and secreted by AgrB, producing extracellular AIP. Binding of AIP to the extracellular 
sensor AgrC, leads to phosphorylation of the response regulator AgrA. Phosphorylation of AgrA 
results in transcription of the P3 promoter, increasing production of extracellular toxins and 







 Models of S. aureus infection 
1.5.1 In vitro infection models  
As S. aureus has evolved to be especially good at infecting and surviving within humans, with 
proteins adapted specifically to subvert the human immune response, this makes modelling the 
infectious process difficult. In vitro and ex vivo models using human cell types such keratinocytes 
(Edwards et al., 2011; Kisich et al., 2007; Rhem et al., 2000), fibroblasts (Almirón et al., 2015; 
Kanangat et al., 2006), endothelial cells (Pöhlmann-Dietze et al., 2000) and even 3D primary co-
culture models of the epidermis and underlying dermis (Popov et al., 2014) have been used to 
study colonization and infection.  Whilst these are useful for investigating the interactions of S. 
aureus with the human ligands the bacteria have evolved specificity to, they are comprised of only 
one or two cell types and are not immune-competent and can only provide limited insight to the 
infectious process.  
As well as epithelial cells, intact skin contains mast cells, dermal dendritic cells, macrophages, T and 
B cells and natural killer (NK) cells which are involved in the cutaenous immune response (Kupper 
and Fuhlbrigge, 2004). These are first line of defense against a pathogen, which cell culture models 
(comprised of a single cell type) lack. Isolation and/or primary culture of immune cell types, 
particularly neutrophils and macrophages are also regularly used to dissect the roles of individual 
S. aureus proteins during the infectious process and have identified bacterial components 
important for pathogenesis (DuMont et al., 2013; Haggar et al., 2004; Kaneko et al., 1997; Laarman 
et al., 2012; Ricklin et al., 2008; Scherr et al., 2015; Stapels et al., 2014; Surewaard et al., 2013). Here 
again, the use of these cells in isolation is not entirely physiologically relevant. Often results do not 
correlate with in vivo models and the procedure of isolating these cell types may perturb inherent 
function. 
1.5.2 Invertebrate models of S. aureus infection 
Manipulation of invertebrates is achieved more rapidly than vertebrates models and reverse 
genetic manipulation through techniques through crispr/cas9 provides a rapid target method of 
creating specific mutations, allowing elucidation of particular genes in disease progression (Tsai et 
al., 2016). However, the use of invertebrate models organisms for infection models is mainly 
limited to the innate immune response, but has the advantage of being more high-throughput than 
vertebrate models. 
1.5.2.1 Caenorhabditis elegans 
Caenorhabditis elegans, is an optically transparent nematode that is approximately 1 mm in size. C. 
elegans will feed off a bacterial lawn and this characteristic can be exploited as a route of 





infection with different well-characterised laboratory strains in addition to clinical isolates. 
Survival of L4 stage (the last larval stage of C. elegans development) C. elegans over the course of 
several days has been followed (Sifri et al., 2003). Upon ingestion, S. aureus colonises the digestive 
system of C. elegans and ~ 90 % are killed within 72 hours of infection. This model has been used to 
identify conserved aspects of S. aureus pathogenesis that are host-independent, the virulence 
regulators sarA, agr, and alternative sigma factor (σb), along with α- toxin and V8 serine protease 
have been identified as essential virulence determinants in this infection model (Sifri et al., 2003). 
An advantage of this model is the natural transparency of the organism, this can be exploited by 
microscopy and flurorescent bacteria can be followed within the host (Garsin et al., 2001). Another 
advantage is access to well characterized mutants, which have indicated that the conserved p38 
mitogen-activated protein (MAP) kinase pathway – is involved in C. elegans defence against 
multiple pathogens, as a key response to S. aureus (Sifri et al., 2003).  
1.5.2.2 Galleria mellonella 
The larvae of Galleria mellonella have become a popular model for microbial infections. The life 
cycle of G. mellonella is short, they are inexpensive, do not require any special laboratory 
equipment and are not protected by Animals (Scientific Procedures) Act 1986 (ASPA) regulations 
and as such it is easy to maintain large numbers of the larvae to obtain statistically relevant data 
(Tsai et al., 2016). Their relatively large larval size makes for easy injection with the pathogen 
(García-Lara et al., 2005). Whilst G. mellonella are evolutionarily distant from mammals, they 
possess many similar components of the innate immune response including hemocytes (phagocytic 
cells) found in the hemolymph – analogous to vertebrate blood. As well as cellular components of 
innate immunity G. mellonella have some analogous components of the humoral response: 
opsonins, AMPs, (García-Lara et al., 2005; Tsai et al., 2016) and melanisation. Importantly they have 
peptidoglycan recognition proteins (PGRPs) (Tsai et al., 2016) and a phenomenon analogous to 
vertebrate nuclear extracellular trap (NET) formation occurs resulting from extracellular 
endogenous nucleic acids from oenocytoids (a subset of hemocytes) (Altincicek et al., 2008). The 
melanisation response is described as the ‘synthesis and deposition of melanin to encapsulate 
pathogens at the wound site’ and is analogous to abscess formation in vertebrates. This response is 
scored and used as a measure of virulence, along with survival of infection larvae (Tsai et al., 2016) 
Unlike some other infection models, G. mellonella can be maintained at 37°c, which is human body 
temperature and the temperature S. aureus are routinely incubated in when cultured in the 
laboratory setting. The model has been used primarily to screen anti-staphylococcal compounds 





1.5.2.3 Drosophila melanogaster 
The fruit fly, Drosophila melanogaster, is a model organism that has been well genetically 
characterised and posseses an innate immune system similar to vertebrates. Their innate immune 
system has the ability to recognise peptidoglycan by TLRs (Leulier et al., 2003) and they have 
professional phagocytes, termed plasmocytes, that are analogous to mammalian monocytes, which 
engulf and destroy invading microbes (Leclerc and Reichhart, 2004). Like G. mellonella it also 
surrounds microbes in melanin and secretes AMPs into the haemolymph (Leclerc and Reichhart, 
2004). D. melanogaster has been used to model S. aureus infection; bacteria are inoculated by 
pricking the thorax of the fruit fly with a needle dipped in bacterial suspension (Needham et al., 
2004). Although this model is evolutionarily far removed from the human host, it was used to 
identify virulence determinants pheP and perR (Needham et al., 2004). PheP mutants were later 
also confirmed as attenuated in vertebrate models of S. aureus infection (Connolly, J., 2015). 
1.5.3 Vertebrate models of infection 
Vertebrate models of S. aureus infection benefit from both innate and adaptive immune systems, 
which can better mimic human infection than invertebrates or an in vitro models. However, the 
specificity of S. aureus adaptions as a human pathogen make challenges in modelling infection even 
in this higher model organisms. 
1.5.3.1 Rabbit models of S. aureus infection 
Rabbits are commonly used for infection of bone and tissue with S. aureus, they are practically 
useful for osteomyelitis models as bone size is larger than mouse, making precise surgical 
manipulations easier. Internal fixation models for both acute and chronic osteomyelitis are used, 
and the longer life span of the rabbit permits monitoring for up to 18 months (Reizner et al., 2014). 
They are used for modelling prothesis infection and testing the addition of anti-microbial polymers 
to prostheses and bone cements. A rabbit model of infective endocarditis (IE) has also been 
developed, as the physiology of the heart is similar to that of humans and bacterial vegetations on 
the heart have been shown to contain a similar number of bacteria as are isolated from patients 
(Spaulding et al., 2012a). Recently advances have been made on the widely adopted methodology, 
initially described by (Garrison and Freedman, 1970) this modifies the method and route of 
inoculation to better mimic the procedure experienced by cardiac patients (Wang et al., 2013). A 
rabbit model for pulmonary infection has been used, where a high dose of S. aureus administered by 
intrabronchial inoculation results in pulmonary illness and death (Strandberg et al., 2010). 
However immunisation using TSST-1 or staphylococcal enterotoxin B (SEB) protected rabbits from 
pneumonia in this lethal challenge model (Strandberg et al., 2010).  This model demonstrated the 
inability to develop neutralising antibodies against the super antigen TSST-1, as previously 





inability of the host to recognise it as non-self. Immunisation with a combination of superantigens 
(including a mutant TSST-1 toxoid) confers the ability of vaccinated rabbits to withstand lethal 
challenge of S. aureus and protects against IE, pneumonia and sepsis (Spaulding et al., 2012b). 
1.5.4 Murine models of S. aureus infection 
The mouse is the primary animal used to model S. aureus infection and many different models exist 
to investigate the different types of staphylococcal infection. The mouse is a natural host of S. 
aureus, however these infections occur from mouse specific strains, primarily causing infection in 
preputial glands of male mice. Mice are not a natural host of human specific strains, which do not 
spread within a murine population and mice are less readily colonized by human strains than those 
of murine origin (Holtfreter et al., 2013). As a result, mice need higher inocula of S. aureus with 
human specific strains. Mouse models for sepsis, septic arthritis, pneumonia, blood borne 
metastatic abscess formation, peritonitis, endocarditis, and subcutaneous skin infection are 
routinely used (Kim et al., 2014). 
1.5.4.1 Sepsis 
Sepsis is commonly caused by S. aureus and is the result of an immune response to bacterial 
replication in the blood which often results in multiple organ failure and can be fatal (Kloos and 
Bannerman, 1994). To recapitulate this, mice are infected via the tail vein with a very high 
inoculum 5x 107 – 5x 108 CFU subsequently they develop septic shock with lethal outcome within 
12 – 48 hours (Kim et al., 2014). Infected mice present with clinical signs of disease within 2-3 
hours such as loss of appetite, diminished movement, ruffled fur, hunched posture and labored 
breathing (Cheng et al., 2009). In this model bacteria can be re-isolated from exsanguinated blood 
and are routinely found in all examined organs, whilst severe, this model has been used to identify 
key virulence determinants for staphylococcal sepsis (McAdow et al., 2011). This model was 
recently used to demonstrate that clonal expansion of bacteria –where only a few cells from the 
initial inoculum replicate leading to abscess formation (McVicker et al., 2014) is decreased when 
increased CFU are used in the inoculum (Pollitt et al., 2018). With higher infectious dose, the 
immune bottleneck responsible for the phenomenon, is bypassed and the host is simply 
overwhelmed. This decrease in survival is concurrent with increased bacterial burden in all 
recovered organs (Pollitt et al., 2018). 
1.5.4.2 Septic arthritis 
The route for administration of inoculum for the septic arthritis model is the same as in sepsis and 
the form of disease progression is determined by administering a lower dose, 7 x 106 – 2 x 107 CFU 
(Tarkowski et al., 2001). Bacteria disseminate to the synovial tissue and penetrate structures of the 
joint cavitiy, this is resultant in swollen and red joints and the animals exhibit joint stiffness. 





disease progression of septic arthritis differ from those identified in sepsis models (Tarkowski et 
al., 2001). 
1.5.4.3 Pneumonia 
A murine pneumonia model has been developed in which the inoculum is delivered via a transnasal 
route to adult mice. This model is dose dependent and requires relatively high doses to cause 
disease with 4 x 108 CFU and 8 x 108 CFU causing 50 % and 90% mortality in 24 hours respectively 
(Wardenburg et al., 2007). A lower dose of 8 x 107 CFU results in no mortality, but animals display 
some symptoms of illness. The lungs of infected mice show disease pathology from 6 hours 
onwards, with infiltration of large number of immune cells and large staphylococcal foci are also 
found at this point (Wardenburg et al., 2007). This model exemplifies the dramatic effect small 
changes in dose can have on the outcome of the infection model and it is likely that the adaption of 
staphylococcal adhesion proteins to a human host is causative of the need for a high inoculum in 
this murine model (Kim et al., 2014). 
1.5.4.4 Bacteraemia and metastatic abscess formation 
There is a prevalence in bacteraemia and distal abscess formation in invasive staphylococcal 
disease in humans. This is modelled by systemic infection of the mouse by intravenous 
administration of the inoculum via the tail vein (Kim et al., 2014). Bacteraemia is achieved with 
doses of 1 x 106 – 1 x 107 CFU, S. aureus then exits the bloodstream and establish organ abscesses 
which can be found within the brain, lungs, liver, kidneys and heart (Cheng et al., 2009). These 
abscesses have a characteristic infiltration of immune cells, mostly neutrophils and are 
predominantly found on the kidneys (Kim et al., 2014). It has been shown that in addition to 
extracellular bacteria infiltrating host tissue, they are disseminated by neutrophils in the manner of 
a trojan horse (Gresham et al., 2000). Recently this model has revealed that neutrophils are also a 
mechanism of dissemination of S. aureus from these abscesses to other tissues (Pollitt et al., 2018) 
but that clonal expansion, occurs in macrophages prior to phagocyte escape. Whilst depletion of 
either neutrophils or macrophages results in decreased host survival, depletion of neutrophils does 
not abolish the immune bottleneck observed in this model (Pollitt et al., 2018).  
1.5.4.5 Peritonitis 
Patients with end-stage renal disease or those which receive peritoneal dialysis frequently develop 
peritonitis caused by S. aureus. To recapitulate this, mice are injected into the peritoneal cavity, to 
achieve disease a very high inoculum is needed, with doses of 5 x 108 and 6 x 109 CFU causing 50 % 
and 90 %. In this model there is formation of peritoneal abscesses, even in survivors of infection, 
but few staphylococci are found in the blood and metastatic abscess formation is rare in this model 





and expansion of memory T-cells and therefore the requirements for a successful vaccination 
against S. aureus (Murphy et al., 2014). 
1.5.4.6 Endocardititis 
Infective endocarditis, usually associated with intra-vascular devices, is often caused by S. aureus in 
the nosocomial setting and the incidence of this is increasing (Federspiel et al., 2012). In addition to 
infection of post-operative patients, endocarditis commonly occurs in intr-venous drug users, 
caused by virulent CA-MRSA strains (David and Daum, 2010). To cause endocarditis in the mouse, 
valve trauma is produced by insertion of a catheter into the aortic valve via the left ceratoid artery. 
A day later the mouse is then infected intravenously with 1 x 106 CFU. Recovery of bacteria from the 
hearts of catheterised mice was 4 orders of magnitude greater then non-catheterised mice. This 
model is used to assess the efficacy of antibiotics on vegetative bacterial growths which occur on 
heart valves (Gibson et al., 2007). 
1.5.4.7 Subcutaneous infection 
S. aureus can cause skin infection in humans where the barrier of the skin has been compromised, 
such as a cut or graze. These infections can result in the production of purulent discharge from the 
infectious site (Kim et al., 2014), whilst these superficial infections are mild they can lead to life 
threatening infections previously described. To model these infections, subsequent to hair removal, 
1 x 107 CFU is delivered by subcutaneous injection. Subcutaneous abscesses and regions of 
dermonecrosis can be measured to monitor infection progression (Bunce et al., 1992; Malachowa et 
al., 2013). More recently development of a model which mimics post-surgical infection that occurs 
in the hospital setting has been developed. This wound model involves a surgical incision to the 
thigh muscle, which is then sutured and inoculated with bacterial suspension. The skin is then 
sutured, and infection of mice is monitored. Excision of the muscle tissue provides insight into 
factors of the host response involved in pathogenesis and bacteria can be quantified by 
homongenisation (McLoughlin et al., 2006).  
 
1.5.5 Humanised mouse models 
As S. aureus has evolved to be particularly pathogenic to humans, many of the virulence factors 
have human specific ligands. As a result, attempts have been made to utilise humanised mice to 
better mimic staphylococcal infection. This was made possible by the recent development of the 
NSG mouse (non-obese diabetic/ severe combined immunodeficient mouse with null mutation in 
Il2R common gamma chain). These mice lack B, T, and NK cells, complement and possess defective 
myeloid cells, making them more susceptible to engraftment and better support human haemato-





Humanisation of the mouse is achieved by transplanting human CD34+ stem cells into irradiated 
NSG pups (Lan et al., 2006). 
 This humanised mouse was first used for S. aureus infection by Knop et al., 2015 who administered 
a non-lethal dose via intraperitoneal injection. These humanised mice had significantly increased 
mortality than non-humanised controls and bacterial counts were higher in liver, spleen, kidney, 
lungs, and brain, demonstrating the ability of S. aureus to target human specific immune cells. In 
addition to this, there was evidence of T cell activation in the humanised mice (Knop et al., 2015). 
Subsequently, humanised mice have also been used in a subcutaneous skin infection model in 
which it was found that 10- 100 fold fewer bacteria were needed to cause analogous disease 
pathology in comparison with control mice and that humanised mice were more susceptible to 
PVL+ strains than control mice (Tseng et al., 2015). After respiratory infection of humanised mice, a 
40-fold higher bacterial burden of the humanised mice in comparison to control mice was found 
(Prince et al., 2017).  This pneumonia model also utilised additional knock-in of human IL3 and Csf2 
improving reconstitution of macrophages. These mice had even higher bacterial burden than the 
standard NSG CD34+ mice. This study also demonstrated a role for the human-specific PVL, 
however no phenotype for the human-specific LukAB was found in this model (Prince et al., 2017). 
All of these pioneering infection models have revealed increased susceptibility of humanised mice 
to S. aureus regardless of the method of inoculation. Further advancements in the humanisation of 
the murine immune response will improve the relevancy of these already promising developments 
in modeling S. aureus infection. These models could provide vital insight in vaccine trials, where 
there has currently been a lack of correlation between successful immunisation of mice and 
translation into human trials. 
1.5.6 The use of zebrafish for modelling infection 
Zebrafish (Danio rerio) is a small fresh-water fish (~4 cm in size) that has long been used for 
embryological and developmental studies, its use as a model organism provides an extensively 
characterised system which has more recently been exploited for vertebrate models of disease. The 
high capability of the zebrafish to reproduce and their small size (both as adults and larvae) make 
them suitable for high-throughput screening. 
The publication of the entirety of the human genome in 2004 (International Human Genome 
Sequencing Consortium, 2004) has provided a reference for genome wide association studies 
(GWAS) and the ability to use whole genome sequencing (WGS) to identify molecular pathology of 
disease. Although the ability to identify genes in silico is a powerful tool, this has rapidly increased 
the number of genes, putatively causative of disease, in need of validation and mechanistic 





favour of murine models (Liu et al., 2017), with zebrafish possessing homologs for 70% of the 
genes in the human genome (Howe et al., 2013). The advent of the CRISPR/Cas9 system has 
accelerated the ability to manipulate the zebrafish genome and provide targeted gene inactivation 
and overexpression (Chang et al., 2013).  
Zebrafish possess leukocytes (including phagocytes) essential for the innate immune response, 
present from 25 hours post fertilisation (Lieschke et al., 2001). This model organism also has a 
well-developed complement system, functioning through classical, alternative, and lectin pathways, 
which play a role in pathogen and clearance (Boshra et al., 2006).  Early embryos (up to 5 days post 
fertilisation) are incapable of independent feeding but are able to phagocytose pathogenic bacteria 
injected into the circulation, mounting an innate immune response and thus are capable of  
preventing overwhelming infections  (Davis et al., 2002; Sar et al., 2003). As a result of these 
characteristics, it has become an attractive host for infection models since the initial use of it to 
study host response to native pathogen Mycobacterium marinum (Davis et al., 2002). It is being 
used as an infection model for an ever-increasing number of non-native pathogens. The advantages 
of the zebrafish embryo as an infection model, in comparison with human cell models and other 
vertebrate infection models, are briefly summarised in Table 1.1. 
1.5.6.1 Zebrafish embryo models of infection with gram positive pathogens 
Along with the zebrafish model for systemic S. aureus infection developed in Sheffield (Prajsnar et 
al., 2008) zebrafish embryos are being utilised as infection models for other gram-positive 
pathogens. Listeria monocytogenes, a food borne pathogen causative of meningitis in newborns, 
injected into the hindbrain of embryos 72 hpf provides a meningitis model for the pathogen and has 
identified the host protein GP96 (a protein of the endoplasmic reticulum) as protective against the 
pore-forming toxin, lysteriolisin O (LLO) which is involved in vacuole escape (Mesquita et al., 
2017). Interestingly, in the model for Streptococcus pyogenes, intra-muscular (IM) injection results 
in massive muscle tissue necrosis, similar to the human necrotising fasciitis typical of S. pyogenes 
infection (Phelps and Neely, 2007).  
Systemic infection of embryos with pathogenic Enterococcus faecalis is resultant in substantial 
tissue damage and host mortality (Prajsnar et al., 2013). Use of fluorescent mutants has 
demonstrated that the enterococcal polysaccharide antigen (epa) mutants are unable to evade 
phagocytosis unlike their WT counterparts. It has also demonstrated that the quorum sensing 
system, Fsr is an essential virulence determinant, but that fsr mutants replicate in embryos and that 
Fsr controls factors involved in later stages of infection (Prajsnar et al., 2013). The model has also 
been used to demonstrate that N-acetylglucosaminidase activity (AtlA) mutants, that form long 
chains, are also attenuated, likely due to an inability for the larger chains of cells to disseminate 





1.5.6.2 Zebrafish embryo models of infection with gram negative pathogens 
The zebrafish has been used as an infection model for the opportunistic pathogen Pseudomonas 
aeruginosa. This model requires a high inoculum as the bacteria is rapidly cleared by both 
macrophages and neutrophils (Clatworthy et al., 2009). The pathogen is primarily a threat to CF 
patients, where in the lungs it switches from planktonic growth to biofilm formation. The zebrafish 
model has shown that type III secretion system (T3SS) and the quorum sensing genes (lasR and 
mvfR) are essential for virulence (Clatworthy et al., 2009). Furthermore, the model has been used to 
identify roles for the LPS modifying SadC and WarA proteins, which modify the distribution of LPS 
O antigen. P. aeruginosa sadC and warA mutants are attenuated, as there is increased neutrophil 
recruitment in comparison with infection of embryos with WT (McCarthy et al., 2017). Embryos 
infected with either sadC or warA mutants had significantly higher levels of TNF-α in comparison to 
embryos infected with WT, suggesting that the modification of LPS has an immune-modulatory 
effect, aiding evasion of the host immune response (McCarthy et al., 2017). 
Zebrafish embryos have also been used to study pathogenicity of the food-borne pathogen Shigella 
flexneri. Systemic infection of embryos with S. flexneri causes macrophage death and pathogenesis 
is again reliant on T3SS, as mutants are attenuated in this model (Mostowy et al., 2013).  The model 
demonstrated that cytosolic S. flexneri are trapped by septins and targeted for autophagy (Mostowy 
et al., 2013), embryos depleted of the Sept15 (the zebrafish homologue of human Sept7) by 
injection of morpholino-modified antisense oligonucleotides (morpholinos) (which alter gene 
expression by binding host RNA targets) had increased mortality and bacterial burden when 
infected with WT in comparison with control embryos (Mazon-Moya et al., 2017). Live-imaging of 
this infection model has provided insight into the role of the cytoskeleton and its role in 
inflammation (Mazon-Moya et al., 2017; Mostowy et al., 2013). 
1.5.7 Humanised zebrafish models 
Recently zebrafish research has expanded into ‘humanised’ models, with the zebrafish genome 
being edited to provide expression of a human protein, rather than paralogs. This approach has 
been applied to pharmacokinetics, with expression of a human detoxification protein by the 
zebrafish liver, altering the metabolic profile of CYP3A4 targets, providing a more relevant drug 
screen (Poon et al., 2017).  
Xenografts of patient T-cell acute lymphoblastic leukemia (T-ALL) into transgenic zebrafish which 
express humanised CXCL12 have been used as a preclinical, chemical genetic screen. This 
technique, which allows the engraftment of patient samples and test them with individual or 
combination chemotherapies, in a one-week time scale, could provide a pivotal tool in personalised 





host to infection was recently attempted, in order to improve the relevance of this infection model 
to S. aureus (Buchan, K. D., 2018). 
 Intravital imaging of host-pathogen interactions 
1.6.1 Intravital imaging of zebrafish embryos 
Intravital imaging techniques are one of the main benefits to the use of zebrafish as a model 
organism. The transparency of the embryos and the ability to fluorescently label cellular 
components and tissues such as macrophage specific mpeg1 promoter (Ellett et al., 2011) and 
neutrophil specific mpx (Gray et al., 2011) and image these living specimens over long time scales 
makes them an attractive candidate for modelling infection. Not only can host components be 
labelled, but bacterial and fungal pathogens either dyed with fluorescent probes or genetically 
manipulated to produce fluorescent proteins can also be visualised (Bojarczuk et al., 2016; Gibson 
et al., 2017; McVicker et al., 2014; Ogryzko et al., 2019; Prajsnar et al., 2012; Willis et al., 2018). Not 
only can these cells be visualised by fluorescence microscopy, but rather elegantly, they can be 
photoactivated by lasers and simultaneously imaged (Brothers et al., 2013; Ellett et al., 2011; Isles, 
2018). Conditionally activated fluorescent reporters such as indicators of oxidative stress or 
phagocytosis can also give insight to the infectious process (Tobin et al., 2012) and commercially 
available molecular probes, such as pH reactive dyes can also be used for live imaging of infected 
embryos (Serba, 2015). 
 Fluorescence stereomicroscopy has been used to visualise the localisation and migration of the 
larger host cells and bacterial cell population at low magnification, allowing for relatively simple 
and quick imaging of the host response to infection. This form of microscopy, imaging on the whole 
animal level, has been useful for the identification of reverse neutrophil migration (Ogryzko et al., 
2019), bacterial abscess formation (Prajsnar et al., 2008), granulopoiesis (Willis et al., 2018), and 
dissemination of fungal pathogens (Gibson et al., 2017).  
Confocal microscopy, obtaining higher resolution and higher magnification, has routinely been 
employed to investigate host pathogen interactions in more detail. This has enabled imaging of sub-
cellular localisation of pathogens within the host such as co-localisation of Mycobacterium marinum 
with the autophagy marker, LC3 (van der Vaart et al., 2014), clonal expansion of S. aureus within 
neutrophils (Prajsnar et al., 2012), and septin cage entrapment of S. flexinori (Mostowy et al., 2013).  
Spinning-disc confocal microscopy lowers the amount of laser exposure to the sample, reducing 
photo-toxicity to the living samples, enabling high resolution time course imaging. This 
methodology has been used to gain insight in infection progression and has aided identification of 





Limitations of in vitro phagocyte 
challenge 
Advantages of larval zebrafish model 
Purification of immune cells can perturb 
function 
Purification unnecessary 
Media does not recapitulate tissue specific 
in vivo nutrients 
In vivo nutrients 
No soluble factors (e.g. opsonins, cytokines) 
from other cell types 
Normal soluble components 
No contact activation or inhibition by other 
cell types 
Normal tissue environment 
No effect of extracellular matrix 
interactions 
Normal extracellular environment 
Cannot monitor dissemination of infection Tissue-to-tissue dissemination can be 
imaged 
Limitations of in vivo mouse infection Advantages of larval zebrafish model 
Too large to examine infection host-wide at 
high resolution 
Possible to image entire live fish 
Opaque skin and organs limit fluorescent 
imaging below ~100 µm 
Fish larvae are transparent 
Elimination of macrophage function 
pleiotropic 
Temporary macrophage ablation feasible 
Very limited high-resolution, non-invasive 
imaging of pathogen or immune 
morphology 
High-resolution, non-invasive imaging 
facile throughout the host 
Table 1.1 Advantages of the use of embryonic zebrafish to study the interactions of 
pathogens with the host innate immune response. 
Adapted from (Tobin et al., 2012). Comparison of zebrafish embryos with in vitro human cell 






resulting in vascular damage of the host (Gibson et al., 2017) and even the transfer of S. aureus from 
neutrophils to macrophages (Serba, 2015). 
1.6.2 Intravital imaging of murine tissue 
Imaging murine tissue has previously been limited to ex vivo imaging after fixation and or clearing 
samples for microscopy. A method for intravital imaging of mouse livers has recently been 
developed: this uses spinning-disc confocal microscopy which allows for time-course imaging of the 
host cells without photo-bleaching (Wong et al., 2011). Briefly, anesthetised mice are injected with 
fluorescently labelled antibodies and positioned laterally. A lateral incision from the costal margin 
to the midaxillary line is made, and tendons retaining the liver are severed in order to excise the 
liver. Blood vessels to the liver are carefully left intact to allow circulation of blood to the liver, the 
exposed liver is mounted on a slide and kept moist with saline (Wong et al., 2011). This intravital 
imaging technique has been used to demonstrate the intracellular survival of S. aureus within the 
tissue resident macrophages, Kupffer cells (Surewaard et al., 2016), and identify that augmentation 
of S. aureus by the peptidoglycan of human commensals also occurs within these Kupffer cells 
(Boldock et al., 2018). 
Intra-vital imaging of the murine liver using two-photon confocal microscopy has recently been use 
to investigate the effect of LPS treatment on neutrophil activity on the liver and have manufactured 
a chamber specially designed for the incubation of the mouse whilst imaging the liver (Park et al., 
2018). This method enables normal circulation of blood to and around the liver and this 
microscopy technique achieved a depth of up to 40 µm using a 20 x objective (Park et al., 2018). 
In contrast with the non-invasive imaging of zebrafish embryos, these techniques are not 
compatible with monitoring for future timepoints, either by observation of survival or additional 
microscopy. It is an invasive method for single use and animals are sacrificed directly after imaging 
(Boldock et al., 2018; Park et al., 2018; Surewaard et al., 2016; Wong et al., 2011). 
A recently developed microscopy technique, light sheet fluorescence microscopy (LSFM) can image 
very large depths within the zebrafish embryo and can achieve relatively high-resolution images, 
from low magnification objectives imaging a large field of view. The nature of this technique 
enables long-term time lapse imaging as the method has lowered phototoxicity to living specimens 







 Aims of this study 
 To combine the unique zebrafish model of S. aureus infection with light sheet fluorescence 
microscopy to enable long term imaging of host-pathogen interactions in physiologically 
relevant conditions. 
 Elucidate the temporal and spatial niche for bacterial expansion within the host. 







Media were prepared using dH2O and sterilised by autoclaving for 20 min at 121 °C and 15 psi. 
2.1.1 Tryptic Soy Broth 
Tryptic soy broth  (Scientific Lab Supplies)  30 g/L 
For tryptic soy agar (TSA) plates 1.5 % (w/v) bacteriological agar was added 
2.1.2 LK broth 
Tryptone   10 g L 
Yeast extract  5 g/L 
KCl   7 g/L 
For LK bottom agar 1.5 % (w/v) bacteriological agar (VWR) was added.  
For LK top agar 0.5 % (w/v) bacteriological agar (VWR) was added. 
 Antibiotics  
Selective antibiotics were added to growth medium when necessary. Antibiotic stock solutions 
were prepared by dissolving antibiotic in appropriate solvent and filter sterilised (0.22 µm pore 
size) and stored at -20 °C. For use in liquid media antibiotics were added immediately prior to use, 
when used in agar plates molten agar was cooled to 55 °C before addition of antibiotics. All 







Kanamycin (Kan) dH2O 50 50 
Chloramphenicol (Cm) 100% (v/v) EtOH 10 10 
Erythromycin (Ery) 100% (v/v) EtOH 5 5 
Lincomycin (Ln) 50% (v/v) EtOH 25 25 
Neomycin (Neo) dH2O 50 50 
Tetracycline (Tet) 100% (v/v) EtOH 5 5 







 Bacterial strains 
Bacterial strains used in this study are stored in Microbank© cryovials (Pro Lab Diagnostics) 
containing beads at -80 °C. These were cultured by streaking out onto TSA plates containing 
selective antibiotics when needed and incubated at 37 °C. Plates were stored short term at 4 °C, 
wrapped in Parafilm© (Bemis) to prevent plates drying out. For growth in liquid culture, bacteria 
were incubated at 37 °C with a volumetric ratio of 1:4 media to air, with 250 rpm shaking. All 
strains used in this study are listed in Table 2.2. 
2.3.1 Bacterial culture 
Unless otherwise stated, bacteria were cultured as follows: for liquid cultures a single colony was 
picked with a sterile loop and used to inoculate 10 ml of medium in a sterile 50 ml falcon tube and 
incubated 37 °C, with 250 rpm shaking. This overnight culture was used to inoculate 50 ml of fresh 
medium in a conical flask, to an OD600 of 0.05 and grown to exponential phase (OD600 0.8 -1.2) at 37 








SJF4618 SH1000 PmalM1:GFP integrated at geh locus Kan Eric Pollitt 
SJF4622 JE2 PmalM1:GFP integrated at geh locus Kan Eric Pollitt 
SJF4631 SH1000 with PmalM1:mCherry integrated at 
geh locus supplemented with lysA::ery lysA+ 
cassette 
Ery  (Pollitt et al., 
2018) 
SJF4634 JE2 with PmalM1:mCherry integrated at geh 
locus supplemented with lysA::ery lysA+ 
cassette 
Ery Eric Pollitt 
SJF4622 SH1000 with PmalM1:mCherry integrated at 
geh locus 
Tet Eric Pollitt 
SJF4625 JE2 with PmalM1:mCherry integrated at geh 
locus 
Tet Eric Pollitt 
SJF4308 SH1000 with pMV158-mCherry plasmid Tet (Prajsnar et al., 
2012) 
SJF4302 JE2 with pMV158-mCherry plasmid Tet Tomasz Prajsnar 
SJF5074 UAMS-1 pDM4 (cidABC:GFP, lrgAB:dsRed) 
dual cid and lrg reporter strain 
Cm (Moormeier et al., 
2013) 
SJF5075 UAMS-1 pCM20 (nuc::gfp), reporter strain for 
nuc expression 
Ery (Kiedrowski et al., 
2011) 
SJF5078 UAMS-1 pEM81 (cidABC:gfp), reporter strain 
for cid expression 
Cm (Moormeier et al., 
2013) 
SJF5079 UAMS-1 pEM80 (lrgAB:gfp), reporter strain 
for lrgAB expression 
Cm (Moormeier et al., 
2013) 
SJF5087 UAMS-1471 (Δnuc) nuc mutant  (Kiedrowski et al., 
2011) 
NE1466 JE2 with Tn insertion in cidR (Tn::cidR) Ery (Fey et al., 2013) 





RN4220 Restriction deficient transformation 
recipient strain 
 (Kreiswirth et al., 
1983) 
SJF5153 JE2-mCherry pCM20 (nuc:gfp), constitutively 
producing mCherry with GFP nuc reporter  
Tet,Ery This study 
SJF5154 SH1000-mCherry pCM20 (nuc:gfp) 
constitutively producing mCherry with GFP 
nuc reporter 
Tet, Ery  This study 
SJF5152 JE2 pMV158-mCherry pEM81 (cidABC:gfp) 
constitutively producing mCherry with GFP 
cidABC reporter 
Tet, Cm This study 
SJF5088 JE2 pMV158-mCherry pEM80 (lrgAB:gfp) 
constitutively producing mCherry with GFP 
lrgABreporter 
Tet, Cm This study 
SJF5091 JE2-mCherry pEM80 (lrgAB:GFP) with 
PmalM1:mCherry integrated at geh locus 
(constitutive mCherry production) with GFP 
lrgAB reporter 
Tet, Cm This study 
SJF5092 JE2-mCherry pEM81 (cidABC: GFP) with 
PmalM1:mCherry integrated at geh locus 
(constitutive mCherry production) with GFP 
cidABC reporter 
Tet, Cm This study 
SJF5155 SH1000 pMV158-smURFP constitutively 
producing smURFP 
Tet This study 
SJF5156 JE2 pMV158-smURFP constitutively 
producing smURFP 
Tet This study 
Table 2.2 Bacterial strains used in this study 
 
 Plasmids 
All plasmids used in this study are listed in Table 2.3, plasmid DNA was isolated by GeneElute 
plasmid MidiPrep kit (method 2.9.7). Plasmids were designed using SnapGene. 





Multicopy plasmid encoding fluorescent protein 
mCherry under the constitutive promoter 
PMal1 
Tet Tomasz Prajsnar 
pMV158-
GFP 
Multicopy plasmid encoding GFP under the 
constitutive promoter PMal1 




Multicopy plasmid encoding smURFP under the 
constitutive promoter PMal1 
Tet This study 
pCM20 GFP reporter for nuc expression Ery (Kiedrowski et al., 
2011) 
pDM4 Dual reporter for expression of lrg (dsRed) and 
cid (GFP) 
Cm (Moormeier et al., 
2013) 
pEM80 GFP reporter for lrg expression Cm (Moormeier et al., 
2013) 
pEM81 GFP reporter for cid expression Cm (Moormeier et al., 
2013) 






 Buffers and solutions 
All buffers were made with dH20 and if necessary autoclaved or filter sterilised. Buffers were stored 
at room temperatures unless stated otherwise.  
2.5.1 Phosphate buffered saline (PBS) 
NaCl    8 g l-1 
Na2HPO4   1.4 g l-1 
KCl    0.2  g l-1 
KH2PO4   0.2 g l-1 
 
2.5.2 Phage buffer 
MgSO4    1 mM 
CaCla2    4 µM 
Tris-HCl pH 7.8  50 mM 
NaCl    0.6 % (w/v) 
Gelatin    0.1 % (w/v) 
 
2.5.3 TAE (50 x) 
Tris   242 g l-1 
Glacial acetic acid 5.7 % (w/v) 
Na2EDTA pH 8.0  0.05 M 
To produce a working TAE solution, the stock solution was diluted 1:49 dH2O. 
 
2.5.4 0.1 M Sodium phosphate buffer (pH 5.5) 
Na2HPO4 (1.0 M) 93 ml 






2.5.5 50 mM Tris-HCl pH 7.5 
Tris base   6.05 g l-1 
The pH was adjusted to 7.5 with HCl before autoclaving 
 
2.5.6 20 mM Sodium acetate buffer 
C2H3NaO2   1.64 g l-1  
The pH was adjusted to 4.5 with 100 % glacial acetic acid before to autoclaving 
2.5.7 Ethanol 70 % (v/v) 
EtOH   700 ml l-1 
dH2O   300 ml l-1 
 Chemicals, compounds, and enzymes 
All chemicals and compounds used in this study were of analytical grade quality and were 
purchased from MilliporeSigma and Thermo Fisher Scientific unless stated otherwise. Restriction 





Lysostaphin 5 mg ml-1 20 mM sodium acetate 
CyGel Sustain 100 % (v/v)  
CaCl2 1 M dH2O 
NaOH 1 M dH2O 
EtBr 5 mg ml-1 dH2O 
3-amino benzoic acid 
ester (Tricaine) 









The following centrifuges were used to harvest samples: 
Eppendorf microcentrifuge 5418, maximum speed of 16,783 RCF (14,000 rpm), capacity 24 x 
1.5-2 ml  
Sigma centrifuge 4K15C, maximum speed of 5525 RCF (5,100 rpm), maximum capacity of 16 x 50 
ml. 
Avanti High Speed J25I centrifuge, Beckman: JA-25.50 rotor, maximum speed of 75, 600 RCF 
(25,000 rpm) capacity up to 6 x 50 ml   
Unless otherwise stated centrifugation was performed at RT. 
 
 Determination of bacterial cell density 
2.8.1 Spectrophotometric measurement (OD600)  
Optical density of bacterial culture was quantified by spectrophotometric measurements at 600 nm 
(OD600). These measurements were taken using aJenway 6100 spectrophometer and Semi-micro PS 
cuvettes (Fisherbrand). If required, samples were diluted 1:10 in culture medium to keep 
measurements below OD600 = 1.0. 
 
2.8.2 Direct cell counts (CFU ml-1) 
The number of viable cells in liquid culture was estimated by direct cell counts. Bacterial samples 
were serial diluted 1:9 in PBS in triplicate and 10 ul samples of each dilution spotted onto TSA 
plates. Plates were incubated at 37 °C overnight and the number of colony forming units (CFU) per 
spot was determined and CFU ml-1 of culture estimated.   
 
 Genetic manipulation of S. aureus 
2.9.1 Primer design 
Primers used in this study were synthetic oligonucleotides (Eurofins) 25 - 50 bp in length based 
upon the DNA sequences of S. aureus strain USA300 FPR3757, plasmids, and encoding fluorescent 
proteins. Primer design for Gibson assembly was performed using NEBuilder Assembly Tool from 
https://nebuilder.neb.com. Lyophilised primers were resuspended in sterile milliQ and either 





2.9.2 PCR amplification 
Polymerase chain reaction (PCR) amplifications were performed using Phusion High Fidelity 
master mix (New England Biolabs). A final reaction volume of 50 µl contained: 
Template DNA     50 – 100 ng 
Forward primer (10 µM)   2.5 µl 
Reverse primer (10 µM)   2.5 µl 
Phusion High Fidelity master mix   25 µl 
Sterile milliQ water    up to 50 µl 
PCR amplification was carried out in Veriti Thermal Cycler (Applied Biosystems), the lid was 
preheated to 105 °C and the following conditions were used: 
1 cycle  Initial denaturation    98 °C   30 s 
30 cycles Denaturation    98 °C  10 s 
  Annealing    55-65 °C 10 s 
  Extension    72 °C  15 s/kb 
1 cycle  Final extension    72 °C  3-5 min 
 
2.9.3 Gel extraction of DNA 
DNA was separated by electrophoresis in 1 % (w/v) agarose in TAE gel containing 0.05 µg ml-1 
ethidium bromide. The DNA band was visualised with a UV transilluminator and excised from the 
gel with a clean scalpel. The excised gel was weighed, and DNA was purified from the gel using 
QIAquick Gel Extraction Kit (QIAGEN) as per manufacturer’s instructions. 
 
2.9.4 PCR purification 
DNA fragments from PCR reactions were purified with the QIAquick PCR purification kit as per the 
manufacturer’s instructions. 
 
2.9.5 Restriction endonuclease digestion 
Restriction endonuclease enzymes were purchased from New England Biolabs, where possible 





instructions, with buffers supplied by the manufacturer, using recommended enzyme 
concentrations. The reactions were incubated at 37 °C for 1 h, if there was further downstream 
manipulation of DNA fragments, these were purified as described in the Methods sections 2.9.3 and 
2.9.4 . 
2.9.6 Lysostaphin cell lysate preparation 
A single colony was used to inoculate 50 ml of TSB (with appropriate antibiotic) in a 250 ml conical 
flask and incubated at 37 °C overnight. Cells were recovered by centrifugation at 3000 RCF for 10 
min at 4 °C, washed in PBS and centrifuged as before. Supernatant was removed and the pellets 
weighed. The pellets were resuspended in PBS (20 ml per gram of cells) before adding 500 µg 
lysostaphin (10 mg ml-1) per gram of cells.  Cell suspensions were incubated with gentle agitation at 
37 °C for 1-4 hours (depending on strain) until lysates had a gelatinous consistency. 
 
2.9.7 Midi prep 
Large scale plasmid purification of plasmid from S. aureus was performed using the ‘GeneElute 
Plasmid MidiPrep Kit’ (Sigma Aldrich). A single colony was used to inoculate 50 ml of TSB (with 
appropriate antibiotic) in a 250 ml conical flask and incubated at 37 °C, with shaking at 250 rpm 
overnight. Overnight cultures were recovered by centrifugation at 3000 RCF, for 10 mins at RT and 
the pellet resuspended in ‘Resuspension buffer’ at this point the ‘lysostaphin digestion’ (Method 
2.9.6) was performed. From this juncture onwards the manufacturer’s instructions were followed 
apart from one other deviation, incubation of column with milliQ at RT prior to elution was 
extended to 10 min and half the recommended volume was used for recovery of plasmid. Plasmid 
concentration was the determined by NanoDrop Lite. 
2.9.8 Gibson Assembly 
Inserts were obtained by PCR amplification (method 2.9.2), DNA vector backbone was prepared by 
MidiPrep (Method 2.9.7) followed by restriction endonuclease digestion (method 2.9.5) and 
purification (Methods 2.9.3 and 2.9.4). Assembly was then performed in a total volume of 10 µl with 
the following components: 
Vector DNA    50ng 
Insert DNA    3 fold excess of vector DNA 
Gibson Assembly Master Mix  (2x)  5 µl 





The ligation was performed at 50 °C for 1 h, the product was then used to transform 
electrocompetent S. aureus (strain RN4220). 
 
2.9.9 Preparation of electrocompetent cells 
The S. aureus strain RN4220 was streaked on TSA and incubated at 37 °C overnight. A single colony 
was used to inoculate 400 ml of TSB, in a 2 L conical flask and cells were grown for 10 h, at 37 °C 
with shaking at 250 rpm. This culture was used to inoculate a fresh 400 ml of TSB, to an OD600 of 
0.1, cells were incubated at 37 °C with shaking at 250 rpm for 1-2 h until an OD600 of 0.4-0.6 was 
reached. Cells were divided into 50 ml aliquots and recovered by centrifugation at 3000 RCF for 10 
min at RT. Pellets were washed 3 times by resuspension in 25 ml sterile dH2O and centrifugation at 
3000 RCF at RT for 10 min. Pellets were resuspended in 20 ml 10 % (v/v) glycerol and centrifuged 
at 3000 RCF for 10 min at RT. The pellets were combined and resuspended in 10 ml 10 % (v/v) 
glycerol and incubated stationary at RT for 30 min. Cells were centrifuged at 3000 RCF for 10 min 
at RT, the pellet was resuspended in 500 µl 10 % (v/v) glycerol. 60 µl aliquots were transferred into 
micro-centrifuge tubes, snap frozen in liquid nitrogen and stored at -80°C.  
 
2.9.10 Electroporation 
A 60 µl aliquot of electrocompetent S. aureus was defrosted at RT, transferred to a 1 mm 
electroporation cuvette (Bio-Rad) and ~1 µg of plasmid DNA (a maximum of 10 µl) was added. A 
Gene Pulser Xcell electroporation (Bio-Rad) was used to carry out electroporation at 2.1 kV, 25 µF 
and 100 Ω. Cells were immediately recovered in 1 ml of TSB pre-warmed to 37°C, added to a 15 ml 
centrifuge tube and incubated for 3 h at 37 °C with shaking at 250 rpm. 200 µl aliquots were spread 
onto a TSA plates containing selective antibiotics and incubated at 37°C until colonies appeared (20 
– 48 h).  
2.9.11 Bacteriophage propagation 
The S. aureus donor strain was grown overnight in selective media. 150 µl of overnight culture was 
combined with 5ml TSB, 5ml Phage Buffer and 100 µl phage lysate stock (Φ11 or Φ85), incubated 








2.9.12 Bacteriophage transduction 
50ml of LK was inoculated with a single colony of the recipient S. aureus strain and incubated 
overnight 37 °C, 250 rpm. The overnight culture was centrifuged at RT, 3000 RCF for 10 min. The 
pellet was resuspended in 3 ml LK. 500 µl of S. aureus suspension was added to 1 ml of LK, 500 µl of 
phage lysate (from donor strain) and 10 µl of 1 M CaCl2. The mixture was incubated statically at 37 
°C for 25 min, followed by 15 min incubation at 37 °C, 250 rpm shaking. 1 ml of ice cold 0.02 M 
NaCit was added to the mixture and incubated on ice for 5 min, followed by centrifugation at 4 °C, 
3000 RCF for 10 min. The pellet was resuspended in 1 ml 0.02 M NaCit and incubated on ice for 45-
90 min, 200 µl aliquots were spread onto selective LK agar plates containing 0.05 % (w/v) sodium 
citrate and incubated at 37 °C for 24-48 hr. Colonies were picked and streaked on selective TSA 
plates to confirm resistance profile. 
 
2.9.13  Agarose gel electrophoresis 
1 % (w/v) agarose, with 0.5 µg/ml ethidium bromide in 1 x TAE buffer was prepared for separation 
of DNA samples. Prior to loading in wells of the gel, samples were mixed with 6 x DNA loading dye 
(Thermo Scientific). Gels were loaded into horizontal electrophoresis tanks (Bio-Rad) and 
submerged in 1 x TAE, samples were electrophoresed using 120 V, 400 mA for 30 – 44 min. 
Separated samples were visualised by UV transillumination at 260 nm and documented by the UVi 
Doc gel documentation system (UviTEC), GeneRuler 1 kb DNA ladder (Thermo Scientific) was used 
for approximation of size and concentration of DNA fragments.  
 
 Zebrafish procedures 
2.10.1 Zebrafish husbandary 
Adult zebrafish were housed in Home Office approved aquaria at the University of Sheffield and 
kept according to Home Office standards with a 14/10 hour light/dark cycle and maintained in a 
continuously re-circulating, closed system at 28 °C. After collection from the aquarium, eggs are 
kept in E3 with added methylene blue. Zebrafish embryos are not protected by Home Office 
regulations until < 5.2 dpf and all experiments were performed on this basis. All experiments that 
ended at < 5.2 dpf were disposed of in accordance to Home Office approved methods. 
2.10.2 Zebrafish lines 







Zebrafish line Use Origin 
London Wild Type (LWT) WT  
Nacre WT – no xanthophores  
Tg(lyz.nfsB:mCherry) SH260 mCherry labelled neutrophils (Elks et al., 2011) 
Tg(mpx:gfp)I114 GFP labelled neutrophils (Renshaw et al., 2006) 
Tg(mpeg.mCherry x 
CAAX)SH378 
Macrophage specific mCherry 
labelled membranes  
(Ellett et al., 2011) 
Tg(c-fms:gfp)SH377 GFP labelled macrophages (Dee et al., 2016) 
Figure 2.1 Zebrafish lines used in this study 
 
 
2.10.3 Zebrafish media  
2.10.3.1 E3 medium (x 10) 
NaCl   50 mM 
KCl   1.7 mM 
CaCl2   3.3 mM 
MgSO4   3.3 mM 
The 10 x E3 stock solution was diluted 1:9 with dH2O to make a 1 x working solution, and 
methylene blue was added to a final concentration of 0.00005 % (w/v) to prevent fungal growth, 
prior to autoclaving. 
2.10.3.2 Methylcellulose  
E3 was prepared (Method 2.10.3.1) and after autoclaving cooling to 70 °C, 2.75 % (w/v) 
methylcellulose was added with stirring in an ice bath to facilitate solubilisation. After the solution 
clarified it was aliquoted into 20 ml syringes and stored at -20 °C. At least  24 h prior to use 
methylcellulose was defrosted at 28.3 °C and temporarily stored at this temperature.  
 
2.10.4 Zebrafish anaesthesia 
Zebrafish embryos were anaesthetised for experimental procedures with 3-amino benzoic acid 
ester (tricaine or MS322, Sigma) stock solution of 0.4 % (w/v) in 20mM tris-HCl (pH 7) stored at 
4°C in dark conditions before diluting 1/20 to a working concentration of 0.02% (w/v) (200mg/L). 
Embryos were incubated in tricaine in E3 for at least 5 mins, covered to prevent exposure to light, 






2.10.5 Microinjection of S. aureus 
Overnight cultures of S. aureus were prepared and subcultured in 50ml TSB inoculated to OD600 = 
0.05 and incubated until the culture reached a density of OD600 = ~1. 40ml of culture was 
centrifuged at 3000 RCF at 4 °C, the supernatant discarded, and the pellet was washed twice in 
sterile PBS by centrifugation and resuspension. The final bacterial inoculum was kept on ice. 
Embryos were manually dechorionated 2 h prior to injection, 30 hpf embryos were anaesthetised 
and immobilised in 2.8 % (w/v) methylcellulose in E3. Bacterial suspension was loaded into a 
microinjection needle, made by heating and pulling glass capillary tubes (World Precision 
Instruments). The glass needle containing the inoculum was transferred to a Micromanipulator 
(WPI) and the inoculum dispensed by a pneumatic micropump (WPI, PV820). A dissection 
microscope (Leica, S6E) was used to visualise injections and 10mm/0.1mm Micrometer Scale 
(Pyser-SGI Ltd., PS1) used to calibrate the injection volume. 25-30 embryos were used per 
experimental group. After infection embryos were unmounted from methylcellulose and 
transferred to a petridish containg 25 ml E3 and incubated for 1-2 h at 28.3 °C. Embryos were then 
washed with E3 and individually transferred to wells of a 96-well plate. 
2.10.6 Determination of embryo mortality subsequent to infection 
To determine survival of embryos post infection, visual inspection of embryos was performed twice 
daily using a dissecting microscope (Leica), mortality of embryos was evidenced by cessation of 
heart beat and circulation. The number of deceased embryos at each timepoint was recorded and 
used to produce a Kaplen-Meier survival curve (Prism, GraphPad).  
2.10.7 Determination of inoculating dose 
During injection of zebrafish embryos, at the beginning and end of each group, 4 doses of the 
inoculum were injected into 1 ml of sterile PBS and incubated on ice. Subsequent to infection of 
embryos, 3 x 10 µl of the diluted dose were spotted onto TSA and dried before incubated at 37 °C 
overnight. CFU per spot were counted and average CFU used to calculate dose as follows: 
𝐷𝑜𝑠𝑒 𝐶𝐹𝑈 =
𝐴𝑣. 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 ×  100 
4
 
2.10.8 Homogenisation of embryos for determination of bacterial burden 
To determine the bacterial burden of individual embryos at any time post infection until 5.2 dpf, 
individual embryos were recovered in 200 µl of E3 and transferred to 500 µl cap tubes containing 
1.4 mm ceramic beads (Peqlab). Embryos were homogenised by PreCellys 24-dual (Peqlab) and 






2.10.9 Mounting embryos for microscopy (spinning disc/ airyscan) 
Embryos were anesthetised before immersion in 0.8 % (w/v) low melting point (LMP) agarose in 
E3 with 0.02 % (v/v) tricaine, in a glass bottom culture dish (0.08-0.012 mm thickness), (embryos 
can be briefly manipulated/aligned before LMP agarose solidifies) E3 with 0.02 % (v/v) tricaine 
was added to maintain hydration of samples during microscopy.  
 
2.10.10 Live imaging embryos by spinning disc confocal microscopy 
An UltraVIEW VoX spinning disk confocal microscope (Perkin Elmer) and Velocity (Image 
Processing and Vision Company Ltd. UK) were used for image acquisition and processing. Images 
were acquired with a 20 x air lens (Nikon) or a 40x oil dipping lens (Nikon) using a 457-514 nm 
argon laser, 561nm sapphire laser and 642nm diode laser to excite fluorophores GFP, mCherry & 
Alexa Fluor 647nm respectively.  
 
2.10.11 Mounting embryos in 0.8 % (w/v) agarose for lightsheet fluorescence 
microscopy 
E3 was made up from 10 x E3 stock with sterile milliQ water and filtered (0.02 µm pore size); the 
solution was heated in the microwave to ~ 70 °C. Approximately 10 ml was added to a Falcon tube 
(50 ml) with pre-weighed LMP agarose (0.08 g) and mixed by vortexing. The solution was heated in 
the microwave in 10 s bursts (to avoid boiling over the solution and vortexed in between) to 
dissolve LMP agarose until homogenous. The solution was transferred to a pre-heated heatblock 
and incubated at 55 °C, when the LMP agarose in E3 had cooled to a temperature below 55 °C 
tricaine was added to give a final concentration of 0.02 % (v/v). Subsequent to infection, embryos 
were transferred to E3 (without methylene blue) containing 0.02 % (v/v) tricaine. The LMP 
agarose containing 0.02 % (v/v) tricaine was added to a glass dimple dish and embryos immersed 
into the LMP agarose using a glass Pasteur pipette. Under a dissecting microscope, a 1.1 mm glass 
capillary with plunger (Zeiss) was used to gently draw the embryos in LMP agarose containing 0.02 
% (v/v) tricaine, head first into the capillary. The capillary was gently rotated as LMP agarose sets 
to keep the embryo in the centre of the capillary. Prior to imaging, once situated inside the Zeiss Z1 







2.10.12 Mounting embryos in CyGel within FEP tubing for lightsheet fluorescence 
microscopy 
To prepare 1.1 mm FEP tubing (Adtech), straightened lengths were cut to 12 cm and sequentially 
sonicated for 10 min in 50 ml Falcon tubes containing sequentially 1M NaOH, 0.5 M NaOH,  dH2O, 
70 % EtOH, dH2O and stored in dH2O. 
E3 was heated and LMP agarose was added to prepare 2 % (w/v) LMP agarose in E3, agarose was 
cooled to 55 °C and tricaine was added to give a final concentration of 0.02 % (v/v) tricaine. The 
mixture was poured into a 35 mm petridish to a depth of 2 mm and left to set.   
To prepare thermoflippable CyGel for microscopy, CygelSustain concentrate was incubated on ice 
and 180 µl transferred to a 500 µl reaction tube, 10 µl of 20 x E3 (double concentration of that used 
in Method 2.10.3.1) and 10 µl of stock tricaine solution added. Reagents were mixed by vortexing 
and incubated on ice, the glass dimple dish used for mounting embryos was also incubated on ice.  
Subsequent to infection, embryos were transferred to E3 (without methylene blue) containing 0.02 
% (v/v) tricaine. The mounting medium was transferred to the glass dimple dish and embryos were 
were transferred using a glass Pasteur pipette. A syringe with a blunt ended canula was inserted 
into the end of a length of FEP tubing, the FEP tubing was pushed into the petridish containing 2 % 
(w/v) LMP agarose E3 containing 0.02 % (v/v) tricaine and twisted. The syringe plunger was 
drawn up slightly as the FEP tubing was removed from the Petri dish so that a plug remains within 
the FEP. On the dissecting microscope, the FEP tubing was placed into the dimple dish and the 
syringe was used to draw up the embryo, tail first, in the mounting medium. Once the embryo was 
within the FEP tubing, another 2 % (w/v) LMP agarose plug was made, as before, beneath the head 
of the embryo. If a second embryo was to be mounted these steps were repeated. To release the 
canula from the tubing, a 21 gauge hypodermic needle was used to pierce holes just above the 
uppermost LMP agarose plug. Additional holes were made through the FEP tubing next to the 
agarose plugs, to allow diffusion of O2 and tricaine from the imaging chamber. FEP tubes containing 
embryos were maintained in an upright position as the temperature of CyGel Sustain increases, it 
will form a micellar gel matrix at 21 °C. 
2.10.13 Live imaging of embryos by lightsheet fluorescence microscopy 
Prior to imaging the infection chamber was fitted to the Zeiss Z1 lightsheet fluorescence 
microscope. The imaging chamber was filled with 70 % (v/v) EtOH for at least 10 min then rinsed 
with dH2O. The imaging chamber was then filled with E3 (without methylene blue) containing 0.02 
% (v/v) tricaine which had been pre-warmed to 28.3 °C and this temperature was maintained by 





The sample was placed in the sample holder and into the 360 ° imaging stage. The Zeiss Z1 
microscope uses two light paths, either side of the sample, to illuminate a plane of the sample. The 
microscope has six laser lines for excitation, 405 nm, 445 nm, 488 nm, 561 nm, and 638 nm, a 20 x 
water dipping objective is perpendicular to the illumination light path for detection of fluorescent 
signal, which is transmitted to two sCMOS cameras.The filter set for simultaneous exicitation and 
detection using multiple laser lines is listed in Table 2.4. Routinely lasers 488 nm and 561 nm were 
used for excitation of GFP and mCherry respectively. Dual-sided imaging (using both left and right 
sided illumination) with pivot scan, was always performed. To enable long term imaging, low levels 
(0.8 – 2.0 %) of laser power were used. Acquisition is controlled by Zen Black software (Zeiss) and 
allows multiview acquisition – which can be performed at any angle, time courses and z-stacks to 
be imaged.  
2.10.14 Reconstruction and analysis of lightsheet fluorescence microscopy data 
Zen Black (Zeiss) was used to process data acquired by the Zeiss Z1 lightsheet fluorescence 
microscope. For image processing black was set at 200 grey levels to elimate background signal. 
The software was used for cropping and evaluating data and reconstructing 4D data into two 
dimensional images and videos.  
ArivisVision 4D was used to reconstruct data in 3D and visualise the spatial location of S. aureus 
within embryos. These reconstructions could be followed through time and the software was also 
used to perform colocalisation analysis.  






1 SBS LP 490 SP 490 LP 505 
2 SBS LP 510 BP 460-500 BP 525-565 
3 SBS LP 560 SP 550 LP 585 
4 SBS LP 580 BP 525-565 LP 585 
5 SBS LP 640 BP 575-615 LP 660 
Table 2.4 Filter set for Zeiss Z1 







3 Developing a method for light sheet fluorescence microscopy of 
zebrafish embryos infected with S. aureus 
 Introduction 
3.1.1 A systemic model for S. aureus infection in zebrafish embryos 
Zebrafish have long been used for embryological and developmental studies, their use as a model 
organism provides an extensively characterised system which has more recently been exploited for 
vertebrate models of infection. The high capability of the zebrafish to reproduce and their small size 
(both as adults and larvae) make them suitable for high-throughput screening and the transparent 
nature of the fish makes them an excellent candidate for interrogating host-pathogen interactions 
by microscopy (Meijer and Spaink, 2011). 
Zebrafish have both adaptive immunity and well developed innate immunity (Kasahara et al., 
2004), with many toll-like receptors (TLRs).  These have high homology to TLRs in other 
vertebrates including humans (Meijer et al., 2004), importantly TLR2 which binds peptidoglycan 
and lipoproteins of S. aureus cell wall (Dziarski and Gupta, 2005; Skerrett et al., 2017; Wolf and 
Underhill, 2018), which are upregulated during viral and bacterial infection (Meijer et al., 2004).  
Additionally zebrafish possess other professional immune cells and signalling molecules; functional 
macrophages are present from 25 hours post fertilisation onwards, immature neutrophils from 18 
hpf and differentiated neutrophils are present from 30 hpf (Lieschke et al., 2001). Many key 
cytokine subfamilies are conserved between zebrafish and mammals, however there has been 
diversification and expansion of some cytokine gene families in zebrafish, including a second 
lineage of interleukin (IL)-8 which is a crucial chemoattractant of neutrophils (Kolaczkowska and 
Kubes, 2013; van der Vaart et al., 2012). 
By infecting zebrafish embryos with S. aureus, a non-native pathogen, the interaction between 
microbe and innate immunity in its entirety can be interrogated. Initial development of zebrafish 
adaptive immunity does not occur until 4 dpf and is not fully present until 4 weeks post fertilisation 
(Meijer and Spaink, 2011). The route of infection of bacteria is key to whether the host can 
withstand the infectious dose, for S. aureus the duct of Cuvier (circulation valley) is used as the site 
of injection, as if injected into the yolk sac the bacteria replicate quickly and overwhelm the host 
(Prajsnar et al., 2008). However yolk sac infection models have been used with other infections 
such as Mycobacterium marinum, and lends itself to automation, increasing throughput (Meijer and 
Spaink, 2011). By inoculating the bloodstream of the embryos, via the circulation valley, this model 
simulates how S. aureus enters mammalian blood causing bacteraemia. There are an increasing 





acting as a Trojan horse for the bacteria, which has evolved many mechanisms to evade host 
immune responses and is able to expand within the phagocyte (McVicker et al., 2014; Pollitt et al., 
2018; Prajsnar et al., 2012; Thwaites and Gant, 2011) .  
The ability of zebrafish host defences to withstand an infectious dose and in some cases control 
proliferation or clear infection when injected in the circulation valley with non-native pathogen 
allows the investigation of which components make bacteria pathogenic to an unknown host, as it 
has been demonstrated that bacteria with mutations in key virulence determinants are attenuated 
in this infection model (Prajsnar et al., 2008) 
3.1.2 Zebrafish ‘tool-kit’ 
In my study the interaction of bacteria and immune cells within the host is to be investigated. Both 
macrophages and neutrophils are able to phagocytose bacteria from the bloodstream and previous 
work has indicated that all bacteria in the circulation have been phagocytosed by 3 hpi (Prajsnar et 
al., 2012). The advent of transgenic zebrafish lines, with fluorescent proteins expressed under 
macrophage and neutrophil specific promoters, delivers the basis for intravital imaging.  
The neutrophil specific myeloperoxidase (mpx) promoter drives GFP expression in the transgenic 
line Tg(mpx:GFP)I114 (Renshaw et al., 2006) which possesses fluorescent green neutrophils. 
Another transgenic reporter line Tg(lyzC:nfsb.mCherry)SH260,which uses the neutrophil specific 
lysozyme C gene with a bacterial nitroreductase (nfsb) fusion, drives mCherry expression (Elks et 
al., 2011; Prajsnar et al., 2012) . This produces mCherry labelled neutrophils, which can be ablated 
by incubation with the drug metronidazole (usually harmless) due to the neutrophil specific 
nitroreductase, which produces a cytotoxic metabolite of metronidazole (Curado et al., 2008).  
More recently a macrophage specific promoter, mpeg1 (expressed from 20 hpf onwards) was 
identified to create the transgenic macrophage reporter line Tg(mpeg.mCherry x CAAX)SH378 (Ellett 
et al., 2011), with red fluorescent macrophages. There is no co-expression of mpx and mpeg1 so 
neutrophils and macrophages are labelled independently of each other in these two lines (Ellett et 
al., 2011). The gene c-fms, encoding a receptor for macrophage colony stimulating factor (M-CSF) 
(Ward and Lieschke) has been used to drive expression of GFP to provide an alternative 
macrophage specific fluorescence reporter (Dee et al., 2016). 
As a model organism, the genome of the zebrafish has been well characterised and before the tools 
existed for efficient targeted mutagenesis such as CRISPR/cas systems, morpholino (MO) antisense 
oligomers were used as a method of gene knockdown in the zebrafish system (as well as other 
model organisms such as Xenopus and chick) and these remain effective tools for gene knockdown 
of  essential genes in the female germ line (Stainier et al., 2017). Injected at the single cell stage, the 





the genetic sequence itself)(Timme-Laragy et al., 2012); morphant embryos can be used to help 
characterise the role of aspects of the host immune response when infected with S. aureus (Prajsnar 
et al., 2012). 
3.1.3 Light sheet fluorescence microscopy 
Prior to the invention of light sheet fluorescence microscopy (LSFM), imaging relatively large 
biological samples stained with, or expressing fluorophores was reliant on confocal and two-photon 
microscopy, both of which have a reasonable resolution and penetration of the sample. A confocal 
microscope discriminates against out-of-focus light by pinholing the detecting objective, increasing 
resolution in comparison with wide-field fluorescence microscopy. A limitation of this microscopic 
technique is that the increase in resolution gained by pinholing comes at the cost of decreased 
signal intensity, so exposure times have to be increased and are relatively long (Reynaud et al., 
2008a). In addition to long exposure times, whilst very little out-of-focus light from outside of the 
focal plane is detected, the entire specimen is illuminated regardless of the depth of image that is 
acquired, so the damaging effects of the lasers (photo-toxicity and photo-bleaching) will affect the 
whole sample. 
Further development of this technique by Stelzer and Lindek involved placing the detection 
objective at an angle (θ) to the illumination objective, reducing the amount of out-of-focus light to 
be discriminated against by the detection objective, and has been termed theta confocal 
microscopy. By reducing the amount of out-of-focus light, less light is needed for excitation of the 
fluorophores, reducing photo-toxicity and photo-bleaching. Like other confocal techniques this still 
relies on scanning across the region of interest with a laser and building up a stack of two-
dimensional images (optical sectioning).  
It was the further research into the theta principle, by Huisken and co-workers, using illumination 
orthogonal to detection, termed ‘Selective planar illumination microscopy’ (SPIM) that became the 
basis for LSFM (Huisken et al., 2004). The principle of SPIM is that focusing the excitation light 
using a cylindrical lens, produces a sheet of light that only illuminates the sample at the focal point; 
there is no out-of-focus light that reaches the perpendicular detection objective. By only exciting 
the plane being imaged, the amount of fluorophore excitations the entire sample receives as a 3D 
image is acquired is greatly reduced, as lasers are not bleaching fluorophores that are not 
simultaneously being imaged. As well as reducing photo-bleaching this reduces photo-toxicity and 
is therefore gentler on a living sample, both factors allow for repeated imaging over time. This 
improvement in photo-toxicity and photo-bleaching is essentially ratiometric to the size of the 
sample, the more z-slices acquired, the better the improvement in comparison to confocal 
microscopes for the same sample (Reynaud et al., 2008a). Resolution of SPIM is, like other 





numerical aperture (NA) of the detection objective and the wavelength of detected light: this is 
known as the abbe limit (Heintzmann and Ficz, 2006). 
Another advantage of the Zeiss Z1 microscope, developed from research output from Huisken’s lab 
(Huisken et al., 2004; Selchow and Huisken, 2013) is that there is 360° rotation of the sample 
within the imaging chamber. As axial resolution (through the Z-stack) is always the lowest in 
comparison with x and y  (acquired in the 2D image)(Reynaud et al., 2008b) the ability to rotate the 
sample and image the same area in another orientation, without worrying about photo-bleaching or 
photo-toxic effects, is incredibly powerful. The SPIM community have developed tools for image 
registration, fusing multiple angles to improve the resolution of the 3D reconstruction of the 
sample, being able to rotate a sample and image from another angle is especially useful in 
specimens which produce a high scatter (Pitrone et al., 2013). 
The major caveat to this technique is the volume of data generated, orders of magnitude bigger 
than data generated by confocal microscopy. Typical experiments, imaging multiple fluorophores 
over time, generate files that are terabytes in size, which are streamed from the microscope to a 
computer during acquisition. The size of these files far exceeds available computer memory, 
because of this, it is challenging just to look at the data, before processing it (Reynaud et al., 2014a).  
Files of this size need to be stored on a redundant array of independent disks (RAID) and ideally 
network cables between acquisition computers, storage, and processing computers should have 10 
Gbit capacity to enable the transfer of such large files. Processing this data can not be done on the 
computers available to most biologists - the best way to handle such data sets is by using parallel 
computing with powerful cluster computers. Some researchers minimise the size of the data set by 
deleting empty slices instantly and compressing black pixels (Eliceiri et al., 2012). More drastically, 
in some laboratories with the capacity to perform in-line processing, raw data is not stored at all, a 
risky strategy when using novel in-house software in a nascent technology, but it is often cheaper to 
repeat the experiment than store the bulky raw files. However, this is an ethically a grey area, as 
many journals and or funding bodies require that data is stored for a certain period of time; in 
Germany it is a legal requirement that raw data is stored for 10 years (Reynaud et al., 2014a). If 
requested by peers, it is unlikely that this processed data could be scrutinised or reconstructed by 
other techniques. 
 With many of the SPIM community using self-built microscopes and software, nearly all have 
individual file formats, and processing pipeline. There is a strong open source community for SPIM 
(Pitrone et al., 2013), sharing tools for reconstruction and analysis, however these are the products 
of applied computer science research, to use these tools biologists must learn programming 
languages (Reynaud et al., 2014a). Some plugins have been developed for FIJI, for the fusion of 





(Schindelin et al., 2012). Whilst there are now commercially available light sheet microscopes, 
producing file formats that can be more readily shared between collaborators and the research 
community, there is a gap in standardised, commercial software that can handle the large files 
produced by light sheet microscopy. Perhaps the breadth of applications means that there is no 
‘one-size fits all’ method for reconstruction and analysis (Reynaud et al., 2014b). 
This microscopic technique was developed in an institute alongside developmental biologists 
(Huisken et al., 2004), as a result of this the Zeiss Z1 microscope has been optimised for imaging 
Medake (Oryzias latipes) and zebrafish, well used model organisms for developmental biology. 
The sample is mounted and suspended in a chamber of medium, in the case of zebrafish this is E3 
which is a very low concentration salt solution, meant to mimic the river-water native to zebrafish. 
The chamber also houses a Peltier unit, which allows incubation of the living sample at the correct 
temperature for development (Huisken et al., 2004; Selchow and Huisken, 2013), these conditions 
theoretically provide a physiologically relevant environment to follow the dynamics of S. aureus 
infection of a zebrafish host and should be representative of the established infection model. 
 Chapter aims 
 To develop a mounting method and acquisition parameters that allow for long term imaging 
of zebrafish embryos infected with S. aureus, by a light sheet fluorescence microscope. 
 To identify a means of reconstruction and analysis of the large data generated by this 







3.3.1 Existing systemic infection model 
The unique, systemic zebrafish model for systemic S. aureus infection, as described by Prajsnar et 
al., 2008 has been developed in Sheffield and has been previously used to identify bacterial 
components required for successful infection of the host. An S. aureus inoculum is administered via 
the circulation valley to embryos 30 hpf (Figure 3.1); survival of infected embryos is monitored up 
until 92 hpf. 
Survival of infected embryos is dose dependent, Figure 3.2 shows that percentage survival of 
embryos decreases with increased dose of S. aureus. Infection with doses of 1500, 3855 and 8275 
CFU resulting in 53 %, 23 % and 6 % survival at 92 hpi, respectively. 
 Constitutive fluorescent strains 
Imaging S. aureus within the host requires brightly labelled fluorescent bacteria as dynamic 
imaging relies upon quick acquisition with low exposure times. Previously strains with GFP or 
mCherry encoded on a plasmid have been used (Serba, 2015) but more recently strains have been 
created with fluorescence encoded on the chromosome (Pollitt et al., 2018). This is better suited to 
long term imaging experiments as there is no risk that without antibiotic selection the bacteria will 
lose the plasmid encoding the fluorophore, so all bacteria within the host will be visualised at any 
stage during infection within the host. 
 The stable fusion strains have single copy genes encoding mCherry or GFP on the chromosome, 
integrated at the lipase locus using the backbone of pGM074 (Bottomley et al., 2014) a derivative of 
pKasBar (Wacnik, K., 2016) with either mCherry or GFP under the control of the pMal1 promoter 
(Nieto and Espinosa, 2003), from the plasmid pMV158-mCherry (S. Mesnage unpublished) which 
drives constitutive expression in S. aureus. 
 The fusion strains were constructed in four different strain backgrounds, with isogenic GFP and 
mCherry made in all backgrounds (Pollitt et al., 2018). The GFP strains have Kan as a selective 
marker and Tet was used as the marker for mCherry strains; however when recovered from mouse 
organs the mCherry strains showed affected tetracycline resistance, so were supplemented with an 
erythromycin resistance encoding cassette from strain SJF3673 (lysA::ery, lysA+) (Pollitt et al., 
2018) 
To characterise the strain, growth curves were carried out with SH1000-GFP strain in comparison 








Figure 3.1 Zebrafish embryo 30 hpf 
Micrograph of embryo acquired under dissecting mictoscope at 30 hpf. The site of infection, duct of 





Figure 3.2 Survival of LWT embryos infected with SH1000 S. aureus. 
LWT embryos were injected with different doses of SH1000: 1500CFU (n=30), 3855 CFU (n=31) & 
8725 CFU (n=32). Survival at 92h was 50%, 23% & 6% respectively, percentage survival between 















It is important that these fluorescent strains do not have altered pathogenicity when compared to 
their WT parents, so that the dynamics of infection when imaged are the same as previously 
published survival experiments. LWT embryos were infected via the circulation valley, 30 hpf with 
strains SH1000-GFP (SJF4618), SH1000-mCherry (SJF4631) and SH1000 WT (SJF861) and survival 
monitored for four days post infection. Results of this experiment (Figure 3.4) show no significant 
difference (P=0.658) in the survival rate of either SH1000-GFP or SH1000-mCherry in comparison 
to WT. With survival between 45-60 % for a dose of ~1500 CFU the infection dynamics are 
comparable to those previously observed (Prajsnar et al., 2008) therefore the addition of the 
fluorescence reporter does not affect pathogenicity of the bacteria in this systemic infection model, 
making them excellent candidates for long-term imaging of infection progression. 
 Bacterial growth kinetics of SH1000-mCherry in vivo 
In order to confirm that the chromosomally encoded constitutive reporter strains replicate as per 
their WT parents in vivo, analysis of bacterial growth kinetics during infection was performed. As 
both the mCherry and GFP fluorescent protein reporters have similar virulence to WT (Figure 3.4), 
only bacterial kinetics of SH1000-mCherry in vivo was analysed. Embryos were infected 30 hpf with 
SH1000-mCherry ~1500 CFU. At regular timepoints five alive embryos and all dead embryos were 
collected, and homogenised, serial dilutions of samples were made and plated out for CFU 
enumeration (Figure 3.5a).  After 26 hpi there is a divergence in host outcome which is concurrent 
with a difference in bacterial number recovered. Embryos that succumb to infection have between 
~1.3 x105 - ~1 x107 CFU, in comparison to those that control infection where ~2x 103 CFU (the 
initial inoculum) or fewer bacteria are recovered per embryo, as the host clears infection. This 
matches previously observed S. aureus infection dynamics (Prajsnar et al., 2012) where there is an 
apparent ‘population bottleneck’ and bacterial expansion only occurs from a small number of the 
initial inoculum. The coinciding survival rate for this experiment is 25 % (Figure 3.5b). Whilst low 
for the dose of 2160 CFU, a proportion of the embryos that were collected alive at early timepoints 
of the experiment may have survived to the end, which would have increased the overall survival.  
As expected, SH1000-mCherry bacterial dynamics correspond with published SH1000 dynamics; 
this further confirms that the constitutive reporters are suitable for long term, real-time imaging of 









Figure 3.3 Comparison of growth of fluorescent reporter strains with WT parents 
Growth of bacteria in liquid media was measured at regular timepoints by spectrophotometry 
(OD600 nm). A) growth of SH1000-GFP vs SH1000 B) growth of JE2-mCherry vs JE2 
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Figure 3.4 Survival of LWT embryos infected with SH1000 WT, SH1000-GFP & SH1000-
mCherry 
LWT embryos were infected with the chromosomally integrated, constitutively fluorescent, 
isogenic SH1000-GFP & SH1000-mCherry in comparison to SH1000 WT parental strain. Survival at 
92 hpi was 55, 60 & 48 % respectively, there is NS difference in survival between SH1000-GFP and 








Figure 3.5 Bacterial growth kinetics of SH1000-mCherry in the LWT zebrafish host 
A) Growth of S. aureus within LWT embryos. Zebrafish embryos were infected at 30 hpi with the 
strain SH1000-mCherry and at each timepoint 5 live and all dead embryos were collected and CFU 








 Standard mounting of embryos for LSFM 
The standard mounting protocol for zebrafish embryos for the Zeiss Z1 light sheet is to embed the 
sample in 0.8 % (w/v) LMP agarose in E3 with 0.02 % (v/v) tricaine, using a proprietary capillary 
with a plunger. Anesthetised embryos are transferred to 0.8 % (w/v) LMP agarose and drawn into 
the capillary, head first, via suction by pulling the plunger. Gentle rotation of the capillary whilst the 
agarose is setting keeps the embryo centred in the medium. When the agarose is set the capillary is 
put into the sample holder which is subsequently placed into the microscope. The plunger is 
depressed, ejecting the agarose into the imaging chamber containing E3. 
 Acquisition zoom/multiple fields of view 
The detection lens on the Zeiss Z1 light sheet in the Wolfson Light Microscopy Facility (WLMF) is a 
20 x water objective, with a numerical aperture (NA) of 1.0, which defines the limit of resolution 
(available 40x objective also has an NA =1.0 so would not increase resolution and only reduce the 
size of the ROI). Since the limit of detection of the Z1 is diffraction limited, the theoretical best 
resolution achieved is 254 nm, half the emission wavelength for GFP. The size of S. aureus is 
approximately 1 µm, so light sheet microscopy has the ability to resolve individual bacteria within 
the host, and theoretically to be able to differentiate between two bacteria. The objective has a 2x 
optical zoom, whilst this does not improve the resolution of the image, it designates the same 
number of pixels to an area half the size, giving the image more ‘definition’ with the ability to 
capture multiple ROI that can be ‘stitched’ together. 
Figure 3.6 of a Tg(lyzC.nfsb:mCherry)SH260 infected with SH1000-GFP shows the same mCherry 
neutrophil containing GFP labelled bacteria A) imaged with 1x optical zoom, 20x objective, B) 
imaged with 2  x optical zoom 20 x objective (equivalent to 40 x) and C) imaged with 1 x optical 
zoom, 20 x objective with 2 x digital zoom after acquisition. Whilst there is more detail in the 
picture generated by the 20 x with 2 x zoom, there is no difference in the ability to see individual 
bacteria within the phagocyte. By comparison of Figure 3.6B and Figure 3.6C it is apparent that the 
digital zoom produces a less sharp image. Whilst reconstruction of data generated with the 2 x 
zoom will be higher quality, it would take twice as long to image the same volume and the data 
produced would double in size, making it more difficult to handle, so lower magnifications were 








Figure 3.6 Comparison of 20 x magnification with 40 x magnification 
Single slice, 1 µm of Tg(lyz.nfsb:mCherry)SH260 embryos with mCherry neutrophils, infected with 
SH1000-GFP, the same neutrophil was imaged consecutively with different magnifications acquired 
with A) 20 x (20 x objective, 1 x optical zoom) B) 40 x (20 x objective, 2 x optical zoom) C) 20 x (20 
x objective, 2 x digital zoom post acquisition) 
  
A    20 µm 
B    20 µm 





 Simultaneous excitation and detection of fluorophores 
Whilst trying to capture dynamic processes within a microscope, the speed of acquisition is 
paramount. As the model for S. aureus infection is systemic, the circulation valley is the ROI, and by 
its very nature there is movement of both host cells and bacteria by the circulation of blood, so 
optimising acquisition time is important. GFP & mCherry are the two fluorophores most widely 
used in the creation transgenic zebrafish lines with fluorescently labelled host cells and are also the 
fluorophores that have had the most success with their use in S. aureus strains. These fluorophores 
have a slight overlap in their emission and excitation spectra, shown in Figure 3.7, 575nm is the 
wavelength at which relative intensity switches over, from stronger GFP emission to mCherry. The 
quickest way to acquire data is by exciting and detecting both fluorophores at the same time, but 
this leaves potential for bleed-through (when the emission of one fluorophore is detected in the 
channel for the second fluorophore). Filter blocks enable this simultaneous excitation and detection 
of both fluorophores without overlap between channels. Filter blocks within the microscope 
combine three types of filter: excitation (to filter the light from the laser to the sample), barrier (to 
filter light from the sample to the detector) and dichroic beamsplitters (these direct the selected 
excitation wavelengths from the objective to the sample, wavelengths shorter than the designated 
wavelength reach the sample, longer wavelengths reach the barrier filter). Excitation filters are 
either short pass (SP) letting wavelengths lower than the ‘cut-off’ pass and blocking longer 
wavelengths, long pass (LP) blocking lower wavelengths and letting higher wavelengths pass or 
band pass (BP) which let a range of wavelengths through, blocking light shorter than the lower cut 
off and higher than the higher cut off. 
3.5.1 Single track imaging 
By using a single ‘track’ in Zen to image, both fluorophores are excited and detected simultaneously, 
the beam splitter and filter used to do this is shown in  
Table 3.1. Whilst this filter set should allow for simultaneous imaging of GFP and mCherry, often 
there is bleed through between channels when setting up image acquisition; this is potentially due 
to a software error, as it does not always occur when repeating the same experiment. To prevent 
the occurrence of bleedthrough the same filter is used but with the two laser lines on separate 
imaging ‘tracks’. Unfortunately, this increases imaging time, but the lasers can be switched with 







Figure 3.7 Excitation and Emission spectra for EGFP and mCherry 
Excitation and emission spectra for EGFP and mCherry (ThermoFisher Fluorescence 
SpectraViewer), overlap in emission spectra is at 565 - 630 nm. Higher relative intensity at 
specified wavelengths switches from EGFP to mCherry at 575 nm, with 10 % relative intensity. 
 
 
 Beam splitter 1st filter 2nd filter 
Filter initially used SBS LP560 SP 550 nm LP 580 nm 
New filter SBS LP580 BP 525-565 nm LP 585 nm 
 
Table 3.1 Filter sets used for imaging GFP and mCherry 
Filter sets with short pass (SP), long pass (LP) and band pass (BP), both should discriminate 







3.5.2 Single track imaging with a new filter set 
During this study a new filter set for the Zeiss Z1 light sheet was acquired that includes a filter 
which has a dichromatic beamsplitter at 580 nm; this prevents the bleed-through previously 
experienced when trying to image GFP & mCherry on the same track, speeding up image 
acquisition. By simultaneously exciting and imaging both fluorophores, there is a reduction in 
temporal difference of sample physiology, increasing the precision of the localisation of 
fluorophores relative to each other. Additional ROI can be acquired for the same timepoint.  
 This filter provides the opportunity to image an additional far red fluorophore whilst only using 
two imaging ‘tracks’ without switching lasers as the excitation and emission spectra of GFP and far 
red does not have any overlap. 
 Frequency of acquisition 
LSFM has been developed with the purpose of long-term imaging of live samples, for up to days at a 
time; it is possible to obtain 500-700 slices, with two fluorescence channels in ~2 minutes. Initially 
whilst trying to image the interaction of S. aureus within the host, capturing a timepoint of the ROI 
as fast as the microscope will allow, embryos were dying within the microscope. Laser levels were 
reduced from ~3-4 % to ~1-2 % laser power for 488 nm laser (excitation of GFP) and from ~6 % to 
~2-3 % laser power for 561 nm laser (excitation of mCherry) to reduce the phototoxicity of the 
sample; however embryos with a low bacterial burden were still dying during imaging.  
When imaging was reduced from as frequently as possible (~2 minutes) to every 5 minutes 
embryos still didn’t survive overnight imaging. The incubation time between timepoints was 
increased to 20 minutes, which is less than the amount of time it takes S. aureus to replicate. After 
this reduction in imaging frequency embryos were able to withstand overnight imaging. 
 Infectious dose that goes on to form a lesion 
As only 50 % of infected embryos succumb to infection when injected with a dose of 1500 CFU, the 
infectious dose was increased to 2000 CFU to increase the probability of the embryo selected for 
long-term imaging to succumb to infection. Whilst higher doses than this will increase the mortality 
of the embryos, Prajsnar and co-workers demonstrated that these higher doses do not result in 
lesion formation, but overwhelm the host immune response, resulting in embryos with ‘cloudy’ 
circulation valleys (Prajsnar et al., 2012). Furthermore, when the infectious dose is increased there 
is a loss of clonality, suggesting that bacteria do not pass through a ‘immune bottleneck’ but expand 






 Acquisition field/ rotation to improve imaging quality 
Initial samples were imaged laterally, exemplified in Figure 3.8A, with autofluorescence from the 
yolk sac providing a spatial point of reference within the embryo; this lateral angle is the same 
orientation used for imaging on the Perkin Elmer spinning disk. Imaging the sample in this 
orientation is usually 600-700 slices 1µm in thickness. The deeper into the z-stack the more scatter 
there is of signal from the sample to the perpendicular detection camera, decreasing the focus of 
the light, producing a more blurred image. In addition to this, a large proportion of the ROI is taken 
up by space occupied by the yolk. By rotating the sample and imaging the embryo ventrally as 
shown in Figure 3.8C, with the first slices above the skin over the circulation valley, directly over 
the yolk, the number of slices in the stack is reduced. Therefore, shortening the light path and 
reducing the amount of tissue between slice and detection camera consequently improving the 
focus of the light detected from the sample. Not only is there improved focus, but the reduced 
thickness of the stack to ~200 slices 1µm in thickness reduces the amount of data produced making 
processing easier. This orientation also increases the amount of ‘useful’ data in each slice compared 
with the slices from the lateral plane, where the yolk occupies a large area of each slice. By imaging 
in this orientation there is a reduction in exposure time of the lasers to sample, concurrently 
further reducing photo-toxicity to the sample. 
 Mounting multiple embyros in 0.8 % (w/v) LMP agarose 
As only 50 % of embryos infected with 1500 CFU succumb to infection, mounting multiple embryos 
within the lightsheet, during the same experiment, increases the likelihood of successfully imaging 
infection progression. Embryos do not need to be mounted in the same orientation, as the 
microscope has 360° rotation; however the two embryos need to be mounted within ~5 mm of 
each other to be able to image both samples. Whilst it is possible to mount two embryos with the 
0.8 % (w/v) agarose, multiple attempts at long term imaging, resulted in loss of the lower embryo 
into the infection chamber, as the agarose in between the two embryos breaks, possibly due to the 
rotation and movement in Y axis. To image multiple embryos during the same experiment an 













Figure 3.8 Imaging orientation of embryos 
Orientation of embryos during image acquisition A) MaxIP of Tg(lyz.nsfb:mCherry)SH260 embryo 
infected with SH1000-GFP imaged laterally B) lateral orientation of an embryo 30 hpf, circulation 
valley indicated by blue arrow C) MaxIP of LWT infected with SH1000-GFP and SH1000-mCherry 
imaged ventrally D) ventral orientation of embryo 30 hpf, circulation valley circled in purpe. B) and 











 FEP tubing 
Whilst the 0.8 % (w/v) LMP agarose mounting method widely adopted for use with the Zeiss Z1 
light sheet microscope provides a medium which gives both high imaging quality and good 
immobilisation of the sample, this concentration of agarose doe not allow for normal development 
of the zebrafish embryos. Ideally there should be normal development of the embryos during 
imaging, enabling infection progression comparable to the existing model of infection. A mounting 
method that enables adequate immobilisation but is simultaneously gentle on the embryo and does 
not constrain the sample and slow development is needed. 
A method using fluorinated ethylene propylene (FEP) tubing to mount embryos has been published 
(Kaufmann et al., 2012). FEP tubing is most commonly used in HPLC machines, but it is well suited 
as a vessel for mounting zebrafish as it has a refractive index that is the same as water (1.338) so 
should not disrupt the light path from the sample to the detection camera.  
3.10.1 Tubing diameter 
FEP tubing is available in many sizes so two sizes of tubing with the same outer diameter of two 
sizes of the glass capillaries used for embedding in 0.8 % (w/v) agarose were tested (as these will 
fit perfectly into the sample holder without the need for adaptation), with an outer diameters (OD) 
of 1.1 mm and 1.9 mm. Both sizes of tubing had a wall thickness of 0.3 mm, as opposed to 0.5 mm in 
published methods, to further reduce any scatter of light from the sample. These were tested with 
E3 0.1 % (w/v) LMP agarose, tricaine 0.02 % (w/v), with a plug of 2 % (w/v) LMP agarose to 
contain the medium, as per Weber and collegues (Weber et al., 2014). The agarose allows for 
diffusion of oxygen and tricaine from media in the imaging chamber. 
FEP tubing is prepped by sonicating for 10 minutes sequentially in 1M NaOH, 0.5NaOH, ddH2O, 70 
% (v/v) EtOH, ddH2O. 
12 cm of FEP tubing is pushed onto the end of a pipette tip and 3 % (w/v) methylcellulose in E3 is 
drawn through and rinsed with ddH2O, this is to prevent the young embryos sticking to the walls of 
the FEP tubing. Anesthetised embryos in 0.1 %  (w/v) LMP agarose are drawn into the tubing, 
whilst maintaining suction, the end of the FEP tube is pushed into a petri dish with a 2 mm layer of 
2 % (w/v) LMP agarose and twisted to form a plug at the end of tube, depicted in Figure 3.9A. To 
test the viability of this method, mounted embryos are incubated in 40 ml E3 with 0.02 % (v/v) 
tricaine in a 50 ml centrifuge tube for 24 h. Mounted embryos were imaged immediately after 
mounting and after 24 h incubation using Apex Minigrab on the Leica dissecting microscope, using 
a graticule for scale as shown in Figure 3.10 and Figure 3.11. Embryos moved position during 
incubation in most of the FEP tubes, embryos mounted in the wider (1.9 mm OD) tubing moved 





mounted in whereas embryos mounted in 1.1 mm inner diameter tubing moved mainly downwards 
towards the plug at the bottom of the tube. 
3.10.2 Multilayer mounting of embryos in FEP tubing 
Embryos mounted in a medium within FEP tubing have a structured casing, enabling the 
concurrent mounting of two embryos, (depicted in Figure 3.9B) without the loss of an embryo into 
the chamber as occurs when multiple embryos are mounted within 0.8% (w/v) agarose. This 
method is based upon work published by Kaufmann and collegues, increasing the number of 
embryos that can be imaged during an experiment (Kaufmann et al., 2012). 
3.10.3 Diffusion holes 
Uninfected, anesthetised embryos mounted in FEP tubing were dying whilst incubated. The 
published methods (Kaufmann et al., 2012; Weber et al., 2014) used as the basis in this study, claim 
to have normal development: it follows that the embryos should not die whilst mounted. There is 
reportedly sufficient diffusion of oxygen and tricaine through the agarose plugs from the 
surrounding E3; however to rule low concentrations of these out, four holes in a ‘sieve like’ manner 
were added to the FEP tubing, using a 21G hypodermic needle, in the area of the middle and top 2 
% (w/v) agarose plugs (depicted in Figure 3.9C, D & E) in order to increase diffusion into the 








Figure 3.9 Schematic to illustrate different FEP mounting arrangements 
A) FEP tubing with 2 % (w/v) LMP agarose plug B) multilayer mounting of two embryos 
in FEP tubing with 2 % (w/v) LMP agarose plug as per published method (Kauffman et 
al.,2012; Weber et al., 2014) C) addition of ‘diffusion’ holes in FEP tubing to area by 
middle 2 % (w/v) LMP agarose plug D) single embryo mounted in CyGel within FEP 
tubing with additional 2 % (w/v) agarose plug above embryo E) multilayer mounting of 
embryos within CyGel in FEP tubing, diffusion holes in middle and top 2 % (w/v) LMP 
agarose plugs 










3.10.4 LMP agarose concentration 
During repeated attempts at replicating the published method of mounting in FEP tubing in 0.1 % 
(w/v) LMP agarose, embryos always fell downwards towards the plug during incubation, 
suggesting that 0.1 % (w/v) LMP agarose did not give adequate immobilisation of the sample. Two 
alternative brands of LMP agarose were tested (Pierce and ThermoFisher) and embryos moved 
whilst mounted in these also. When left at room temperature, 0.1 % (w/v) LMP agarose inside a 1.5 
ml centrifuge tube would set slightly over 48 hr but would lose any form when moved gently. When 
incubated at 28.3 °c the 0.1 % (w/v) LMP agarose does not set and remains the consistency of 
water.  
After contacting authors to ascertain nuances in the published method were not being omitted and 
the method was being reconstructed correctly, no discrepancies were found. Following this, 
increasing concentrations of LMP agarose inside the FEP tubing were tested: 0.15% (w/v), 0.20% 
(w/v), 0.25% (w/v), 0.3% (w/v), 0.4% (w/v). Only the highest concentration, 0.4 % (w/v) LMP 
agarose immobilised the embryo. 
Whilst the low LMP agarose concentrations do not immobilise the embryos, it also proved difficult 
to get the embryos to rest, head first, onto the agarose plug in the short time frame needed between 
infecting embryos and imaging.  
NB After contacting the authors (Kaufmann et al., 2012; Weber et al., 2014) it transpired that the 
step of coating the inside of FEP tubing with 3 % (w/v) methylcellulose E3, is to prevent embryos 
from sticking to the walls of the FEP tubing. Since embryos are being imaged directly after infection, 
mounted in methylcellulose (as described in method 2.10.5), this step was subsequently omitted, as 
the embryos themselves are coated in methylcellulose.  
3.10.5 Imaging embryos mounted in 0.4 % (w/v) LMP agarose within FEP tubing 
 Tg(mpx:GFP)i114  embryos were infected 30 hpf with SH1000-mCherry immediately after embryos 
were washed in E3 (without methyl blue) and mounted as previously described within FEP tubing, 
as per schematic Figure 3.9D, in 0.4 % (w/v) LMP agarose, head downwards with a 2 % (w/v) LMP 
agarose plug.  
When setting up image acquisition using this mounting method, the image is less focused in 
comparison with 0.8 % (w/v) LMP agarose mounting. Automated and manual adjustment of light 
sheet thickness could not compensate for this, likely caused by an increase in scatter from the 
combination of FEP with 0.4 % (w/v) LMP agarose. Figure 3.12 shows individual z slices acquired 





and detection lens) individual bacteria within neutrophil (highlighted in blue) are 
indistinguishable. The focus of signal from the sample decreases as the depth of image acquisition 
increases, Figure 3.12B is from halfway through the  z-stack, (45/100) and focus on neutrophils is 
poor. This combination of 0.4 % (w/v) LMP agarose within FEP tubing is not a suitable alternative 
to 0.8 % (w/v) LMP agarose mounting method as the required depth of focus for this study cannot 
be achieved. 
 Cygel thermo-flippable immobilisation medium 
Cygel is a novel thermo-flippable compound that has a micellular formula, a gel developed as an 
immobilisation medium, an alternative to LMP agarose. Unlike most gelling reagents (such as 
agarose) commonly used whilst maintaining living cells, instead of heating a solution to liquify, 
which then cools to a semi-solid state, Cygel is liquid when cold and starts to gel when heated. The 
flipping point from liquid to solid is 21 °C, and as such would be a suitable matrix for immobilising 
an embryo incubated at 28.3 °C. Another benefit is that the solution is thermo-reversible, so can be 
cooled down to recover the sample without damage; whilst possible to recover an embryo from 
LMP agarose it is very difficult to do so without damaging it. The ability to remount embryos 
previously imaged, enables imaging of multiple embryos at multiple timepoints during the 
experiment, which could be incubated in normal conditions. Previous methods used by researchers 
(Serba, 2015) have involved leaving the samples mounted in an incubator between timepoints; not 
only does this have limited success when re-imaging (there is often movement of the original 
sample) but these embryos are constrained by relatively high percentages of agarose and do not 
develop normally. 
Cygel has the same refractive index as water, so should not affect the focus of the light sheet and its 
micellular chemistry should not produce scatter of the light from the sample.  The reagent comes 
readymade and can be mixed with buffers to provide the correct physiological environment for the 
sample; it needs to remain at concentrations of 80 % (v/v) and above for it to be able to gel, whilst 
it needs to immobilise the sample, a softer matrix to allow normal development is preferable.  
To achieve the same salinity as 1 x E3, when in solution with Cygel and tricaine (but maintain a 
Cygel concentration of 80 % (v/v)) a 20 x E3 solution was made and different concentrations of 
Cygel were tested (Table 3.2), as molarity of the solution affects the flipping point. The lower 
concentrations of Cygel have a softer consistency, as expected; however when at a concentration of 
75 % (v/v) there is no gelling of the formula at 28 °C. Although the flipping temperature is 23 °C 
there was thickening of the solutions at around RT, so for mounting experiments the solutions were 





For each concentration apart from the non-gelling 75 % (v/v), 2 FEP tubes were prepared, each 
with two embryos mounted; these were incubated in 50ml reaction tubes, containing 40 ml E3 with 
0.02 % (w/v) tricaine. Initially incubation was for 20 h and survival was monitored; after 26 h E3 in 
the reaction tubes was changed and fresh tricaine added in case of the anaesthetic wearing off.  
Since the compound has the consistency of water when at 4 °C, by mounting the embryos in cooled 
medium, it was possible to draw the embryo into the FEP tubing. Vertical incubation, briefly on ice, 
allowed the head of the embryo to fall onto the agarose plug, shown in Figure 3.13 . As the sample 
moves quickly through the thin mounting medium and it thickens as it reaches temperatures above 
21 °C, the embryo is sufficiently immobilised when incubated at 28 °C within the imaging chamber 


















n = 8 
Embryo 
survival 
44 h (%) 
n =8 
75 150 10 10 30  - - 
80 160 10 10 20  100 100 
85 170 10 10 10  100 75 
90 190 10 10 0  100 100 












Figure 3.10 Images of embryos mounted in 0.1 % (w/v) LMP agarose within FEP tubing 
with OD 1.1 mm 
Embryos (30 hpf) were mounted in 0.1 % (w/v) LMP agarose within FEP tubing with an OD of 
1.1 mm, images 1A and 2A were taken directly after mounting. Images 1B and 2B (of the same 
two embryos), were taken after 24 h incubation of mounted embryos in E3 containing 0.04 % 
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Figure 3.11 Images of embryos of mounted in 0.1 % (w/v) LMP agarose   within FEP tubing   
with OD of 1.6 mm 
Embryos (30 hpf) were mounted in 0.1 % (w/v) LMP agarose within FEP tubing with an OD of 1.6 
mm, images 1A and 2A were taken directly after mounting. Images 1B and 2B (of the same two 
embryos), were taken after 24 h incubation of mounted embryos in E3 containing 0.04 % (w/v) 














Figure 3.12 Imaging embryos in 0.4 % (w/v) LMP agarose within FEP tubing 
Tg(mpx:GFP)I114 embryo infected with SH1000-mCherry, 1 hpi mounted in 0.4 % (w/v) LMP 
agarose within FEP tubing acquired with 20 x objective with 2 x optical zoom A) single slice (1 µm) 
from the top of the z stack (98/100), neutrophil (GFP) with intracellular bacteria (mCherry) circled 










Figure 3.13 Embryo resting on LMP agarose plug 
A Tg(lyzC.nsfb:mCherry)SH260 embryo 30 minutes post infection, mounted in CyGel, head 
downwards resting on 2 % (w/v)LMP agarose plug within FEP tubing. Blue arrow indicates top 








Keeping embryos anesthetised during imaging is vital, not only so that the region of interest 
remains static, but also if the tricaine wears off whilst the embryo is mounted, it will cause stress 
and damage to the embryo. Long term exposure to tricaine has been implicated in slowing down 
the development of embryos and causing oedemas (Kaufmann et al., 2012). During light sheet 
experiments the sample is normally exposed to the same concentration of tricaine used to 
anesthetise before infection: stock solution is 0.4 % (w/v) before diluting 1/20 to a working 
concentration of 0.02 % (w/v) (200 mg/L).  
If oedemas develop during the experiment, areas of the circulation are moved out of the ROI, 
beyond the imaging stack. Additional ‘empty’ planes in the z dimension are set up at the beginning 
of acquisition to allow for development of the embryo; however oedemas can double the z stack so 
important events can be missed. 
Embryos with a low bacterial burden and oedemas have been recovered from the light sheet post 
imaging, as shown in Figure 3.14 in which an unmounted Tg(mpx:GFP)I114 embryo was examined by 
dissecting microscope after 18 h imaging. Figure 3.14A shows the oedema the fish has developed 
whilst mounted in the microscope, and panel B highlights an internal bleed associated with 
oedemas. From the LSFM time course, there are GFP neutrophils in the region of the bleed, the final 
timepoint is shown in Figure 3.14D. There are no visible bacteria either inside or outside of the 
phagocytes in this region, suggesting neutrophils are recruited to the injury rather than an 
infectious foci. It would not be representative to study the interaction of the immune system with 
bacteria whilst there are concurrent immunological events. 
 To investigate why oedemas were developing, a tricaine titration bathing experiment was 
performed. Embryos 30 hpi (n = 20 per group) were immersed in 250 µl of E3 with the following 
dilutions of tricaine: 1/20 (0.02 % w/v), 1/40 (0.01 % w/v), 1/60 (0.0066 % w/v) and 1/80 (0.005 
% w/v) with E3 control and the number of embryos with oedemas at regular timepoints quantified. 
E3 was changed every 24 h, unless movement of the embryo was previously detected. Results in 
Figure 3.15 show that there is a decrease in oedema with decreasing tricaine concentrations. The 
standard 1/20 dilution used caused oedemas in 87.5 % of the embryos over 68 h, with oedemas 
observed from 26 h. All replicates of this experiment had lower occurrence of oedema then 
reported by Kaufmann et al., 2012, with oedemas initially occurring after relatively long periods of 
incubation (26 h). However, the dissecting microscope only provides 4 x magnification; the 
macroscopic determination of oedema formation might contribute to this lower incidence 
 At each timepoint embryos were checked for movement; the mirror on the dissecting microscope 





well-plate was also gently shaken to prompt movement. There were no visible movements from the 
1/20 and 1/40 groups, however at 44 h & 68 h there was movement in 1/60 group. Movement in 
the control and 1/80 group was observed at all timepoints. 
Whilst movement was first observed in the 1/60 & 1/80 dilution after 44 h incubation, embryos 
that were anesthetised in the standard 1/20 dilution and then mounted in 1/60 medium, with 1/60 
dilution in the chamber; embryos moved whilst imaging was being set up. This occurred in both the 
0.8 % (w/v) LMP agarose method & the CyGel FEP tubing method. A fresh stock of tricaine was 
tried with the same result. 
A 1/40 dilution of tricaine was tried but showed inter-repeat variability; embryos initially 
remained still whilst mounted in this concentration, however sometimes embryos would move 
despite there being no difference in sample preparation. This is potentially due to batch variation in 
the tricaine stocks from the aquarium, as even stocks prepared by aquarium staff on the same day 
as experiments (suggesting no time for degradation of stocks) sometimes do not work at the 1/40 
dilution. 
To avoid movement of mounted samples, embryos were anesthetised in 1/20 and mounted in 1/20, 
with 1/40 dilution of the tricaine in the imaging chamber to maintain anaesthesia whilst imaging 








Figure 3.14 Embryo with oedema post LSFM timecourse 
Panel A,B show Tg(mpx:GFP)I114 embryo (with GFP labelled neutrophils), unmounted post 18 h of 
LSFM imaging, A) Embryo on dissecting microscope, blue arrow indicating oedema B) mirrored 
light on dissecting microscope, internal bleed associated with oedema circled C) MaxIP of last 
timepoint from LSFM, Tg(mpx:GFP)I114 infected with SH1000-mCherry, GFP neutrophils in region of 
bleed circled. D) Schematic of embryo in ventral orientation with purple square for approximation 










Figure 3.15 Effect of tricaine concentration on embryos 
Embryos (n=24 per group) were immersed in 1/20, 1/40, 1/60 & 1/80 dilution of stock solution of 
tricaine 0.4 % (w/v) in E3, A) percentage of embryos with oedemas during incubation B) 
percentage of embryos moving during incubation in tricaine. During extended incubation some 






If an embryo moves after mounting in the 0.8 % (w/v) LMP agarose that has set, there is disruption 
the texture of the medium, this ‘lumpy’ agarose disrupts the light path to or from the sample, 
degrading the clarity of the acquisition. Figure 3.16 shows a Tg(mpx:GFP x 
mpeg:mCherry.CAAX)I114,SH378 embryo (with GFP neutrophils and mCherry macrophages) infected 
with JE2-mCherry, first mounted and imaged directly after infection in 0.8 % (w/v) LMP agarose 
(Figure 3.16A ) and the same ROI acquired with the same parameters after movement of the 
embryo (Figure 3.16B). Initially there was near-perfect resolution of individual bacteria both inside 
and outside the phagocyte, with low point spread function (PSF) shown inFigure 3.16A. This was 
obtained within the 1/40 dilution of tricaine in the chamber and 1/20 dilution used for injection 
and within the agarose. If there is movement of the sample, even if the concentration of tricaine is 
increased and the embryo no longer moves, there is no way of recovering the clarity of the image, 
even after realignment of the light sheet thickness. 
 Figure 3.16B shows the same slice and ROI of the embryo after movement disrupted the matrix of 
the set LMP agarose. After additional tricaine is added to the imaging chamber to anesthetise the 
sample, there is no clear resolution of either host macrophages and neutrophils or JE2-mCherry, 
even after manual re-alignment of the light sheet thickness. At this point a new sample needs 
mounting; in this instance the embryo was dissected out of the 0.8 % (w/v) LMP agarose and re-
mounted into LMP agarose from the same batch. Light sheet alignment often needs re-adjusting for 
a new sample even for the same batch of embedding medium. After remounting the embryo and 
manual adjustment of light sheet thickness, resolution of bacteria and host cells was restored, as 
shown in Figure 3.17A. Orientation of the embryo after remounting and ROI for imaging is shown in 
the bright field image (Figure 3.17B). 
 Data handling 
Imaging multiple fluorophores in 4D generates very large sized data sets, with a typical data set 
from a 24 h experiment exceeding 3 TB in size; this makes data handling difficult and requires a lot 
of computer processing power. The open SPIM community have developed some useful tools for 
cropping and compressing data sets, however the Zeiss Z1 light sheet produces a proprietary file 
type (.czi) incompatible with these open source tools. Not only is processing data difficult, but just 
moving the files and storing them is lengthy in itself. It is important to find a method of data 
processing that makes the data easier to handle and does not lose/hide important temporal/spatial 







Figure 3.16 Resolution of light sheet prior and post movement in 0.8 % (w/v) LMP agarose 
Tg(mpx:GFP x mpeg:mCherry.CAAX)I114,SH378 infected with JE2-mCherry mounted in 0.8 % 
(w/v)LMP agarose with 0.02 % v/v tricaine, incubated at 28 °C in E3 with 0.01 % v/v tricaine. A) 1 
hpi, individual slice 0.7µm, 1.4 zoom, focused light sheet (light sheet thickness = 3.8 µm) resolves 
individual JE2-mCherry within both neutrophils (GFP) and macrophages (mCherry) and 
extracellular bacteria. B) 1.5 hpi, individual slice 0.7 µm, 1.4 zoom, non-focused light sheet (light 
sheet thickness = 3.8 µm) C) Schematic of embryo in ventral orientation with purple square for 
approximation of FOV 
A      50 µm 






Figure 3.17 Resolution of light sheet of embryo remounted in 0.8 % (w/v) LMP agarose 
Tg(mpx:GFP x mpeg:mCherry.CAAX) I114,SH378 infected with JE2-mCherry re-mounted in 0.8 % (w/v) 
LMP agarose with 0.02 % (v/v) tricaine, incubated at 28°c in E3 with 0.015 % v/v tricaine. A) 3 hpi, 
individual slice 0.7 µm, 1.4 x zoom, focused light sheet (light sheet thickness = 3.55 µm) resolves 
individual JE2-mCherry within both neutrophils (GFP) and macrophages (mCherry) B) 3 hpi, 1.1 x 
zoom, bright field of embryo orientation after re-mounting, focused on the circulation valley. C) 
Schematic of embryo in ventral orientation with purple square for approximation of FOV 
 
A   50 µm 





3.13.1 Zen- Black edition 
The proprietary Zeiss software Zen can be used to process data after acquisition, but this is an 
updated version of existing software; although tools within the package have been developed for 
handling LSFM data, the software struggles to handle the large files. During the course of this study, 
numerous software updates have undoubtedly made processing within Zen a less troublesome 
experience but still does not parallel the brilliance of the hardware. 
3.13.1.1 Data cropping 
Often ‘empty’ slices are obtained during the experiment, these images, acquired with a highly 
sensitive sCMOS camera are 16-bit images, capable of storing 65,535 (216) levels of colour, 
therefore storing 16-bit black is very bulky. To make data easier to manoeuvre, it would be prudent 
to remove these ‘empty’ slices. Zen does not contain a function to detect and/or remove all slices 
below a certain threshold, so this needs to be verified manually, throughout the data set, at every 
timepoint. For volumetric continuity, any slices removed need to be removed from all timepoints, 
so that data can be properly aligned and reconstructed. To crop these slices from the data set, a 
‘subset’ must be created and rather than just deleting the specified images from the file, all the 
wanted slices in the data set are copied, this means a temporary near-doubling of data, before 
deleting the original file. Sometimes is not possible due to lack of space on local data drives needed 
for the processing. 
3.13.1.2 Maximum intensity projection 
 A maximum intensity projection (maxIP) flattens the stack turning the brightest voxel in the ROI 
into a pixel, creating a single plane from hundreds of slices. This can be performed in ZEN and is 
relatively straightforward for a single timepoint (Figure 3.18); however, to follow infection over a 
long time scale, with imaging every 20 minutes, creating a video which comprises of maxIP over 
time can take over 14 h, often the software will crash during this process. These projections are a 
means of quickly determining whether events of interest occurred during the LSFM timecourse, 
producing files that are GB in size rather than TB. An example of this can be viewed in the ‘Video 1- 
MaxIP timecourse of embryo with mCherry labelled neutrophils infected with SH1000-GFP’ 
These are a useful overview to evaluate the experiment, however by flattening the stack, there can 
be misinterpretation of co-localisation. When GFP is within a mCherry labelled immune cell, the 





same pixel within the ROI but are axially distant. As well as this, when there is a foci of infection, it 
can be difficult to distinguish immune cells from each other.  
3.13.1.3 ‘Fly-through’ of z stack 
After identifying timepoints of interest from a MaxIP, a video moving through all of the slices within 
the z-stack can be created, providing a more detailed insight to the spatial association between host 
cells and bacteria, whether the bacteria are intra- or extra-cellular. This can also distinguish 
between host phagocyte which appear close together in a MaxIP, if these cells are being recruited to 
a specific site or whether they are distance axially within the circulation. An example of this can be 
viewed in ‘Video 2- Flythrough of embryo with mCherry labelled neutrophils infected with 
SH1000-GFP’ 
3.13.2 Arivis 
During this study a new software, Arivis 4D was launched. This software has been developed 
specifically for the handling of large microscopy data sets, like those produced by the Zeiss Z1 
microscope. The capacity of software to open large file sizes is usually limited by the amount of 
available random-access memory (RAM) with 16GB RAM being the largest, widely available size of 
RAM on the market; it is likely this that causes the problems experienced using Zen.  However, 
Arivis can open the large file formats, regardless of RAM available on the processing computer, 
after developing their ‘Image core’ format. This can store large files without redundancy, and can 
access arbitrary regions of the data set, across 4D, nearly instantaneously. This parallelisation of 
the data set allows for files that exceed the available RAM by 2 orders of magnitude to be opened 
and explored. 
After converting files from the proprietary Zeiss format (.czi) to the Arivis ‘Image core’ format (.sis) 
data can automatically be opened in 3D; this provides rapid rendering of the data at individual 
timepoints which can be explored and freely rotated. These can be exported as videos, please view 
‘Video 3 – rotating 3D reconstruction of mpeg:mCherry embryo infected with SH1000-GFP’. 
 These renders give good spatial insight to the data and readily show whether or not bacteria are 
inside or outside of the phagocytes. Arivis can be used to view the progression of the timecourse in 
3D and to create videos of these reconstructions or produce a projection of 3D render into a 2D 







Figure 3.18 Maximum intensity projection, single timepoint 
A)Tg(lyz.nfsb:mCherry)SH260 embryo (with mCherry labelled neutrophils)infected with SH1000-
GFP, single timepoint at 2 hpi. MaxIP composed from 270 slices (1µm). B) Schematic of embryo in 
lateral orientation with purple square for approximation of FOV 
 
  







Figure 3.19 2D projection of 3D reconstruction created using Arivis 4D 
A)Tg(mpeg:mCherry x CAAX)SH378 embryo (with mCherry labelled macrophages) infected with 
SH1000-GFP, imaged 4 hpi. 2D projection of 3D reconstruction created in Arivis 4D. Gridlines are 
30 µm x 30 µm and minor gradations are 6 µm. B) Schematic of embryo in lateral orientation with 









The established zebrafish model for S. aureus infection has been used to identify bacterial factors 
important for pathogenesis. Previous microscopic techniques have been used to image lesions 
within the host with low magnification lenses, and interaction of bacteria within the phagocyte with 
high aperture, high magnification (40 x and 62 x ) lenses (Prajsnar et al., 2012; Serba, 2015). These 
are limited by the depth of penetration of the sample and the size of the FOV. LSFM provides an 
opportunity to use high aperture, low magnification lenses enabling high resolution image 
acquisition over large ROI. Lightsheet can penetrate the sample deeper than 500µm; however 
deeper imaging has a greater scatter of signal from the sample and reduces focus of the light to the 
detecting lens. 
Another advantage of the Zeiss Z1 microscope over other imaging techniques is that the living 
sample can be incubated during imaging to provide conditions that should allow for the normal 
development of the host and infection progression. Although the microscope has been designed for 
the long-term imaging of living samples incubating in a chamber of medium, in practice the 
recommended protocols do not deliver the professed normal development of the sample. In this 
chapter many imaging parameters have been optimised and methods adjusted to deliver a protocol 
that can be used to image an infected embryo over long time scales.  
Decreasing the laser power for acquisition, elongating the gap in between timepoints and changing 
the ROI, cumulatively has reduced phototoxicity to the embryo and resulting in imaging for over 24 
h, that keeps the sample alive. In addition to the sample being able to withstand repeated imaging, a 
mounting technique that is gentler on the sample has been developed. The published FEP 
alternatives to 0.8 % (w/v) LMP agarose mounting did not work when replicated and a new 
method using a CyGel as an embedding matrix has been developed this should provide a matrix 
which can sustain the development of the embryo during imaging and enables getting the embryo 
into the correct position within the FEP tube in a short time after infection whereas other methods 
using 0.1-0.3 % (w/v) LMP agarose could not get the sample to rest on the agarose plug within an 
hour of infection, the sample would drift during acquisition. It is important to get the sample into 
the microscope as quickly as possible after infection to capture initial phagocytosis of bacteria 
within the host.  
In addition to a mounting medium that allows for better development of the embryo in comparison 
with the 0.8 % (w/v) LMP agarose, the amount of tricaine used in long term imaging experiments 
has been reduced by 50 % to reduce the incidence of oedemas in mounted embryos. Although 





that oedemas are not caused by other factors other than infection, altering the dynamics between 
host and bacteria. 
Having established a protocol that can maintain an infected embryo during long term imaging, 
methods of reviewing and reconstructing data were explored. After acquisition data is initially 
cropped to eliminate extraneous data and this raw data is stored on a RAID. MaxIP are then created 
from data to provide an overview of the imaging outcome. Data is then cropped to highlight regions 
of interest and exported in video format. This cropped data can also then be converted into 4D 
using Arivis to gain spatial insight to the interaction between phagocytes and bacteria. A flowchart 
outling the process developed in this chapter is shown in Figure 3.20. 
Development of these techniques has provided the basis for interrogating real time, host pathogen 
interactions, across four dimensions.  
 
 
Figure 3.20 Process for imaging real-time interactions of S. aureus within a zebrafish embryo 








4 Dynamics of S. aureus infection of zebrafish embryos 
 Introduction 
On infection of zebrafish embryos with S. aureus, of those that succumb to infection, previous work 
has demonstrated one third have clonal lesions (Prajsnar et al., 2012). By infecting with an 
inoculum of 1:1 isogenic strains carrying different fluorescent and antibiotic resistance markers 
Prajsnar et al. established that lesions are formed from only a few cells of the initial inoculum. 
These undergo population expansion within the host after passing through an immune 
“bottleneck”. This bottleneck is found across different models of S. aureus infection; clonality has 
also been observed in murine models and is independent of bacterial strain (McVicker et al., 2014; 
Pollitt et al., 2018; Prajsnar et al., 2012). Moreover, successful bacteria which have overwhelmed 
the host subsequent to infection by a mixed inoculum are not genetically advantaged, as if isolates 
are used to infect more embryos as part of a mixed inoculum, they are not preferentially selected 
for (McVicker et al., 2014).  
Immune bottlenecks have also been identified in Salmonella enterica (Grant et al., 2008) and 
Streptococcus pneumoniae (S. pneumoniae) (Manso et al., 2014). In the S. pneumoniae murine model 
of invasive disease a switch in distinct epigenetic profile is found when bacteria are reisolated from 
mice, whereas  there was no detection of change of these epigenetic profiles in a murine 
nasopharyngeal colonisation model, suggesting the blood as the cause of this skew in profiles 
(Manso et al., 2014). Simultaneous systemic infection with isogenic S. enterica strains in a murine 
model have demonstrated that the bactericidal action by NADPH oxidase (required for generation 
of ROS by phagocytes) in the early stages of infection, is responsible for the change in ratio of 
isogenic strains reisolated in comparison with the inoculum. This indicates that phagocytes are the 
immunological bottleneck causing localised clonality in the S. enterica systemic model of murine 
infection (Grant et al., 2008).  
Clonality has been observed within blood vessels of zebrafish systemically infected with 
Cryptococcus neoformans (C. neoformans)(Gibson et al., 2017). When infected with a mixed 
inoculum of fluorescently marked but otherwise isogenic strains, early formation of a single 
coloured cryptococcal mass within the vasculature of an embryo corresponded to overwhelming 
infection of the same strain. Multiple clonal cryptococcal masses of different isogenic strains were 
observed within different blood vessels of a single embryo; in these embryos a mixed strain 
overwhelming infection was observed. It has therefore been proposed that the spatial confinement 
of the small blood vessels trap individual C. neoformans which then develop clonal cryptococcal 
masses. These cryptococcal masses may lead to vascular damage and dissemination of the pathogen 





Macrophages are critical in the control of C. neoformans infection but a failure in macrophage 
response is not the only defect in embryos which succumb to infection. Intracellular proliferation of 
the pathogen within the phagocyte has been observed and are a source of increasing cryptococcal 
burden within the host. The in vivo properties of the cryptococcal cells affects the ability of 
macrophages to phagocytose the pathogen, with early response to systemic infection critical to the 
outcome of the host (Bojarczuk et al., 2016). In this systemic infection model both extracellular and 
intracellular factors are involved in the progression of cryptococcal infection (Bojarczuk et al., 
2016; Gibson et al., 2017) 
Previous research implicated neutrophils as the niche for S. aureus to expand within the host before 
a lesion if founded and overwhelming infection occurs in the zebrafish embryo model of systemic S. 
aureus infection (Prajsnar et al., 2012). Recently macrophages were identified as the niche for S. 
aureus expansion within a murine host (Pollitt et al., 2018); depletion of macrophages abolished the 
bottleneck seen in multiple infection models (McVicker et al., 2014; Pollitt et al., 2018; Prajsnar et 
al., 2012) and with it loss of clonal abscesses that arise from a mixed inoculum (Pollitt et al., 2018).  
Another study utilising the systemic zebrafish embryo model of S. aureus infection established that 
there is more intake of S. aureus into macrophages (which can contain over 100 bacteria) then 
there is into neutrophils, both as a percentage of the cell population and the number of bacteria 
phagocytosed per cell. The percentage of the neutrophil population that contains S. aureus 
decreases from ~60 % at 1-5 hpi to 20 % during later stages in infection (24-28 hpi); this is partly 
due to a 30 % increase in neutrophil population as the embryo develops but could also be due to 
intraphagocyte killing of S. aureus (Serba, 2015). 
 Chapter aims 
 Imaging infected embryos directly following infection though to formation of lesion, 
utilising transgenic zebrafish lines with fluorescent phagocytes to investigate expansion of 
S. aureus in the host. 
 Investigate the effect of macrophage depletion on clonal infection of the host and the role of 
macrophages as a possible niche for bacterial expansion. 
 Create a new bacterial strain expressing a novel fluorophore complementary to GFP and 






 Early embryo infection  
Tg(lyzC.nsfb:mCherry)SH260 embryos (with mCherry labelled neutrophils) were infected with 
SH1000-GFP 1 hpi and mounted in 0.8% (w/v) LMP agarose and imaged by LSFM every 15 minutes 
for 20 h.  A MaxIP of this timecourse can be viewed in ‘Video 4 – lyz:mCherry SH1000-GFP naïve 
lesion formation video’. At the beginning of this experiment 1 hpi (Figure 4.1A), bacteria are 
present within the circulation of the embryo, prior to phagocytosis.  Bacteria are initially 
phagocytosed by neutrophils (Figure 4.1B). As time progresses (5.5 – 14.5 hpi) neutrophils are 
recruited to a site with increasing GFP signal (Figure 4.1C). In Video 5, an increase in bacterial 
aggregates is concomitant with increasing number of circulating neutrophils. From 5.5 hpi onwards 
the GFP signal (from S. aureus) increases over time at this bacterial foci and neutrophils are 
observed collecting at this site within the host. When imaging is terminated at 21 hpi (Figure 4.1D) 
the bacteria are not within a labelled neutrophil. The increase in GFP signal from this region within 
the circulation is indicative of a small bacterial aggregate, that may have gone on to form a lesion 
within the host. It is also possible that these bacteria were within an unlabelled macrophage; in this 
case bacteria were either replicating within this immune cell or being passed from neutrophils to 
macrophages. This phenomenon has been observed in the zebrafish model for S. aureus infection 
previously (Serba, 2015), however as only neutrophils are labelled in the transgenic line used 







Figure 4.1 Early stages of infection  
MaxIP of Tg(lyz.nfsb:mCherry) SH260 embryo (with mCherry 
labelled neutrophils) infected with SH1000-GFP A) whole FOV 
of circulation over yolk sac 1 hpi, extracellular bacteria visible 
within circulation, white box indicates ROI magnified in 
subsequent timepoints (B,C and D) B) 5.5 hpi bacteria are 
visible within neutrophils C) 14.5 hpi neutrophils are recruited 
to site of initial bacterial aggregation D) 21 hpi small 
extracellular bacterial aggregate not phagocytosed by 













 Imaging of established infection highlighting macrophages 
Tg(mpeg.mCherry:CAAX)SH378 (mCherry labelled macrophages) embryos were infected with 
SH1000-GFP, and at 28 hpi embryos with visible lesions were imaged by LSFM. The topology of a 
typical lesion was reconstructed in 3D, a projection of this is shown in Figure 4.2. Within the 
circulation is a large lesion ~120 µm x ~150 µm and with mCherry macrophages on edge of the 
lesion. The same reconstruction rotating can be viewed in ‘Video 5- rotating 3D reconstruction of 
GFP lesion’. A large area of yellow co-localistion ~50 µm x ~50 µm, shows macrophages that 
contain a large number of bacteria, on the periphery of the lesion. Smaller aggregates that could be 
within unlabelled neutrophils are visible within the circulation, but there are also individual 
bacteria which can be resolved throughout the circulation as S. aureus disseminates throughout the 
host.  
When trying to image embryos with formed lesions, embryos with bacteria spread over the 
endocardium of the heart have been observed; an example of this is shown in Figure 4.3, a 
Tg(fms:GFP)SH377 embryo (GFP macrophages) infected with JE2-mCherry. Multiple bacterial 
aggregates are within the oedema, above the circulation valley of the embryo which has been 
imaged; some of these could be within unlabelled neutrophils but some aggregates are larger than 
the expected size of neutrophils (> 15 µm). Individual bacteria can be resolved within the ROI and 
over the endocardium. Due to movement of the heart it is difficult to focus directly over the area; 
rapid continuous imaging (FOV images every 40s) allows for resolution of different volumes of the 
heart over successive timepoints. This movement causes nearby (or adherent) immune cells to 
become segmented, appearing as multiple cells. A video of 3D reconstruction of the movement of 
macrophages around the bacterial aggregates and infected endocardium can be viewed in ‘Video 6 
– fmsGFP JE2 mCherry endocarditis like reconstruction’. Whilst movement over the heart 
artificially increases the number of macrophages in the ROI, segmentation co-localisation analysis 
performed in Arivis shows that 96% of macrophages in within the FOV contain JE2-mCherry. 
After infection of Tg(mpeg.mCherry:CAAX)SH378 embryos (mCherry macropahges) infected with 
SH1000-GFP were mounted in 0.8 % (w/v) LMP agarose imaged 44 hpi by LSFM. A layer of 
SH1000-GFP covering the endocardium was observed, where individual bacteria can be resolved. 
To image movement of the heart with bacteria, a single slice (1 µm) was acquired continuously, as 
fast as acquisition would allow for 40 timepoints in 15 s. Figure 4.4 shows four successive 
timepoints (35-38) with individually resolved S. aureus and two macrophages. This quick 







Figure 4.2 3D projection of GFP lesion within embryo with mCherry macrophages 
A) Tg(mpeg.mCherry:CAAX)SH378 (embryo with mCherry labelled macrophages) infected with 
SH1000-GFP with large lesion was imaged 28 hpi by LSFM and reconstructed in 3D with Arivis 
Vision 4D. Gridlines are 30 µm x 30 µm, minor gradation are 6 µm. Macrophages are observed on 
the edge of the lesion and contain many bacteria. Individual bacteria which have disseminated from 
the lesion are also observed within the circulation. B) Schematic of embryo in lateral orientation, 









Figure 4.3 3D reconstruction of embryo with GFP macrophages infected with JE2-mCherry, 
with bacteria covering endocardium 
A) Tg(fms:GFP)SH377 (GFP labelled macrophages) embryo infected with JE2-mCherry, was imaged 26 
hpi by LSFM and reconstructed in 3D with Arivis Vision 4D. The region imaged is an oedema 
formed in the circulation. Blue ellipses highlight region of bi-valve heart, where bacteria are 
attached to the endocardium. Gridlines are 50 µm x 50 µm, minor gradations are 10 µm. B) 
Schematic of embryo in venteral orientation with purple box for approximation of region of 











Figure 4.4 Single slice of infected endocardium 
Individual slice (1µm) of Tg(mpeg.mCherry x CAAX)SH378 
embryo (mCherry macrophages) infected with SH1000-GFP 
imaged by LSFM 44 hpi. Slice is centred on the heart inside of 
an oedema. Images were acquired as fast as possible, every 
0.375 s for 15 s A) timepoint 35 (13.12 s) B) timepoint 36 
(13.50 s) C) timepoint 37 (13.88 s) D) timepoint 38 (14.25 s). 
GFP S. aureus attached to the endocardium move in the FOV 
with the heartbeat. E) Schematic of embryo in venteral 













 Imaging of established infection highlighting labelled neutrophils 
Tg(lyz.nfsb:mCherry)SH260 (with mCherry labelled neutrophils) embryos with visible lesions were 
imaged 20 hpi. An embryo with a typical large lesion was reconstructed in 3D, and a projection the 
lesion topology of the lesion is shown in Figure 4.5.  Within the circulation of this embryo is a large 
lesion ~250µm x ~200µm and mCherry neutrophils are present nearby. The same reconstruction 
rotating can be viewed in ‘Video 8- rotating 3D reconstruction of GFP lesion mCherry 
neutrophils’. There are 6 neutrophils near the lesion, with two that have internalised bacteria near 
an area of less dense bacteria. This embryo had a high bacterial burden of 2.8 x 107 CFU when 
enumerated after imaging. Focus of bacteria and neutrophils within this embryo is poor in 
comparison to other embryos with lower bacterial burden in this experiment imaged with 
comparable acquisition parameters, 3D reconstruction’s of these can be viewed in ‘Supplementary 
video 1 – lyz mCherry 6.3 x 104 SH1000-GFP’ and ‘Supplementary video 2 - lyz mCherry 9.8 x 
104 SH1000-GFP’. It is often difficult to focus the lightsheet on embryos that have a high bacterial 
burden. It is possible that this is due to increased light scatter through the sample from bacteria 
within the embryo, much in the way that bacterial growth is measured by a spectrophotometer: as 













A) Tg(lyz.nfsb:mCherry)SH260 embryo (with mCherry 
labelled neutrophils) infected with SH1000-GFP with 
lesion was imaged 20 hpi by LSFM and reconstructed in 3D 
with Arivis Vision 4D. Gridlines are 50 µm x 50 µm, minor 
gradations are 10 µm. B) Schematic of embryo in venteral 
orientation with purple box for approximation of region of 






 Infection dynamics with labelled macrophages 
Tg(fms:GFP)SH377 embryos (with GFP labelled macrophages) were infected with 2050 CFU JE2-
mCherry and mounted for LSFM imaging. After lightsheet adjustments imaging of 6 ROI began 1 hpi 
and the samples was imaged every 20 minutes.  Initially individual bacteria are visible within the 
circulation. A MaxIP of the 4 FOV acquired ventrally (at the same imaging angle) over the 
circulation of the infected embryo 1 hpi is shown in Figure 4.6. During the timecourse, a lesion 
develops at the top of the circulation valley (FOV 2). MaxIP of this FOV in which the lesion develops 
is shown in ‘Video 9– timecourse MaxIP fmsGFP infected with JE2-mCherry view 2’ the video 
captures 17 hr of imaging, (1-18 hpi).  High scatter in this data set makes it more difficult to 
determine whether the bacteria that founded the lesion came from within a macrophage.  
A second ROI acquired 40° rotation from this also captures the development of the JE2-mCherry 
lesion, MaxIP of this FOV can be viewed in ‘Video 10 – timecourse MaxIP fmsGFP infected with 
JE2-mCherry view 5’. In both angles over the ROI the initial volume of bacteria that develops into a 
lesion is not associated with GFP signal from macrophages . A MaxIP which shows the 4 FOV over 
the circulation, at the last timepoint of this timecourse is shown in Figure 4.7, by this point there 
are multiple large bacterial aggregates, whilst some of these may be within unlabelled neutrophils, 
most of these are too large to within a host cell, individual bacteria within the circulation are also 
visible, indicating infection has disseminated through the circulation. When an embryo has a high 
bacterial burden there is increased scatter of lights from the sample (as previously mentioned this 
is possibly a similar phenomenon to measuring bacterial density in a spectrophotometer) to the 
detection camera, all imaging channels, which is detrimental to focus. Another problem that arises 
during imaging is that as bacteria replicate exponentially when overwhelming infection occurs, 
there is increased signal in this imaging channel, which combined with scatter produces out of 
focus light in the detection plane. The putative site of initial bacterial expansion is shown in a split 
channel MaxIP (Figure 4.8), due to the high intensity from the mCherry (which sometimes obscures 
GFP in the MaxIP). A white circle highlights the area that proceeds to expand. There are no labelled 
macrophages in this region, the bacteria could be within an unlabelled neutrophil (although the size 
of the 4 aggregates are larger than average sized neutrophils) or they could have expanded from a 








Figure 4.6 1 hpi MaxIP of four FOV over the circulation valley of 
embryo infected with JE2-mCherry 
A) MaxIP of Tg(fms:GFP)SH377 embryo (with GFP labelled 
macrophages) infected with JE2-mCherry at 1 hpi. Overlapping FOV 
were acquired at the same imaging angle to cover the circulation 
valley (ROI circled in purple). Dashed line shows regions of overlap 
with adjacent FOV, order of FOV acquisition numbered in outer 
corner of each image. Individual bacteria can be observed in the 
circulation prior to phagocytosis B) Schematic of embryo in 
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Figure 4.7 18 hpi MaxIP of four FOV over the circulation valley 
of embryo infected with JE2-mCherry 
A) MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) 
infected with JE2-mCherry at 18 hpi. Overlapping FOV were 
acquired at the same imaging angle to cover circulation valley (ROI 
circled in purple). Dashed line shows regions of overlap with 
adjacent FOV, order of FOV acquisition numbered in outer corner of 
each image. A large lesion can be observed in FOV 1 and a smaller 
aggregate associated with macrophages is within FOV 3 B) 
Schematic of embryo in venteral orientation with purple circle for 















Figure 4.8 MaxIP of FOV 2 of embryo infected with JE2-mCherry  
MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) infected with JE2-mCherry at 9 hpi. A) 
GFP channel (macrophages) B) mCherry channel (JE2-mCherry) C) merge.  White circle highlights 
the putative region of initial bacterial expansion. D) Schematic of embryo in venteral orientation 













Figure 4.9 20 hpi MaxIP of four FOV over the circulation 
valley of embryo infected with JE2-mCherry 
A) MaxIP of Tg(fms:GFP)SH377 embryo (with GFP 
macrophages) infected with JE2-mCherry at 20 hpi. 
Overlapping FOV were acquired at the same imaging angle to 
cover the circulation valley (ROI circled in purple). Dashed 
line shows regions of overlap with adjacent FOV, order of 
FOV acquisition numbered in outer corner of each image. A 
large lesion is visible at the top of  the circulation valley in 
FOV 1 and 2 another smaller aggregate is also visible at the 
bottom of the circulation in FOV 3. B) Schematic of embryo 












In another independent experiment Tg(fms:GFP)SH377 embryos (with GFP labelled macrophages) 
were infected with 2140 CFU JE2-mCherry and mounted for LSFM imaging. The timecourse 
experiment began 1 hpi and extracellular bacteria are visible within the circulation, MaxIP of four 
FOV over the circulation is shown in Figure 4.11. Two additional FOV were imaged at 42° rotation 
(FOV 2) from FOV 3 and 30° rotation (FOV 1) from FOV 4. A MaxIP of the timecourse in FOV 2 is 
shown in ‘Video 11 – MaxIP timecourse of embryo with GFP macrophages infected with JE2-
mCherry – endocarditis to overwhelming infection’ During the course of imaging initially 
bacteria are phagocytosed and then infection spreads over the endocardium (Figure 4.11A) and 
finally infection progresses through the circulation valley (Figure 4.11B). There were 3.1 x 106 CFU 
were recovered from this sample at 20 hpi when the timecourse was terminated.  
At 7 hpi bacteria the mCherry signal becomes visible in the region of the heart (and as such is out of 
focus) a split channel MaxIP of FOV 2 at this time point is shown in Figure 4.12, (the area is circled 
in white). From this viewing angle it seems that there are no macrophages present and that this 
bacteria that are moving with the heart are outside of a phagocyte (possibly on the endocardium) 
or within unlabelled neutrophils.  However, inspection of the same volume from FOV 3 has a 
macrophage with internal bacteria, split channel MaxIP shown in Figure 4.13. Whilst the two FOV 
are acquired instantaneously of one another, movement of the heart in this region will disrupt the 
position of nearby immune cells and it is not likely the heart would be imaged in the same position 
from one heartbeat to the next. The macrophage in this area in Figure 4.13 resembles the 
macrophage next to the circled area in Figure 4.12 and it is possible this macrophage was moved by 
the heart in between the FOVs being acquired. By 7.66 hpi bacteria are spreading over the 
endocardium a MaxIP of FOV 2 at this timepoint is shown in Figure 4.14. Although the mCherry 
signal from the region of the heat is blurred, there are only two small areas of GFP signal in this 
region and these could be from the same macrophage as the heartbeat multiplies & segments 
immune cells as previously described. When looking at FOV 3 (split channel MaxIP shown in Figure 
4.15)  at the same timepoint no macrophages are visible in the region of the heart. From this 
timepoint onwards the mCherry signal from S. aureus in the region of the heart increases. It is not 
possible to perform colocalization analysis on the timepoints at which bacteria are spread over the 
endocardium due to movement in the volume caused by the heart. However, from 8 hpi onwards 
the mCherry signal in this region increases rapidly and it is unlikely that bacteria occupying regions 
of this size could be within unlabelled neutrophils. As seen in in ‘Video 11 – MaxIP timecourse of 
embryo with GFP macrophages infected with JE2-mCherry – endocarditis to overwhelming 
infection’ individual bacteria start to increase within the circulation from 9 hpi and multiple 







Figure 4.10 MaxIP of four FOV over circulation valley of 
embryo with GFP macrophages infected with JE2-
mCherry 
A) MaxIP of Tg(fms:GFP)SH377 embryo (with GFP 
macrophages) infected with JE2-mCherry at 1 hpi. 
Overlapping FOV were acquired at the same imaging angle 
to cover circulation valley (ROI circled in purple). Dashed 
line shows regions of overlap with adjacent FOV, order of 
FOV acquisition numbered in outer corner of each image. B) 
Schematic of embryo in venteral orientation with purple 













Figure 4.11 MaxIP of embryo with labelled macrophages infected with JE2-mCherry 
A) MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) infected with JE2-mCherry at A)11 












Figure 4.12 Split channel MaxIP of FOV 2 of embryo with GFP macrophages infected with JE2-
mCherry 7 hpi 
MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) infected with JE2-mCherry at 7 hpi, 
FOV 2. A) GFP channel (macrophages) B) mCherry channel (JE2-mCherry) C) merge.  White shape 
highlights region of heart. D) Schematic of embryo in venteral orientation with purple box for 
approximation of FOV 
 










Figure 4.13 Split channel MaxIP of FOV 3 of embryo with GFP macrophages infected with JE2-
mCherry 7 hpi 
MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) infected with JE2-mCherry at 7 hpi, 
FOV 3. A) GFP channel (macrophages) B) mCherry channel (JE2-mCherry) C) merge.  White shape 
highlights region of heart. D) Schematic of embryo in venteral orientation with purple box for 














Figure 4.14 Split channel MaxIP of FOV 2 of embryo with GFP macrophages infected with JE2-
mCherry 7.66 hpi 
MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) infected with JE2-mCherry at 7.66 hpi, 
FOV 2. A) GFP channel (macrophages) B) mCherry channel (JE2-mCherry) C) merge. White shape 
highlights region of heart. D) Schematic of embryo in venteral orientation with purple box for 















Figure 4.15 Split channel MaxIP of FOV 3 of embryo with GFP macrophages infected with JE2-
mCherry 7.66 hpi 
MaxIP of Tg(fms:GFP)SH377 embryo (with GFP macrophages) infected with JE2-mCherry at 7.66 hpi, 
FOV 3. A) GFP channel (macrophages) B) mCherry channel (JE2-mCherry) C) merge.  White ellipses 
= region of heart. D) Schematic of embryo in venteral orientation with purple box for 













 Infection dynamics with labelled neutrophils 
Tg(lyz:nsfb.mCherry)SH260  embryos (with mCherry labelled neutrophils) were infected with 1600 
CFU, SH1000-GFP and mounted for LSFM imaging. After initial set up of the microscope imaging 
began 2 hpi, the infected embryo was imaged every 15 minutes for 20 h. When recovered from the 
microscope the embryo had a slow heartbeat and was overwhelmed by infection, the embryo was 
homogenised and CFU enumerated. The infected embryo had a high bacterial burden of 1.6 x 106 
CFU and was most likely at the terminal stages of infection. 
 A MaxIP of infection from the early stages (2 hpi) to endpoint 22 hpi is shown in ‘Video 12 – 
Biofilm like infection progression MaxIP’. Initially bacteria are still visible within the circulation 
before being phagocytosed, bacteria that are in small aggregates not inside labelled neutrophils are 
potentially within unlabelled macrophages. Progression of infection reveals a lesion that rapidly 
disseminates within the host, forming many large aggregates of bacteria within the circulation 
valley of the embryo. At 6 hpi the beginnings of this large lesion can be seen, this can be traced back 
to faint, diffuse GFP signal at 2.5 hpi (Figure 4.16A) there are no mCherry neutrophils in this region 
prior to initial bacterial spread, suggesting the bacteria could be within an unlabelled macrophage, 
or are in the circulation valley and have not been phagocytosed. At 3 hpi a neutrophil that does not 
contain any bacteria is near the region of initial bacterial spread (Figure 4.16B) however there are 
no neutrophils in this region at subsequent timepoints. 
Strikingly within this embryo S. aureus has spread over the membrane of the yolk, covering it with a 
thin layer of bacteria, as well as thicker parts and multiple additional bacterial aggregates A 3D 
reconstruction of the infected embryo at 20 hpi this can be viewed in ‘Video 13 – biofilm like 
infection 3D rotation’. Figure 4.17 shows an individual slice (0.54µm in thickness) from the ROI at 
A) 22 hpi & B) 25 hpi bacteria that have spread over the membrane of the yolk can be individually 
resolved and there is an increase in the number of bacteria in this focal plane between these two 
timepoints. 
Colocalisation analysis was performed on ROI at 2.5 & 20 hpi, a 3D rendering of the result of this is 
shown in Figure 4.18. This first identifies mCherry neutrophils by segmentation analysis (size 
>10µm) then identifies GFP labelled S. aureus by segmentation analysis (>2µm). Colocalisation 
identifies segments identified as S. aureus within identified neutrophils. These voxels are 
represented by yellow centroids in Figure 4.18. At 2.5 hpi, 48 % of identified neutrophils contain S. 







Figure 4.16 MaxIP of initial point of lesion formation 
MaxIP of Tg(lyzC:mCherry)SH260 embryo (mCherry neutrophils) infected with SH1000-GFP, imaged 
by LSFM, at A) 3.5 hpi and B) 4 hpi C) Schematic of embryo in lateral orientation with purple box 










Figure 4.17 Individual slices from embryo infected with SH1000-GFP 
Tg(lyz:mCherry)SH260 embryo infected with SH1000-GFP, imaged by LSFM, individual slice from Z-
stack (1µm) acquired at same imaging depth at timepoints A) 22 hpi and B) 25 hpi C) Schematic of 














Figure 4.18 Colocalisation anaylsis of embryo infected with SH1000-GFP  
3D reconstruction of Tg(lys:mCherry) SH260 (mCherry neutrophils) infected with SH1000-GFP. 
Colocalisation analysis of SH1000-GFP within mCherry labelled neutrophils was performed in 
Arivis 4D. Yellow centroids indicate voxel co localisation of GFP & mCherry. Gridlines are 100 µm x 
100 µm and minor gradations are 20 µm A) 2.5 hpi B) 20 hpi C) Schematic of embryo in lateral 








 Macrophage depletion 
During long-term imaging experiments following infection progression of S. aureus in embryos with 
labelled macrophages, expansion of bacteria from inside of a neutrophil have not been observed. 
Furthermore, when following dynamics in embryos with labelled macrophages, many macrophages 
are phagocytosing bacteria from early in the infectious process and frequently macrophages have a 
high bacterial load. As macrophages seem to be crucial for controlling systemic infection from 
initial inoculation and bacterial expansion occurring from 6 hpi onwards it is possible that 
macrophages are providing a niche for S. aureus to replicate within.  To test this hypothesis and 
ascertain the role of macrophages on bacterial expansion embryos were depleted of macrophages 
prior to infection. 
4.8.1 Effect of clodronate on S. aureus infection of zebrafish embryos 
To elucidate whether macrophages are the niche in which S. aureus are expanding within the 
zebrafish host, LWT embryos were depleted of macrophages by injection with clodronate 
containing liposomes 24 hpf. Control embryos were injected with liposomes containing PBS. Both 
groups were infected with JE2-mCherry 30 hpf and survival monitored. Results are shown in Figure 
4.19. As expected, survival of macrophage depleted embryos is significantly lower (P = <0.0001), 
with no survival of embryos in the clodronate treated group by 92 hpi. 
4.8.2 Effect of macrophage depletion on clonal expansion of S. aureus 
To investigate infection dynamics of S. aureus in a macrophage depleted host, clodronate treated 
embryos were infected with a mixed inoculum of two isogenic strains in a 1:1 ratio, with different 
antibiotic markers (Kan & Ery). All dead embryos were collected at regular timepoints and 
homogenised. Samples were plated out on both plain and selective media after serial dilution for 
enumeration. Total CFU count per embryo are shown in Figure 4.19B and there is no significant 
difference (P = 0.5784) in bacterial burden between the clodronate liposome treated and control 
PBS liposome groups. The proportions of strains recovered from macrophage depleted fish at the 
terminal point are shown in Figure 4.20, and proportions of strains recovered from control PBS 
treated fish at the terminal point are shown in Figure 4.21. In both macrophage depleted and 
control groups either of the isogenic strains can predominate, demonstrating there is no fitness 
benefit to either resistance marker. 
 For each sample the Shannon diversity index (H) (Equation 1) was calculated for the two isogenic 
strains and this was used to calculate population evenness, (EH) (Equation 2) which defines how 
evenly matched different populations of organisms within a given environment (in this case the 
embryo) are. EH of 1 is a balanced mixed population of the two isogenic strains and EH of 0 means 





be expected that species evenness from samples inoculated with 1:1 ratio of isogenic strains would 
have a EH near 1. 
𝐻 = − (𝑃𝑖 ∗ 𝑙𝑛𝑃𝑖) 
Equation 1 Shannon diversity index 
H = Shannon diversity index, Pi  = fraction of the entire population made up of species  
I,  S = number of species encountered, Σ sum from species 1 to species S 
𝐸 = 𝐻/𝑙𝑛𝑆 
Equation 2 Population evenness 
EH=Population evenness (Shannon equitability), H = Shannon diversity index, , S = number of 
species encountered 
 
The distribution of population evenness over time is shown in Figure 4.22, linear regression of 
Figure 4.22A & B (clodronate treated and PBS control respectively) was performed: slope A) was 
not significantly non-zero (F = 0.116, P = 0.735) therefore there is no linear relationship between 
species evenness and hpi. Slope B) is significantly non-zero (F = 14.6, P = 0.0009) demonstrating a 
statistically significant correlation between time of death and decrease in EH. The observed 
decrease in EH shows an increased chance of a population being clonal over time and that these 
bacteria had likely passed through a population bottleneck. This is in concordance with the findings 
of Pollitt et al., (2018), who demonstrated a decrease in EH (increase in clonality) over time in 
infected LWT embryos.  
Comparison of distribution of species evenness between the clodronate treated & PBS control 
groups was performed by (non-parametric) Mann-Whitney test, the distributions are significantly 
different (P = 0.0023). This suggests macrophages are a potential immunological bottleneck for 
clonal expansion of S. aureus within the host, however clonal populations are observed in the 
clodronate treated group at 68 and 74 hpi, this could be due to an increase in macrophages over 
elapsed time since clodronate treatment, as has been quantified in the zebrafish infection model for 
Cryptococcus neoformans (Bojarczuk et al., 2016). 
 A previous study implicated neutrophils as the immunological bottleneck and found that there was 
a significant difference in the variance in ratios of two isogenic strains between groups of 
transgenic embryos ablated of either neutrophils or macrophages (Prajsnar et al., 2012). However, 
it is a possibility this could be due to less efficient depletion of the macrophages by metronidazole 
as opposed to using clodronate liposomes as the method of depletion. This study also infected 
neutrophil and macrophage depleted embryos at 54 hpf as opposed to 30 hpf usually used in the 





development that professional immune cells present are more mature. Whilst survival of embryos 
depleted of macrophages was lower than survival of embryos depleted of neutrophils, there was 
~40 % survival in this group (Prajsnar et al., 2012) compared with 0% survival of infected embryos 
depleted of macrophages by clodronate in this study (Figure 4.19A) . Furthermore the 
quantification of population variance was calculated as a ratio of the two isogenic strains; however 
this study utilised the more robust population evenness calculation adopted by Pollitt et al., 2018. 
As a metric, EH is better suited for this analysis, because it is based upon H, the calculation of which 
is equally sensitive to both very rare and very abundant species within a sample (this is useful as 
samples in these experiments can be both evenly mixed or comprised predominantly of only one 







Figure 4.19 Bacterial dynamics of S. aureus within a macrophage depleted host 
A)  Survival of embryos depleted of macrophages by injection of clodronate liposomes 
prior to infection with JE2-mCherry. Mantel-Cox curve comparison P = 0.0001. B)  CFU 
recovered from dead embryos after infection with mixed inoculum of isogenic strains, 
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Figure 4.20 Proportions of isogenic strains recovered from macrophage depleted embryos 
Embryos were treated with clodronate liposomes and infected with a 1:1 mixture of 
isogenic strains with Kan and Ery markers. Dead embryos were collected at regular 
timepoints and the proportion of bacteria recovered from individual embryos are 
shown in pie charts (with red and blue representing Kan and Ery respectively). The 
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Figure 4.21 Proportion of isogenic strains recovered from control embryos 
Embryos were treated with PBS liposomes and infected with a 1:1 mixture of isogenic 
strains with Kan and Ery markers. Dead embryos were collected at regular timepoints 
and the proportion of bacteria recovered from each embryo are shown in pie 
charts(with red and blue representing Kan and Ery respectively). The number inside 


















Figure 4.22 Population evenness of embryos infected with isogenic strains 
Embryos were treated with clodronate or PBS liposomes and infected with a 1:1 
mixture of isogenic strains with Kan and Ery markers. A) population evenness of 
clodronate treated embryos B) population evenness of PBS treated embryos. Line = 
mean linear regression. Linear regression: A) P=0.735, F= 0.1156, R2=0.0018 B) P= 







 Following infection dynamics with labelled neutrophils and 
macrophages  
Tg(mpx:gfp)I114 and Tg(mpeg:mCherry x CAAX)SH378 were cross bred to produce Tg(mpx:gfp, 
mpeg:mCherry xCAAX)I114, SH378 embryos. Embryos were screened after dechorionation at 24 hpf 
and embryos that were positive for both GFP neutrophils and mCherry macrophages were selected. 
At 30 hpf, embryos were infected with ~2000 CFU JE2-mCherry and mounted for LSFM. Although 
both the bacteria and macrophages are labelled with the same fluorophore (mCherry) the 
Tg(mpeg:mCherry x CAAX) I114, SH378  labels the perforin-2 protein (encoded by mpeg1) which is an 
integral membrane component of the macrophage, as such it is possible to resolve bacteria within 
the macrophages even though they express the same fluorophore. 
 Initially imaging began whilst there were still extracellular bacteria, at 2.5 hpi and a MaxIP of the 
multiple FOV covering the circulation valley are shown in Figure 4.23. A timecourse imaging every 
20 minutes was started from 4 hpi, a MaxIP of the multiple FOV covering the circulation at the 
beginning of the timecourse is shown in Figure 4.24. At the beginning of this timecourse 
experiment bacteria have been phagocytosed and are not visible within the circulation at 4 hpi. The 
JE2-mCherry used in this experiment produce a stronger signal when excited by 561nm laser and 
are clearly visible within the mCherry labelled macrophages of which only the membrane expresses 
the mCherry fluorophore, where labelling is not as strong.  
During the experiment a lesion forms and is visible in multiple FOV from 6 hpi, a MaxIP of the time 
course can be viewed in ‘Video 14- dual labelled embryo JE2-mCherry 4 hpi onwards view 5 
MaxIP’ and the a MaxIP of the timecourse imaged 43° rotation can be viewed in ‘Video 15 – dual 
labelled embryo JE2-mCherry 4 hpi onwards view 1 MaxIP’.  
The lesion seemingly originates from an area occupied by 3 macrophages (mCherry) and a 
neutrophil (GFP) all of which have internalised bacteria (mCherry); the macrophages in this area in 
particular have a high number of intracellular S. aureus. To clarify the origin of initial lesion 
formation, a MaxIP of 130 slices (83 µm thick) from the z-stack of FOV 5 was made for the first 10 
time points and can be viewed in ‘Video 16- dual labelled embryo JE2-mCherry 4 hpi onwards 
view 5 subset t1-10 z340-460 MaxIP’ at the 5th time point (5.66 hpi) a macrophage appears to 
lyse and at the 6th time point (6 hpi) extracellular bacteria are visible in the area. A 3D 
reconstruction of this volume was performed and the first 10 timepoints can be seen in ‘Video 17 – 
rotating 3D render of dual labelled embryo JE2-mCherry 4 hpi onwards view 5 subset t1-10 
z340-460 MaxIP’ this shows distinct macrophages with internalised bacteria at timepoints 1-4, at 
the 5th timepoint the signal in the same volume becomes diffuse, a 3D rendering of timepoints 3 (5 





 A MaxIP of 200 slices (128 µm thick) from the z-stack of FOV 1, 43° rotation of the same volume 
can be viewed in ‘Video 18 - dual labelled embryo JE2-mCherry 4 hpi onwards view 1  subset 
z450-650 MaxIP’  this FOV has been cropped to center around formation of the lesion. This angle 
also shows that timepoint prior to the 5th timepoint bacteria in the region are all internalised, with 
intense bright mCherry signal coming from internalised bacteria within macrophages at timepoints 
1-4. The 5th timepoint has diffuse mCherry in this ROI where previously a large macrophage with 
internalised JE2-mCherry occupied the area. A MaxIP of the same 200 slices (128 µm) for the whole 
FOV (1) can be viewed in ‘Video 19- dual labelled embryo infected with JE2 mCherry 4 hpi 
view 1 z450-650 MaxIP’ 
A 3D reconstruction of the lesion at 17 hpi from FOV 5 is shown in Figure 4.26 and video showing 
the interaction of the labelled phagocytes around the bacterial aggregate can be seen in ‘Video 20- 
dual labelled JE2-mCherry lesion t39 view 5 rotation’. Due to the macrophages and bacteria 
both being labelled with mCherry it was not possible to perform segmentation co-localistion 







Figure 4.23MaxIP of dual labelled embryo infected with JE2-mCherry 2.5 hpi  
A) MaxIP of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114,SH378 embryo (with GFP neutrophils and 
mCherry macrophages) infected with JE2-mCherry imaged by LSFM at 2.5 hpi. FOV were acquired 
at the same imaging angle to cover the circulation valley (ROI circled in purple) order of FOV 
acquisition numbered in outer corner of each image. B)  Schematic of embryo in ventral orientation 


















Figure 4.24 MaxIP of dual labelled embryo infected with JE2-mCherry 4 hpi 
A) MaxIP of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114,SH260 embryo (with GFP neutrophils and 
mCherry macrophages) infected with JE2-mCherry imaged by LSFM at 4 hpi. FOV were 
acquired at the same imaging angle to cover circulation valley (ROI circled in purple). Dashed 
outline shows region of overlap between FOV 4 and 5 which became FOV 7, order of FOV 
acquisition numbered in outer corner of each image. B) schematic of embryo in ventral 












Figure 4.25 3D rendering of dual labelled embryo FOV 5 
Subset of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114,SH260 embryo (with GFP neutrophils and mCherry 
macrophages) FOV 5, 120 slices 0.64 µm thick (83 µm) was reconstructed in Arvivis A) ROI at 5 hpi 
B) ROI at 5.66 hpi. Gridlines are 30 x 30 µm, with 6 µm gradations   C) Schematic of embryo in 
ventral orientation with purple box for approximation of reconstructed region. At 5.66 hpi (B) 
distinct punctate signal is observed in a diffuse area, previously occupied by a macrophage 











Figure 4.26 3D reconstruction of JE2-mCherry lesion within dual labelled embryo 
A) 3D rendering of of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114,SH260 embryo (with GFP neutrophils 
and mCherry macrophages) imaged by LSFM, FOV 5 at 17 hpi B) Schematic of embryo in ventral 









 Development of smURFP as a reporter for labelling S. aureus during 
infection 
It is desirable to have another fluorophore, that could be expressed by S. aureus, complementary to 
GFP & mCherry to enable three colour imaging. Far-red (FR) and near infra-red (NIR) proteins are 
an attractive candidates as these wavelengths minimise light-scattering and absorbance by 
endogenous tissue, so there is reduced auto-fluorescence from living samples in the emission 
wavelengths of these channels (Jun et al., 2017). Previously, a method of staining S. aureus with 
Alexa fluor 647 succinimidyl ester was developed  (Serba, 2015), which is useful for imaging S. 
aureus within embryos in the initial stages of infection, however this protocol stains the cell wall, so 
signal intensity is lost as the bacteria replicate within the host. It is therefore necessary to have a 
fluorophore genetically encoded for long term imaging. 
A novel far red fluorescent protein has recently been developed (Rodriguez et al., 2016); this 
protein has been engineered without a chromophore: formation of these can be energetically costly 
to produce, take hours within the bacteria and produce ROS as a by-product. Instead the protein, 
small ultra-red fluorescent protein (smURFP) makes use of the native chromophore biliverdin (BV) 
and binds it covalently(Rodriguez et al., 2016). This reporter is the brightest FR protein created to 
date, (Luker et al., 2015; Rodriguez et al., 2016) with 96% molecular brightness relative to eGFP 
compared with 49% of mCardinal, previously the brightest FR fluorescent protein (Chu et al., 2014; 
Luker et al., 2015).  smURFP has high photo-stability needed for long-term imaging, comparable to 
eGFP and higher than mCherry, tdTomato fluorescent proteins. 
Developed for use in tissue culture and studies using animal models, without confirmed success in 
bacteria (although the protein has been engineered from light-harvesting phycobiliproteins of the 
cyanobacteria Trichodesmium erythraeum) smURFP was used as a candidate fluorophore for a 
constitutive far red marker in S. aureus. 
4.10.1 Gibson assembly of pMV158-smURFP 
The published sequence, GenBank: KX449134.1 was codon optimised for expression by S. aureus 
(appendix 8.1), and synthetic DNA was ordered. The plasmid pMV158-mCherry (Stephane Mesnage 
unpublished) was chosen for the plasmid backbone, the promoter controlling expression of the 
fluorophore is pMal1 promoter, which provides constitutive expression in S. aureus.  The plasmid 
was isolated by midi-prep from strain SJF4308 and digested with NdeI & BglII to remove the 
fragment encoding mCherry, producing a linearised plasmid backbone of 6607 bp (Figure 4.27).  
Primers ‘smURFP_forward’ & ‘smURFP_reverse’ (Table 4.1) were designed for Gibson assembly and 





The two fragments were combined by Gibson assembly, the recombinant plasmid was purified by 
gel electrophoresis and the product was recovered by gel extraction, Figure 4.27 depicts the Gibson 
assembly and Figure 4.28 shows the plasmid map. 
4.10.2 Creation of smURFP S. aureus strains 
The resulting plasmid was transformed by electroporation into electro-competent S. aureus strain 
RN4220 and grown on Tet (5). Colonies containing resistance to Tet were isolated and the plasmid 
was moved by phage transduction by φ11 into the WT strains SH1000 & JE2. Colonies of both 
SH1000 & JE2 which grew on selective media after transduction were isolated, producing SH1000-
smURFP & JE2-smURFP.  
4.10.3 Confirmation of smURFP fluorescence  
Isolated colonies were grown in selective media and Tg(mpx:GFP)i114 embryos (with GFP labelled 
neutrophils) were infected with either SH1000-pMV158smURFP or JE2-pMV158smURFP and 
mounted in 0.8 % (w/v) LMP agarose for imaging by LSFM. Both fluorophores were excited on the 
same imaging track, as they are spectrally distinct, using the usual filter set previously described in 
3.5.2; the 638 nm laser was used to excite S. aureus expressing smURFP. The fluorophore was very 
bright, needing only 1.5 % laser power, 30 ms exposure time to produce 632 grey levels with low 
background levels, in comparison with 2.8 % laser, 30 ms exposure time to prodce 550 grey levels 
detected from the 488 nm (GFP) laser. Individual JE2-smURFP and SH1000 smURFP are visible 
within brightly labelled GFP neutrophils of the host (Figure 4.29). 
4.10.4 Time-lapse imaging of smURFP in vivo 
Timecourse imaging of Tg(mpx:GFP)i114 infected with JE2-pMV158smURFP by LSFM was set up 
overnight, from 2 hpi, imaging 6 FOV every 20 min to ensure that the novel fluorophore can 
undergo long-term imaging without photobleaching. Subsequent to overnight imaging, a second 
timecourse at 23 hpi, of a single FOV (containing some bacterial aggregates) was imaged 
continuously for 10 minutes, . A MaxIP of this can be seen in ‘Video 21- Short term timecourse of 








Figure 4.27 Plasmid design and assembly for pMV158_smURFP 




















Figure 4.29 Individual S. aureus expressing smURFP resolved within a neutrophil 
MaxIP of Tg(mpx:GFP)i114 embryos (GFP neutrophils) infected with either A) JE2-pMV158smURFP 













Figure 4.30 MaxIP of embryo infected with JE2-pMV158smURFP 22 hpi 
A) MaxIP of Tg(mpx:GFP)i114 embryos (GFP neutrophils) infected with JE2-pMV158smURFP imaged 











Figure 4.31 MaxIP of embryos infected with JE2-pMV158smURFP 20 hpi 
A) and C) MaxIP of Tg(mpx:GFP, mpeg:mCherry x CAAX) i114, SH260  (GFP neutrophils and mCherry 
macrophages) with brightfield image for orientation with the embryo. Distinct smURFP bacteria 
can be observed within the macrophages  at 20 hpi. B & D) schematics of embryo in ventral 
orientation with purple squares for approximation of FOV for A) and C) respectively.
A     50 







  Discussion 
In this chapter LSFM was used to investigate infection progression of S. aureus within a zebrafish 
host, utilising fluorescent bacteria and transgenic zebrafish lines. Whilst this technique has low 
throughput and therefore does not lend itself to statistical analysis when the event of lesion 
formation has occurred within the host, initial expansion events of bacteria can be traced back to 
around 6-8 hpi before subsequent lesion formation and overwhelming infection occurs.  
Throughout this chapter it has been shown that there are trends of more signal from internalised 
bacteria in macrophages then in neutrophils and a higher proportion of the macrophage population 
have internalised bacteria; often many neutrophils contain no bacteria even when terminally 
infected. Although recent addition of analysis modules to Arivis4D can provide statistical analysis of 
this within the sample, comparison between samples is not possible due to differences in imaging 
volumes and length of timecourse experiments and is beyond the scope of this study.  
When overwhelming infection has occurred during long-term imaging, bacteria have been observed 
to come from within a macrophage prior to expansion. The number of expansion events that have 
been captured by LSFM is low, but bacteria have not been observed to expand from within a 
labelled neutrophil, although more replicates would be needed to definitively prove that this does 
not occur. 
To further investigate the dynamics of S. aureus infection and the role of macrophages in clonal 
expansion of bacteria within the host, clodronate liposomes were used to deplete macrophages. 
There was 0% survival of macrophage depleted embryos at 92 hpi, in comparison with 40-50% in 
control groups infected with the same inoculum. There was no difference in bacterial burden of 
terminally infected macrophage depleted embryos and control embryos. By infection with two 
isogenic strains the effect of macrophages on clonal expansion of S. aureus within the host was 
investigated. There is a decrease in species evenness between the two isogenic strains recovered 
from terminally infected control embryos as time post infection increases, however evenness of 
isogenic strains recovered from macrophage depleted embryos does not decrease overtime. The 
distribution of species evenness was significantly different (Mann-Whitney, P = 0.0023) between 
macrophage depleted and control groups. These data implicate macrophages as an immunological 
bottle neck which results in predominance of one isogenic strain that proceeds to overwhelm the 
host.  
When overwhelming infection has occurred, S. aureus has a propensity to spread over membranes 
within the host, which has not previously been observed within this infection model. However, this 
observation is not surprising as S. aureus colonises human naso-pharynx (DeLeo et al., 2010) and 





caused by the pathogen such as endocarditis, chronic wound infection and infection of lung 
epithelia in cystic fibrosis patients (Bhattacharya et al., 2015). Biofilms are also associated with 
these diseases and it is possible that these layers of S. aureus within the embryos and the lesions 
that form are biofilms forming in vivo. 
To enable timelapse imaging with three fluorophores, a plasmid encoding a novel NIR fluorescent 
protein was designed and transduced into the WT strain JE2 & SH1000. The resulting JE2-
pMV158smURFP & SH1000-pMV158smURFP strains fluoresce brightly when excited by a 638 nm 
laser and did not photobleach during overnight timelapse imaging; the bacteria are easily resolved 
within host immune cells. The NIR fluorescent protein smURFP does not have an electron accepting 
chromophore, designed for use in mammalian culture utilising native chromophores such as heme 
(Rodriguez et al., 2016). As a result of this it was possible that the fluorescent protein might not 
work when expressed by S. aureus. It is possible that staphyloxanthin, the carotenoid natively 
produced by S. aureus, performs the chromophore role as the structure (Pelz et al., 2005) is not 
dissimilar to the that of the native biliprotein produced by the cyano bacteria that the smURFP 
fluorescent protein was engineed from (Rodriguez et al., 2016). 
Expression of smURFP by S. aureus on multicopy plasmid pMV158-smURFP was successful and the 
produced fluorophore is bright and does not photo-bleach during long -term imaging. As such it 
would be useful to have the NIR fluorophore as a single copy on the chromosome with expression 
under the control by the same promoter (PmalM) integrated at the lipase locus, the same as the 
chromosomal mCherry & GFP strains used in this study. A suicide plasmid using the pKASBAR 
vector system (Bottomley et al., 2014; Wacnik, K., 2016) has been designed and primers have been 
made for the production of this plasmid by Gibson assembly using the smURFP under control of 
PmalM from the plasmid pMV158-smURFP with plasmid backbone pGM074, the resulting plasmid 
is shown in Figure 4.32. Production of S. aureus strains with chromosomally encoded constitutively 
expressed NIR fluorophore would enable long term imaging of the S. aureus within a host with 
multiple cell types labelled with GFP and mCherry. The ability to image three fluorophores 
simultaneously over extended time scales would allow further insight into the dynamics of 
interaction between S. aureus and the zebrafish host. As the resultant strains would be isogenic to 
SH1000-GFP, SH1000-mCherry, JE2-GFP & JE2-mCherry, used in this study, experiments with a 
mixed inoculum and labelled host cells could be performed, to examine formation of clonal lesions 














5 Evaluation of S. aureus in vivo lesions as biofilms 
 Introduction 
Within the host S. aureus has the propensity to attach and persist on surfaces, these can be either 
biotic such as bone and heart valves (causing osteomyelitis and endocarditis respectively) or 
abiotic such as cathethers, bone prostheses and pacemakers (Barrett and Atkins, 2014; Chatterjee 
et al., 2014; Kiedrowski and Horswill, 2011; Lister and Horswill, 2014) and even facial fillers (which 
contain a hyaluronic acid matrix) used in aesthetic procedures (Dumitraşcu and Georgescu, 2013). 
Host components or synthetic material surfaces, are targeted by adhesins produced on the surface 
of S. aureus. Of these, the microbial surface components recognising adhesive matrix molecules 
(MSCRAMMs) mediate attachment to host components such as fibronectin, collagen and fibrinogen 
(Corrigan et al., 2007; Foster et al., 2014; Merino et al., 2009; O’Neill et al., 2008). 
 Once attached to a surface, S. aureus become embedded in an extracellular, polymeric matrix 
(ECM) comprised of both environmental factors and eDNA, polysaccharide and proteins secreted by 
the bacteria. These can cause chronic infections which are difficult to treat as the biofilm impedes 
the host immune response, such as phagocytosis by macrophages (Scherr et al., 2014). The bacteria 
within a biofilm have increased tolerance to antibiotics, resulting from their physiological status 
and lack of access, rather than acquired resistance (de la Fuente-Núñez et al., 2013). Due to their 
lowered susceptibility to antibiotics and host defences, biofilm associated infections are difficult to 
treat, often requiring removal of an implanted device or physical debridement of infected host 
tissue (Darouiche, 2004). 
Biofilms are defined as “an aggregate of microorganisms in which cells are frequently embedded 
within a self-produced matrix of extracellular polymeric substance, adhere to each other and/or to 
a surface” (IUPAC definition). S. aureus which have adopted this sessile state, have a distinct 
phenotype and although the anoxic environment results in lower rates of metabolism and down-
regulated cell division (Lewis, 2010) rather than being dormant, maturation of the biofilm is a 
highly regulated process (Moormeier and Bayles, 2017b). Previously accepted as a three-stage 
process 1) attachment 2) accumulation 3) detachment/dispersal, recent insights into the 
development of S. aureus has redefined it as a 5 stage developmental process shown in Figure 5.1. 
This new model for biofilm development consists of; 1) attachment 2) multiplication 3) exodus 4) 
multiplication 5) dispersal  (Moormeier and Bayles, 2017b). It includes distinct characteristics of 
ECM during development (Kiedrowski et al., 2014; Moormeier et al., 2014; Otto, 2013; Schwartz et 
al., 2015) and differential gene expression controlled by numerous regulators including: Agr, SarA, 
SaeRS and σB (Archer et al., 2011; Beenken et al., 2010; Moormeier et al., 2014; Valle et al., 2003; 





differentially expressed to allow the appropriate temporal and spatial development. Study of these 
key mediators allow biofilm progression to be investigated and understood. 
5.1.1 Nuclease 
Nuclease (Nuc) is a S. aureus secreted protein which has robust DNase & RNase properties, working 
on both single and double stranded DNA (Cuatrecasas et al., 1967). It was one of the first enzymes 
to be investigated extensively with folding and structural studies. Production of this enzyme is 
conserved across both methicillin sensitive and MRSA strains (Kiedrowski et al., 2011) and as such 
can be used as a bio-marker for the direct detection of S. aureus in blood cultures (Lagacé-Wiens et 
al., 2007). 
 Nuc is responsible for the degradation of eDNA within the biofilm matrix and has been shown 
repeatedly to decrease cell density within the biofilm (Kiedrowski et al., 2011, 2014; Mann et al., 
2009; Moormeier et al., 2014)  Expression of nuclease in mature biofilms is putatively triggered by 
quorum sensing (Cheung et al., 2011) in response to cell density. In S. aureus the quorum-sensing 
system is controlled by Agr, a major-regulator of gene expression (Rutherford and Bassler, 2012). 
In addition to expression in mature biofilms, more recently Nuc has been shown to be responsible 
for a newly characterised stage of biofilm development ‘the exodus’ phase, where after confluence 
is reached, expression of Nuc by a subpopulation of bacteria results in the detachment of most of 
the biofilm population (Moormeier et al., 2014). Surprisingly expression of nuc at this stage is 
independent of regulation by Agr. Recently it has been shown that nuclease expression is under the 
control of the regulator SaeRS (Olson et al., 2013), a two-component regulatory system, controlling 
expression of many S. aureus virulence factors where no Nuc dependant exodus event occurs in an 
saeRS mutant (Moormeier et al., 2014). 
Although Nuc was first identified in 1956 by Cunningham et al., (1956), only recently has the 
importance of the protein in pathogenesis been investigated. As such, Nuc has been described as a 
virulence factor involved in the evasion of host immune defences whilst establishing infection 
within the host (Berends et al., 2010; Olson et al., 2013). There is decreased bacterial burden in 
mice 8 hours post peritoneal infection (Olson et al., 2013) and increased clearance of S. aureus from 
the lung tissue of mice infected intranasally (Berends et al., 2010) when infected with a Δnuc 
mutant. It has been proposed that the higher bacterial burden of mice infected with WT is due to 
the activity of nuclease in escaping neutrophil extracellular traps (NETs) (Berends et al., 2010), 








Figure 5.1 Stages of biofilm development – adapted from Moormeier and Bayles, 2017 
S. aureus biofilm development a) attachment to surfaces via MSCRAMMs b) cells multiply within a 
proteinaceous matrix and eDNA c) when confluency is reached there is an exodus event and a sub-
population of cells are released from the biofilm by degradation of eDNA d) three dimensional 
microcolonies form from cells that remain, during this stage there is rapid cell division e) Agr 
mediated quorum sensing initiates matrix modulation resulting in dispersal of cells via production 





antimicrobial peptides (AMPs) (von Köckritz-Blickwede and Nizet, 2009).  NET formation is a 
programmed cell death event distinct from apoptosis and necrosis, requiring the generation of ROS 
by NADPH oxidase (Fuchs et al., 2007). S. aureus has been shown to stimulate NET formation in 
vitro (Berends et al., 2010; Fuchs et al., 2007; von Köckritz-Blickwede and Nizet, 2009). 
5.1.2 Cid 
The cid operon consists of three genes, cidA, cidB, & cidC regulated by a LysR type transcriptional 
regulator, CidR. The cidR regulator responds to acetic acid accumulation in the growth media, a 
product of glucose metabolism (Rice et al., 2005). CidR positively regulates expression of cidABC 
and enhances murein hydrolase activity (Yang et al., 2005). The cidA gene encodes a putative holin 
protein, based on high similarity of the predicted secondary structure and homology (Brunskill and 
Bayles, 1996a). Fluorescent protein fusion and membrane fractionation studies have determined 
that CidA is a membrane bound protein (Ranjit et al., 2011). Mutation of the cidA gene has been 
shown to eliminate most  murein hydrolase activity of S. aureus (Rice et al., 2003). 
Recent studies have revealed CidC is a pyruvate oxidase, catalysing the removal of carboxylate from 
pyruvate forming acetate, contributing to the generation of acetic acid (Patton et al.) This activity of 
CidC, produces an environment which stimulates production of CidA and in turn, cell lysis. In 
contrast to the ‘pro-death’ actions of CidA & CidC, studies show that CidB is involved in sensing 
oxidative stress and cidB mutants are less sensitive to H2O2 (Windham et al., 2016). 
5.1.3 Lrg 
Expression of the lrgAB operon results in tower structures forming, during the ‘maturation’ stage of 
biofilm development, and it has been proposed that these structures arise due to a differential 
‘micro-niche’ experienced within the biofilm (Moormeier et al., 2013). This follows as it has been 
shown that lrgAB expression is induced during overflow metabolism, occurring during growth on 
glucose in the presence of oxygen (Rice et al., 2005). The TCS LytSR regulates expression of lrgAB 
(Brunskill and Bayles, 1996a). This TCS was initially identified as a regulator of murein hydrolase 
activity and autolysis (Brunskill and Bayles, 1996b). More recently it has been proposed that 
activity of LytSR is mediated by it’s sensing of acetyl phosphate (Sadykov and Bayles, 2012). 
Disruption of lytS abolishes expression of lrgAB within biofilms and concomitantly the rapid tower 
forming phenotype (Lehman et al., 2015). 
LrgA is a hydrophobic membrane protein and based on its secondary structure and homology is a 
putative anti-holin (Brunskill and Bayles, 1996a). LrgA is thought to decrease murein hydrolase 
activity by binding CidA thus preventing homo-tetramers from forming a pore in the bacterial 
membrane (Ranjit et al., 2011). Disruption of the lrgAB operon results in increased biofilm 





2000). In addition to this the lrgAB mutant exhibits increased lysis, strengthening its proposed role 
as an inhibitor of cell death (Mann et al., 2009) and the mutation also enhances penicillin-induced 
killing suggesting that LrgAB contributes to antibiotic tolerance exhibited by biofilms (Groicher et 
al., 2000). 
Disruption of nuc, cidABC and lrgAB operons alters the development and maturation of the biofilm. 
Together expression of these genes contributes to programmed cell death of a sub-population for 
the benefit of the rest of the population (Moormeier and Bayles, 2017b). There is a heterogeneity of 
expression profiles within the biofilm, corresponding to both spatial and metabolic variation in 
vitro (Moormeier et al., 2014). This plasticity allows the biofilm to adapt to a rapidly changing 
environment (Moormeier and Bayles, 2017b).  
Whilst biofilms are commonly isolated from patients and of great clinical importance, most biofilm 
studies are performed in vitro, and lack host factors known to be involved in the process. By 
studying the expression of biofilm associated components within the living host their impact on the 
dynamic infection process can be investigated. 
 
 Chapter aims 
 To investigate in vivo expression of components relevant to biofilm development in lesions 
formed in the zebrafish embryo model of S. aureus infection, using reporters for Nuc, Cid & 
Lrg production and different microscopic techniques to elucidate temporal and spatial 
production within biofilm-like lesions. 
 Correlate biofilm component production with infection progression using transgenic 







 Expression of Cid and Lrg in vivo 
The S. aureus strain UAMS-1 pDM4 (cid::GFP, lrg::DsRed), a WT strain containing a plasmid with 
transcriptional reporters (promoter fusions) for both Cid and Lrg production (Moormeier et al., 
2014) was initially used to test whether reporter expression was detectable within the host.  LWT 
were infected with ~2000 CFU of UAMS-1 pDM4 and embryos with visible lesions were imaged 
from 26-31 hpi using the Perkin Elmer spinning disk microscope. Figure 5.1 shows an infected 
embryo with an already formed lesion, at 26 hpi was a small focus of DsREd, the (reporter for lrg 
expression). Over the 5 hours of timelapse, expression of lrg spreads within the lesion from this 
focus. There is GFP expression distinct from the lesion, at all timepoints during imaging, the 
distribution of GFP suggests that S. aureus expression cid are inside phagocytes. 
5.4.1 Role of Cid & Lrg proteins in S. aureus pathogenesis in vivo 
Strains from the Nebraska transposon mutant library (NTML) were used to determine the 
importance of proteins Cid and Lrg in infection progression of S. aureus within the host. The strains 
NE 1466 (JE2 Tn::cidR) and NE 1726 (JE2 Tn::lrgB)  and the WT parent strain JE2, were injected 
into the circulation of Nacre WT embryos 30 hpf (Figure 5.3). There was no significant difference in 
survival of embryos infected with NE 1466 (JE2 Tn::cidR) (46.87 %) or NE 1726 (JE2 Tn::lrgB) 
(39.29 %) compared to JE2 (51.72 %) at 92 hpi , p = 0.89 and p = 0.26 (Mantel-Cox comparison) 
respectively, indicating that cidR and lrgB are not required for S. aureus pathogenesis. However, Cid 
and Lrg are both multi-component systems (CidABC and LrgAB) and recently it has been shown 
that as well as being regulated by CidR, cidABC is also repressed by the TCS SrrAB (Windham et al., 
2016) so infection with triple and double mutants is necessary to fully determine whether the 
CidABC and LrgAB holin and anti-holin system have a role in S. aureus pathogenesis. 
5.4.2 Construction of cid & lrg expression reporters in a constitutively fluorescent S. 
aureus background for in vivo imaging by microscopy 
In order to gain temporal and spatial insight into expression of cid & lrg in vivo utilising 
fluorescence microscopy, single reporters for these proteins needed to be moved into a strain with 
a background constitutive fluorescence. The strains JE2 pMV158-mCherry (SJF 4403) & JE2-
mCherry (SJF4625) which both have mCherry under the same promotor (pMal1) were compared 
on Nikon inverted Ti Dual camera microscope (LMF) and JE2 pMV158-mCherry was ~4x brighter 
(data not shown) so this strain was chosen as the background for the reporter strains.   
Strains UAMS-1 pEM80 (lrg::GFP) & UAMS-1 pEM81 (cid::DsRed) (gift from Ken Bayles, UNMC) 





Figure 5.2 Expression of cid and lrg within S. aureus lesion  
LWT embryo infected with UAMS-1 pDM4 (cidABC::GFP, lrg::DsRed) imaged 26-31 hpi, maximum 
intensity projection of fluorescence, with brightfield midstack. In the first panel (26 hpi) the region 
of auto-fluorescence from the yolk is highlighted in orange, the large lesion within the circulation is 
circled in blue. Scale bar = 200 µm. Expression of lrg (DsRed) begins at a focus within the already 
formed lesion (white arrow) and spreads over time throughout the lesion. Expression of cid (GFP) 
is seen above the lesion. From 29 hpi onwards, colocalisation of cid with lrg within the lesion is 
visible in yellow foci (indicated by purple arrowheads). 
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Figure 5.3 In vivo characterisation of strains NE 1466 (Tn::cidR), NE 1726 (Tn::lrgB) and JE2 
in the zebrafish infection model 
Survival curves for embryos infected with ~1500 CFU of JE2 (n=29), NE 1466 (Tn::cidR)(n=32) and 
NE 1726(Tn::lrgB)(n=28). There is no significant difference (Mantel-Cox comparison) in survival of 







pEM80 & pEM81 were isolated by midi prep following cell wall digestion by lysostaphin, to allow 
introduction into other S. aureus backgrounds. 
The plasmid pEM80 is reporter for lrgAB, with production of sGFP under the control of the native 
lrg promoter, the plasmid backbone is based upon pCN51 (Charpentier et al., 2004). The reporter 
plasmid pEM81 is also based upon that same backbone with production of sGFP controlled by the 
native cid promoter. 
Plasmids were subsequently transformed by electroporation into strain RN4220 and transformants 
were selected on LB containing chloramphenicol (20 µg/ml). Colonies resistant to Cm were 
selected and the plasmids were moved from RN4220 into JE2 pMV158-mCherry, SH1000 pMV158-
mCherry, JE2 and SH1000 by transduction using φ11.  
5.4.3 Expression of cid in vivo 
Nacre embryos were infected with JE2 pMV158-mCherry pEM81 (pMal1::mCherry, cid::GFP)(N = 
10) and mounted in a glass bottomed petri dish, in 0.8 % (w/v) LMP agarose 0.04 % (w/v) tricaine 
for spinning disc microscopy. Embryos were imaged from 1 hpi, where S. aureus is visible within 
unlabelled phagocytes (Figure 5.4). At this point all intracellular bacteria are expressing GFP, the 
reporter for cid expression.  The same embryos were imaged again at 20 hpi, at this time some 
embryos had visible lesions within the circulation, shown in Figure 5.5; however these lesions did 
not fluoresce when excited by either 488 nm (GFP) or 631 nm (mCherry) lasers. Bacteria not 
associated with the lesion (inside phagocytes) at this timepoint are visible in the mCherry channel. 
As mCherry is constitutively expressed, all bacteria within an embryo should fluoresce in the 
mCherry channel. To determine why there was no signal from the lesions, all embryos with visible 
lesions were homogenised for total CFU counts on plain and selective media, selection of Tet and 
Cm was used to check for the presence of plasmids pMV158-mCherry and pEM81 (cid::GFP) 
respectively.  All embryos had high bacterial burden ranging 3.3 x 105  - 2.5 x 106 CFU, but none of 
the embryos contained a bacterial population that had retained both of the plasmids, percentage of 
S. aureus recovered with Tet and Cm are shown in Figure 5.6. All samples contained both antibiotic 
markers within the population, whilst it seems that the reporter plasmid pEM81 was retained 
more, the group sizes from this experiment are not sufficient for statistical analysis. Since many 
bacteria recovered from embryos containing lesions were not resistant to Tet, this confirms that 
non-fluorescing lesions had lost the constitutively expressed plasmid, pMV158-mCherry. It is 
possible that bacteria within the host that have lost either plasmid would have a fitness benefit 
within the bacterial population, as they are likely able to replicate more rapidly as production of the 







Figure 5.4 Expression of cidABC during early stages of S. aureus infection 
Nacre (WT) embryos (no labelled host cells) infected with JE2-mCherry pMV158 
pEM81(cidABC::gfp) were imaged 1 hpi. Extended focus projections (10-20 µm) A) & B) GFP, 
mCherry & brightfield composite, C) D) and E) are the same image showing C) mCherry D) GFP E) 
mCherry, GFP & brightfield composite. S. aureus, constitutively expressing mCherry are visible 
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Figure 5.5 Expression of cidABC within Nacre embryos during late stage infection with S. 
aureus 
Two Nacre (WT) embryos (no labelled host cells) A) and B) infected with JE2-mCherry pMV158 
pEM81 (cidABC::GFP) (constitutively expressing mCherry, GFP expression controlled by native cid 
promoter) were imaged 20 hpi. Extended focus, z = (10-20 µm) Purple circle indicates large 











Figure 5.6 Proportion of antibiotic resistant  bacteria recovered from embryos with visible 
lesions  
All embryos from imaging experiment (Figure 5.5 and Figure 5.8) (Nacre infected with JE2 
pMV158-mCherry pEM80 or JE2 pMV158-mCherry pEM81) with visible lesions were homogenised 
for bacterial enumeration. Percentage of bacterial population with resistance marker is shown for 
the two groups. Cid reporter: Cm marker = pEM81 plasmid, Tet = pMV158-mCherry  












































5.4.4 Expression of lrg in vivo 
Nacre embryos were infected with JE2 pMV158-mCherry pEM80 (pMal1::mCherry, lrg::GFP) (N = 
10) and mounted in a glass bottomed petri dish, in 0.8 % (w/v) LMP agarose 0.04 % (w/v) tricaine 
for spinning disc microscopy. Embryos were imaged from 1 hpi, S. aureus constitutively expressing 
mCherry, are visible within unlabelled phagocytes shown in Figure 5.7, at this timepoint no 
production of GFP, the reporter for lrg expression, is visible. The same embryos were imaged 20 
hpi, some had visible lesions within the circulation valley, however like the lesions within embryos 
infected with JE2 pMV158-mCherry pEM81 (pMal1::mCherry, cid::GFP)  (section 5.4.3), these large 
aggregates did not fluoresce when excited by a 631nm laser (mCherry). Some lesions had regions of 
GFP within the lesion, indicating expression of lrg by bacteria within the lesion. To determine why 
there was no mCherry signal from the lesions, all embryos with visible lesions were homogenised 
for total CFU counts on plain and selective media, Tet and Cm were used to check for the presence 
of plasmids pMV158-mCherry and pEM80 respectively.  All embryos had high bacterial burden 
ranging 1.0 x 105  - 1.2 x 106 CFU, none of the embryos contained a bacterial population that had 
retained both of the plasmids, percentage of S. aureus recovered with Tet and Cm are shown in 
Figure 5.6. All samples had populations containing either resistance markers and neither pMV158-
mCherry or pEM80 appear more dominant within the group of embryos that had formed lesions, 
however the group size (N =5) is was insufficient for statistical analysis. When the population 
percentages for all embryos with lesions are considered together (both groups infected with JE2 
pMV158-mCherry pEM81 and JE2 pMV158-mCherry pEM80) there is no significant difference 
between proportion of the population that carries Tet (pMV158-mCherry) or Cm (cid/lrg reporter), 
Two-way ANOVA, p = 0.544.  
To investigate plasmid retention of reporter strains groups of LWT embryos were infected with the 
strains JE2 pMV158-mCherry pEM80 or JE2 pMV158-mCherry pEM81, ~1500 CFU. Following 
infection, all embryos with visible lesions were collected (N =10 & N = 11 respectively), 
homogenised and plated on selective media for enumeration (data not shown). Two-way ANOVA 
found no statistical difference between the distribution proportions of pMV158-mCherry and 
pEM81 recovered (p = 0.560) and no statistical difference between the distribution proportions 
pMV158-mCherry and pEM80 recovered from the embryos (p = 0.259). Neither the reporter 
plasmids, or constitutive plasmids are more likely to be retained by the bacteria that overwhelm 
the embryo. It is evident that both plasmids cannot be tolerated by the same strain and the lack of 






Figure 5.7 Expression of lrgAB during early stages of S. aureus infection 
Nacre embryos infected with JE2 pMV158-mCherry pEM80 (lrg::GFP), imaged 1 hpi, extended focus 
projections (10-20 µm). A) & B) GFP, mCherry & brightfield composite, C) D) and E) are the same 
image showing C) mCherry D) GFP E) mCherry, GFP & brightfield composite. S. aureus, 
constitutively expressing mCherry are visible within cells, no signal was detected from bacteria in 
the GFP channel at this timepoint.  
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Figure 5.8 Expression of lrg within Nacre embryos during late stage infection with S. aureus 
Two Nacre (WT) embryos (no labelled host cells) A) and B) infected with JE2-mCherry pMV158 
pEM80 (lrg::GFP)(constitutively expressing mCherry, GFP expression controlled by native lrg 
promoter) were imaged 20 hpi. Extended focus, z = (10-20 µm) Purple circle indicates large 











 Construction of cid & lrg reporters integrated in the chromosomal 
background 
To circumvent the problem with the constitutive expression of the background and the reporter 
from a plasmid, a chromosomally located fusion was used. Strains with mCherry under the control 
of the pMal1 promoter, integrated at the geh locus on the chromosome, as described by (Pollitt et 
al., 2018) were chosen as the strain background for the cid and lrg promoter fusions. The plasmids 
pEM80 and pEM81 were transferred by phage transduction into strains JE2-mCherry, SH1000-
mCherry, JE2 & SH1000. Resultant colonies resistant to Cm were isolated and re-streaked onto 
media containing both Tet & Cm creating the strains JE2-mCherry pEM80, SH1000-mCherry 
pEM80, JE2 pEM80 & SH1000 pEM80, JE2-mCherry pEM81, SH1000-mCherry pEM81, JE2 pEM81 & 
SH1000 pEM81. Presence of plasmids pEM80 & pEM81 was confirmed by isolation by mini prep, 
followed by restriction digest by BamHI to linearise the plasmid and analysis by agarose gel 
showed a band of ~6400 bp from all samples (data not shown). 
5.5.1 Comparison of pathogenesis of cid and lrg reporter strains with WT 
To ensure that the addition of the reporter plasmids does not impact infection dynamics of S. 
aureus within a zebrafish embryo host, the strains JE2-mCherry pEM80 (GFP cid reporter), JE2-
mCherry pEM81 (GFP lrg reporter) and JE2-mCherry were injected into the circulation valley of 
LWT embryos, 30 hpf (~1500 CFU) and survival was monitored, Figure 5.9. In all biological 
replicates, survival was slightly higher in groups infected with reporter strains, at 92 hpi survival 
was 39.3 %, 55.8% for reporter strains pEM80 and pEM81 respectively, in comparison with 36.7 % 
of the parental strain (Figure 5.9). There was no significant difference (Mantel-Cox curve 
comparison) between groups infected with JE2-mCherry pEM80 and JE2-mCherry pEM81 and the 
parental JE2-mCherry strain (p = 0.75, p = 0.145 respectively); this result indicates that imaging 
experiments performed to examine cid and lrg expression with these strains are representative of 







Figure 5.9 Infection of LWT with fluorescent reporter strains  
Survival curves for LWT embryos infected with ~1500 CFU of JE2-mCherry (n=30),  
JE2-mCherry pEM80 (lrg::GFP) (n=28) and JE2-mCherry pEM81(cid::GFP) (n=34). 
There is no significant difference (Mantel-Cox comparison) in survival of embryos 
infected with JE2-mCherry pEM80 (lrg::GFP) and JE2-mCherry pEM81 (cid::GFP) in 







5.5.2 Expression of cid in lesions in vivo 
Nacre embryos (N = 28) were infected 30 hpf with JE2-mCherry pEM81(cid::GFP), ~2000 CFU via 
the circulation valley. At 26 hpi embryos with visible lesions (N = 5) were mounted for microscopy 
in 0.8 % (w/v) LMP agarose in E3 containing 0.04 % (w/v) tricaine. Embryos were imaged by 
LSFM, demonstrating no GFP expression (from the cid reporter) in any of the samples imaged in 
this experiment, but as expected mCherry expression was found throughout all lesions. A 3D 
reconstruction of one of these embryos is shown in ‘Video 22 – Nacre embryo infected with JE2-
mCherry pEM81’.  When homogenised after imaging, all bacterial burdens (N=5, 1.1 – 1.8 x 105  
CFU/embryo) were comparable when plated on plain and selective (Cm) media, indicating that the 
lack of GFP signal in this preliminary experiment was due to lack of expression of cid within the 
lesion, as opposed to loss of the reporter plasmid that was experienced with previous strains. 
Repeats using larger initial infection groups for single time point imaging may reveal expression of 
Cid within the lesion. Ideally long-term timelapse imaging of embryos with formed lesions by LSFM 
should provide more insight into real-time temporal expression of Cid within lesions in vivo. 
 
5.5.3 Expression of lrg in lesions in vivo 
Nacre Embryos (N = 24) were infected 30 hpf with JE2-mCherry pEM80, ~2000 CFU via the 
circulation valley. At 26 hpi embryos with visible lesions (N = 4) were mounted for microscopy in 
0.8 % (w/v) LMP agarose in E3 containing 0.04 % (w/v) tricaine. Embryos were imaged by LSFM, 
and GFP expression was found in all large lesions (>50 µm) at this timepoint. A MaxIP is shown in 
Figure 5.10, where most of the lesion within the circulation valley is expressing GFP, the reporter 
for lrg expression, at this single timepoint. All lesions expressed the constitutive mCherry 
throughout. Subsequent to imaging, all embryos were homogenised and bacterial burdens (N = 4, 
0.9 – 1.9 x 105 CFU/ embryo) were comparable when plated on plain and selective media (Cm), 
demonstrating that the plasmid (pEM80) is stable in the background of JE2-mCherry. Repeats of 
this preliminary experiment, with larger initial infection groups (more lesions at this timepoint) 
and may provide more insight into the topological expression of Lrg within the lesion. Time-lapse 
imaging from an earlier timepoint (20 hpi) might provide information about temporal control of 








Figure 5.10 Expression of lrg within a lesion in vivo 
A) MaxIP of Nacre embryo (no labelled immune cells) infected with JE2-mCherry pEM80 (lrg::GFP) 
(constitutive expression of mCherry, GFP lrg reporter) imaged by LSFM 26 hpi. Circulation of 
embryo was imaged laterally. A lesion ~100 x ~50 um is visible within the circulation, GFP signal is 
visible throughout most of the lesion showing expression of lrg at this timepoint, with two distinct 
foci of expression also at the top of the lesion. A smaller secondary lesion, not expressing GFP is also 
visible at the top of the circulation. B) schematic of embryo in laterral oriention, purple square for 










 Role of Nuc in S. aureus pathogenesis in vivo 
To determine whether the nuc reporter plasmid pCM20 (nuc::GFP) affects pathogenesis UAMS-1 
pCM20 (nuc::GFP) and its parent UAMS-1 were injected (~2000 CFU)  into the zebrafish circulation 
valley 30 hpf. UAMS-1 pCM20 (nuc::GFP)had virulence comparable to the parent strain UAMS-1 
(Figure 5.11). For comparison the Nuc mutant UAMS-1 Δnuc was also injected into the zebrafish 
and was significantly attenuated compared to the parent strain (p = 0.0014) indicating that 
expression of nuc is important for infection progression (Figure 5.11). 
5.6.1 Construction of a nuc reporter in a constitutively fluorescent background 
The strain UAMS-1 pCM20 contains a reporter plasmid for Nuc, with sGFP under the native 
promoter for Nuc as described in Kiedrowski et al., 2011. In order to visualise the bacteria 
irrespective of nuc expression within a fluorescence microscope the plasmid required transferral to 
a strain with constitutive fluorescence from a contrasting fluorophore. After the problems 
encountered with the plasmid incompatibility of pEM80 and pEM81 promoter fusions with the 
constitutive pMV158-mCherry strains, JE2-mCherry (mCherry encoded on the chromosome at geh 
locus) was chosen as the background. As previously described (section 3.1), the chromosomal JE2-
mCherry strain (SJF 4625) had shown affected Tet resistance when recovered from a murine 
infection model so had been supplemented with an Ery resistance cassette (strain SJF 4634) 
As erythromycin is the resistance marker for pCM20 (nuc::GFP) plasmid, the previous SH1000-
mCherry & JE2-mCherry strains (SJF 4622, SJF4625) with affected tetracycline resistance were 
used as the parental strain.  
SH1000-mCherry (SJF4622) and JE2-mCherry (SJF4625) were streaked out from -80 °C stocks on 
TSB containing no antibiotics and Tet 2.5 µg/ml, 5 µg/ml, 10 µg/ml, both strains grew on all 
concentrations of Tet and colonies were comparable to plain TSB (data not shown). These strains 
were also streaked out on Ery 2.5 µg/ml, 5 µg/ml, 10 µg/ml; neither SJF4622 or SJF4625 grew on 
any concentration of Ery, as expected. Both SJF4622 and SJF4625 grow a yield similar to WT when 
cultured overnight in a working concentration of Tet. Presence of the fluorophore was confirmed 
by excitation by 561 nm laser in Z1 light sheet microscope. 
When recovered from infected embryos CFU counts on Tet (5 µg/ml) were comparable to plain 
media. As both strains grew on double working concentration of Tet and reach an expected density 
overnight, it seems neither has ‘affected’ resistance and both have a working copy of mCherry, 
rendering them suitable as the background for the Nuc reporter.  
Attempts to propagate bacteriophage φ11 or φ89 on UAMS-1 pCM20 were unsuccessful; an 





prep. The plasmid was transformed by electroporation into electrocompetent RN4220 and grown 
on erythromycin.  Colonies resistant to erythromycin were selected and the plasmid was 
transferred by phage transduction with φ11 into the strains JE2-mCherry (SJF 4625), SH1000-
mCherry (4625), JE2 & SH1000, creating the strains JE2-mCherry pCM20 (nuc::GFP), SH1000-
mCherry pCM20 (nuc::GFP), JE2 pCM20 (nuc::GFP), and SH1000 pCM20 (nuc::GFP). 
 Expression of nuc in vivo 
5.7.1 Expression of nuc in lesions 
To investigate whether lesions that form within embryos express nuc, Tg(lyzC:mCherry)SH260 (with 
mCherry labelled neutrophils) were infected with JE2-mCherry pCM20 (constitutively labelled 
mCherry, GFP Nuc reporter). Embryos with established lesions were mounted in 0.8% (w/v) LMP 
agarose and imaged by LSFM 24-28 hpi. At this point of infection all established lesions (>50 µm) 
express nuc. Figure 5.12 is a projection of a 3D reconstruction of a large lesion expressing nuc, S. 
aureus has disseminated, and extracellular bacteria are visible within the circulation of the embryo, 
the rectangle highlights a volume of bacteria, not expressing nuc are visible within the circulation, 
some of these ‘aggregates’ could be inside labelled neutrophils. A fly-through of this region, 
showing individual bacteria can be viewed in in ‘Video 23 -flythrough of region containing non-
lesion associated S. aureus within lyz:mCherry embryo 24 hpi’. A rotating 3D reconstruction of 
this can be viewed in ‘Video 24 - 3D reconstruction of large lesion expressing nuc within 
lyz:mCherry embryo 24 hpi’. Reconstruction of an embryo 24 hpi with a large lesion is shown in 
Figure 5.13, a region of the lesion ~32 x 24 µm expressing Nuc at the edge of the lesion, spanning 
the depth of the lesion. A 3D reconstruction centred on this region can be viewed in ‘Video 25 – 
Large lesion with partial expression of nuc within lyz:mCherry embryo 24 hpi’. 
To understand how nuc expression occurs over time, time lapse imaging of an embryo with large 
lesion (~200 x 200 x 280 µm), from 26 hpi was performed by LSFM. A 3D reconstruction of the first 
timepoint is shown in Figure 5.14 and a video showing a rotating 3D reconstruction as time 
progresses can be viewed in ‘Video 26- Expression of nuc in terminally infected, lyz:mCherry 
embryo’. There is an increase in GFP signal from the lesion as time progresses, between 2.66 - 3 
hours into imaging (29 hpi), the circulation valley ruptures as infection overwhelms the embryo. As 
well as large areas of nuc expression throughout the lesion, there is expression of nuc in bacteria 







Figure 5.11 In vivo characterisation of Nuc mutant and Nuc reporter strains in zebrafish 
infection model 
Survival curves for UAMS-1 (n=29), UAMS-1 pCM20 (n=30) and UAMS-1 Δnuc (n=34),  
UAMS-1 Δnuc is significantly attenuated in comparison with WT (** p<0.005 
bonferroni corrected) whereas UAMS-1 pCM20 shows no difference in virulence in 









Figure 5.12 Lesion expressing nuc within Lyz:mCherry embryo  
A) Tg(lyz:mCherry)SH260 embryo (mCherry neutrophils) infected with JE2-mCherry pCM20 
(nuc::gfp) (constitutive expression of mCherry, GFP nuc reporter) imaged by LSFM 26 hpi, 
reconstructed in Arrivis 4D. Dashed rectangle shows area of extracellular bacteria not associated 
with lesion. Grid squares = 40 x 40 µm, minor gradations = 10 µm. B) Schematic of embryo in 









Figure 5.13 Lesion expressing nuc within embryo 
A)3D projection of Tg(lyz:mCherry)SH260 embryo (mCherry neutrophils) infected with JE2-mCherry 
pCM20 (nuc::GFP) (constitutive expression of mCherry, GFP nuc reporter) imaged by LSFM 24 hpi, 
reconstructed in Arrivis 4D. Grid squares = 40 x 40 µm, minor gradations = 10 µm. Large lesion is 
visible within the circulation valley of the embryo, with a small region of nuc expression at one edge 








Figure 5.14 3D reconstruction of large lesion within embryo  
A) 3D projection of Tg(lyz:mCherry)SH260 embryo (mCherry neutrophils) infected with JE2-mCherry 
pCM20 (nuc::GFP) (constitutive expression of mCherry, GFP nuc reporter) imaged by LSFM 24 hpi, 
reconstructed in Arrivis 4D. Grid squares = 40 x 40 µm, minor gradations = 10 µm. Large lesion is 
visible within the circulation valley of the embryo, with a small region of nuc expression at one edge 
B) Schematic to show orientation of embryo, with purple rectangle representing area of 
reconstruction C) GFP channel showing areas of nuc expression D) mCherry channel showing all 








Individual, extracellular disseminated bacteria, not expressing nuc are also visible within the 
circulation of the embryo. 
To gain a more detailed insight of expression of nuc by S. aureus within a lesion, Nacre (WT) 
embryos, infected with JE2-mCherry pCM20 were imaged with Zeiss LSM 880 AiryScan microscope 
at 26 hpi. AiryScan microscopy does not pinhole light like a standard confocal microscope, instead 
it utilises a concentric, hexagonal, detector array, thus increasing the SNR. The acquired ‘Airy disc’ 
is processed by Zen, producing deconvolution, super-resolution images within a living sample 
(Huff, 2015). Figure 5.15 shows S. aureus from the lesion within the circulation of the embryo, the 
majority of these bacteria are expressing nuc. The resolution reveals individual bacteria in this 
image. To track nuc expression of individual cells within a lesion, time lapse imaging of Nacre (WT) 
embryos with  visible lesions 26 hpi was performed. Figure 5.16 shows a 3D reconstruction of a 
typical lesion at 26 hpi from this experiment, a rotating reconstruction can viewed viewed in ‘Video 
27 – Lesion expressing nuc within Nacre embryo’. This exemplifies the differential production of 
the Nuc protein by the population; however, bacteria deeper within the lesion produce lower 
fluorescence due to more scatter of fluorescent signal, as there is a longer lightpath through tissue 
to the dectector. Imaging to a depth of 100 µm by this method of microscopy over time bleaches the 
sample, even using low levels of laser power (488 nm: 0.5 % laser power, 561 nm: 1.0 % laser 
power). Figure 5.17 shows the timelapse of this volume (timepoints 2-5), with the decrease in 
fluorescence signal from bacteria within the lesion over time. Although this microscopic technique 
can give localisation of nuc expression within a lesion on a per bacteria basis, it is not suited to 
following expression of the reporters within embryos over time. 
5.7.2 Temporal and spatial localisation of nuc expression during infection 
To investigate whether nuc is expressed during the infectious process, dual labelled Tg(mpx:GFP, 
mpeg:mCherry CAAX) I114, SH378 embryos (GFP neutrophils, mCherry macrophages) were infected 
with JE2-mCherry pCM20 (nuc::GFP) and imaged from 1 hpi by LSFM. A MaxIP of the first timepoint 
is shown in Figure 5.18, there are extracellular bacteria visible in the circulation and inside both 
labelled macrophages and neutrophils. A MaxIP of the infection timecourse (FOV 6) can be viewed 
in ‘Video 28 – MaxIP of dual labelled embryo infected with JE2-mCherry pCM20’. Expression of 
Nuc by phagocytosed bacteria is visible from 9 hpi inside both neutrophils (Figure 5.19) and 
macrophages (Figure 5.20) but only by a small proportion of the phagocytosed bacteria. As both 
phagocytes and S. aureus are both labelled with both GFP and mCherry, it is difficult to determine 
whether Nuc is being expressed within neutrophils (although bacteria expressing nuc are brighter 








Figure 5.15 MaxIP S. aureus expressing nuc within a lesion  
MaxIP (8µm) of Nacre WT (no labelled phagocytes) infected with JE2-mCherry pCM20 (nuc::GFP) 
(constitutive expression of mCherry, GFP nuc reporter), 26 hpi with lesion within circulation A) 
mCherry (all S. aureus) B) GFP (Nuc expressing S. aureus) C) merge. There is differential 
expression of nuc by bacteria within the same lesion and evidence of bacterial replication in the 






Figure 5.16 3D projection of lesion expressing nuc within Nacre embryo 26 hpi 
3D reconstruction of Nacre WT (no labelled phagocytes) embryo infected with JE2-mCherry pCM20 
(nuc::GFP) (constitutive expression of mCherry, GFP nuc reporter), 26 hpi with lesion within 











Figure 5.17 Timelapse of nuc expression within a lesion 
3D reconstruction of Nacre WT (no labelled phagocytes) embryo infected with JE2-mCherry pCM20 
(constitutive expression of mCherry, GFP nuc reporter), imaged every 20 minutes from 26 hpi 
onwards. Bacteria are constitutively expressing mCherry, with differential expression of nuc. A) 
26.33 hpi B) 26.66 hpi C) 27 hpi D) 27.33 hpi repeated imaging of the same stack shows bleaching 
of the fluorescent proteins produced by the bacteria over a short time scale. 
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To avoid missing nuc expression within the embryo, FOV 6 was reconstructed in Arrivis 4D, 
macrophages were identified by segmentation analysis (diameter >10µm, mCherry) and S. aureus 
expressing nuc were identified by segmentation analysis (diameter >1.5µm, GFP) and colocalization 
analysis (objects identified by second segmentation analysis (GFP) completely covered by first 
segmentation analysis (mCherry)). This analysis can only identify S. aureus expressing nuc within 
the neutrophil if there is a large volume of S. aureus (diameter >10µm) within the neutrophil, but all 
nuc expressing S. aureus within macrophages will be identified. This analysis is more sensitive then 
manually examining individual slices within the volume, from 8 FOV over 65 timepoints, (21.66 h) 
and removes human error. This lower FOV was picked for analysis as it is further away from the 
heart, and there is less movement in the stack caused by the heartbeat. This analysis identified 
expression of nuc within the macrophage from 5.6 hpi, earlier than was detected when images were 
examined manually. Only a small proportion of the macrophages identified contained bacteria that 
were expressing nuc. Often only a few bacteria within the phagocyte will be expressing nuc, 
although the phagocyte can contain a large number of bacteria (this occurs in both neutrophils and 
macrophages). Reconstruction of the timecourse with co-localisation can be seen in ‘Video 29 - 
Colocalisation analysis of S. aureus expressing nuc within phagocytes’ with pink ‘centroids’ 
marking areas of expression of Nuc within the phagocyte (volume of centroids is not proportional 
to Nuc expression).  
The number of voxels occupied by nuc expressing S. aureus over time is shown in Figure 5.22, not 
only does the number of co-localised segments increase over time, but the volume (voxel count) of 
the co-localisation increases over time. This suggests that as time spent within the phagocyte 
increases S. aureus responds to an environmental queue which induces expression of nuc. Since the 
volume of voxels increases over time it is possible that nuc expression by an individual bacterium 
within the phagocyte, stimulates expression of nuc by other cells within the phagocyte similar to 
the way expression of nuc spreads within a lesion. The expression of nuc at this stage of the 
infectious process, when S. aureus is within the phagocyte, is potentially controlled by SaeRS, a 
known regulator of nuc  (Olson et al., 2013). SaeS of the two-component systems SarRS, is located in 
the membrane of S. aureus and responds to phagocytosis related effector molecules, alpha defensins 
(found in both neutrophils and some macrophages), hydrogen peroxide and human neutrophil 
peptide (HNPs)(Geiger et al., 2008). In the zebrafish model of systemic S. aureus infection, ROS has 
been quantified in both neutrophils and macrophages, with more ROS in neutrophils than 
macrophages (Serba, 2015). Therefore both labelled host cell types in my experiment provide an 
environment that would activate SaeRS and its ensuing upregulation of nuc.  
Interestingly macrophages containing nuc expressing bacteria appear to remain in the same region 





rotation nuc expression within macrophage, timelapse subset FOV 6, t35-37’  it is possible 
that the expression of nuclease is specific to a subpopulation of macrophages. This observation is 
suggestive of the instances when bacteria have expanded in number and escaped the macrophage, 
proceeding to overwhelm the host (see section 4.9). It could be that a type of ‘resident’ subset of the 







Figure 5.18 MaxIP of embryo with labelled macrophages and neutrophils infected with S. 
aureus reporter for nuc expression 1 hpi 
A) MaxIP of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114, SH378 embryo (with GFP neutrophils and 
mCherry macrophages) infected with JE2-mCherry pCM20 (nuc::GFP) (constitutive expression of 
mCherry, GFP nuc reporter), imaged by LSFM at 1 hpi. FOV were acquired at the same imaging 
angle to cover circulation valley (ROI circled in purple). Dashed line shows regions of overlap with 
adjacent FOV, order of FOV acquisition numbered in outer corner of each image. B) schematic of 
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Figure 5.19 Expression of nuc by S. aureus within a neutrophil  
Tg(mpx:GFP, mpeg:mCherry x CAAX)I114,SH260 embryo (GFP neutrophils, mCherry macrophages) 
infected with JE2 mCherry pCM20 pCM20 (nuc::GFP) (constitutive expression of mCherry, GFP nuc 
reporter), imaged by LSFM, 9hpi. A), B), and C) are the same MaxIP (8 µm) of 16 slices (0.5µm) 
showing A) mCherry B) GFP C) merge.  D), E), and F) are the same MaxIP (6 µm) of 12 slices 
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Figure 5.20 Expression of nuc by S. aureus within a macrophage 
Tg(mpx:gfp, mpeg:mCherry x CAAX)I114,SH260 embryo (GFP neutrophils, mCherry macrophages) 
infected with JE2 mCherry pCM20 (nuc::GFP) (constitutive expression of mCherry, GFP nuc 
reporter), imaged by LSFM, 9hpi. A), B), and C) are the same MaxIP (7.5 µm) of 15 slices (0.5µm) 
showing A) mCherry B) GFP C) merge. D), E), and F) are the same MaxIP (6 µm) of 8 slices showing 
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Figure 5.21 MaxIP of embryo with labelled macrophages and neutrophils infected with S. 
aureus reporter for nuc expression 23 hpi 
A) MaxIP of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114,SH260 embryo (with GFP neutrophils and 
mCherry macrophages) infected with JE2-mCherry pCM20 (nuc::GFP) (constitutive expression of 
mCherry, GFP nuc reporter) imaged by LSFM at 23 hpi. FOV were acquired at the same imaging 
angle to cover circulation valley (ROI circled in purple). Dashed line shows regions of overlap with 
adjacent FOV, order of FOV acquisition numbered in outer corner of each image. B) schematic of 
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Figure 5.22 Volumetric analysis of nuc expression within phagocytes 
Results of colocalization analysis of FOV 6 from timelapse imaging of Tg(mpx:GFP, mpeg:mCherry 
xCAAX)I114,SH260 embryo (GFP neutrophils, mCherry macrophages) infected with JE2-mCherry 
pCM20 (nuc::GFP) (constitutive expression of mCherry, GFP nuc reporter). The number of 
colocalization events (GFP >1µm within mCherry >10 µm) and the respective volume (in voxels) of 
each colocalization event plotted against timepoints during the experiment -timepoints every 20 



























Reporters for the expression of cid and lrg, involved in the regulation of biofilm maturation through 
their modulation of murein hydrolase activity, were investigated in vivo to determine whether the 
lesions exhibit biofilm like expression. With interesting initial results from infection with a dual Cid 
and Lrg reporter strain, single reporters in constitutively fluorescent backgrounds were made. 
Initially these were made in a background with fluorescence from the pMV158-mCherry plasmid, as 
this multi-copy plasmid is brighter than the strains with fluorescence encoded on the chromosome 
so could be used in conjunction with microscopy techniques that are less sensitive than the LSFM 
but have higher throughput. After these strains were produced, plasmid incompatibility was 
experienced despite the promoters and resistance cassettes not being listed in any published 
incompatibility tables (Lozano et al., 2012; McCarthy and Lindsay, 2012; Novick and Brodsky, 1972; 
Udo and Grubb, 1991) and the reporter plasmids were moved into the chromosomal background. 
Although time constraints meant the reporters for cid and lrg expression were not followed in real-
time during infection progression, stable reporter strains for these experiments have now been 
created to enable LSFM imaging of the cid and lrg system in vivo. Expression of cid inside 
phagocytes is likely due to the acidic environment, as cidR has been shown to be activated by low 
oxygen environment (Moormeier et al., 2014). Furthermore, a recent study has shown that the TCS 
SrrAB, also regulates cidABC transcription (Windham et al., 2016), senses H2O2 and modulates H2O2 
resistance factors. The srrAB mutant has decreased survival in stationary phase culture due to 
increased sensitivity to ROS (Mashruwala et al., 2017). Inactivation of cidB in an srrAB mutant 
rescues the phenotype of increased stationary phase and has implicated the CidB protein as a direct 
mediator of PCD in response to ROS (Windham et al., 2016).  
The expression of the cid and lrg system can now be explored within transgenic embryos with 
labelled immune components, to elucidate the environments within the host which stimulate 
production of these proteins. Mutations in the individual cidA, cidB, cidC lrgA & lrgB are now 
available and the effect of these protein on S. aureus pathogenesis within a zebrafish host can be 
explored.  
This study has determined that the nuc mutant is attenuated in the zebrafish model of systemic S. 
aureus infection, suggesting that the protein is important in pathogenesis. Production of the Nuc 
protein has been identified in both early and late stages of systemic S. aureus infection. If the 
temporal regulation of nuc expression follows the expression pattern in vitro, expression of nuc in 
the terminal stages of infection, throughout lesions, is regulated by Agr. Previous work (Prajsnar, 
2009) determined that an agr mutant is not attenuated in the zebrafish embryo systemic infection 





al., 2018; Ferreira et al., 2013; Traber et al., 2008) and has been implicated in persistence (Chong et 
al., 2013; Xu et al., 2017). It has also been observed that host mortality is negatively correlated with 
the proportion of agr mutants recovered from a bacterial population (Pollitt et al., 2013). Previous 
experiments with the agr mutant in the zebrafish infection model were conducted with a higher 
initial infection dose and McVicker et al., 2014 showed that clonal lesions do not occur in embryos 
infected with higher CFUs. It would be interesting to investigate the agr mutant infection phenotype 
and whether lesions form during infection progression, and if lesions do form whether there is nuc 
expression in lesions formed, as with WT nuc reporter strains. 
Nuc expression has been observed in intracellular bacteria inside both macrophages and 
neutrophils. This expression will be in response to the intracellular environment, as the bacterial 
population are not expressing Nuc when initially injected into the embryo. Whilst expression has 
been followed during the timecourse of infection, overwhelming infection did not occur, so it is not 
possible to determine whether Nuc production contributes to phagocyte escape leading to lesion 
formation. 
With recent developments in the Arrivis 4D processing software it would be possible to quantify 
the proportion of intracellular bacteria that express nuc during the timecourse of infection. This 
would be made simpler by transferring the nuc reporter to the newly constructed strain which 
constitutively expresses smURFP (section 4.10.2). By tracking bacteria from initial injection to 
overwhelming infection using this reporter strain, it could be determined whether expression of 
nuc within a phagocyte is responsible for escape of extracellular bacteria which proceed to 
overwhelm the host. It is also possible that attenuation of the nuc mutant in this model is due to the 
role of nuc expression in the evasion of NETs. A new transgenic zebrafish line has been produced, 
Tg(lyz:histone2a.mCherry, mpx:GFP) with mCherry labelled histones, as a reporter for NET 
formation (Isles, 2018). Infection of these embryos with S. aureus containing the nuc reporter or the 
nuc mutant with constitutive fluorescence plasmid could show NET formation and evasion by S. 








Even though the pathogen S. aureus has been characterised for over a hundred years, it still poses a 
great threat to human health, with the continuing spread of antibiotic resistance and no successful 
vaccine. Much research has determined the role of bacterial and host factors in disease interactions, 
but mostly measured at a fixed endpoint (mortality, bacterial number in organs, host chemokine 
levels etc.). 
There is still little known about disease dynamics within a host between initial infection and the 
outcome, be that resolution or the host succumbing. Intra-vital imaging is beginning to provide 
valuable insight into real-time infection dynamics both temporally and spatially. 
The use of zebrafish embryos as a model for vertebrate infection is not only attractive from an 
ethical standpoint but has a high throughput and good genetic tractability. The transparent nature 
of the zebrafish embryos and ability to fluorescently labelled specific host cells and organelles lends 
this model to microscopic evaluation. It is for these reasons that it is being used to study host-
pathogen interactions for a ever increasing number of pathogens (Ogryzko et al., 2019; Phelps and 
Neely, 2007; Prajsnar et al., 2013; Sar et al., 2003; Willis et al., 2018). 
Our lab has pioneered the use of the zebrafish model for S. aureus infection (Prajsnar et al., 2008) 
and has primarily been used to identified factors important in pathogenesis (McVicker et al., 2014; 
Prajsnar, 2009; Prajsnar et al., 2008). The survival assays are a valuable tool when investigating 
bacterial components, not just as classical virulence determinants but proteins involved 
metabolism, biosynthesis and antibiotic resistance. This model has identified that the virulence 
regulator saeR, the peroxidase regulon repressor (perR) and phenylalanine permease (pheP) as 
important virulence determinants (Prajsnar, 2009). The S. aureus mutants with disruption of purA 
and purB genes, involved in the purine biosynthesis pathway, has revealed the mutants to be 
unable to replicate in vivo (Connolly et al., 2017). More interestingly pabA (involved 
tetrahydrofolate biosynthesis) mutants are also attenuated in the systemic embryo infection model, 
but do replicate in vivo, highlighting the pyrimidine salvage pathway as a potential therapeutic 
target (Connolly et al., 2017). The model has also identified the augmentation of S. aureus 
pathogenesis by human skin commensals (Boldock et al., 2018). 
From the host side the model has also shown that both neutrophils and macrophages are essential 
for combatting S. aureus infection (Prajsnar et al., 2008; Serba, 2015). During the initial stages of 
infection there is an immune bottleneck, with phagocytes providing a niche for bacterial expansion, 





Our previous imaging methods have been limited to a small FOV, with a limited depth of imaging 
and have only been able to focus on a small number of host cells. Any imaging of samples that has 
been performed at multiple timepoints was done on embryos that were not maintained in the 
standard conditions (incubated at 28.3 °C in E3 in the absence of anesthetic).  
The work in my study has built upon our background knowledge, utilising novel microscopy 
methods to follow infection progression, in more physiologically relevant conditions throughout 
disease development. The imaging parameters in my study enable imaging of larger areas of the 
embryo and are able to track most bacteria within the host. 
 Host-pathogen dynamics 
In order to track infection progression over extended time periods, LSFM was chosen as this type of 
microscopy can be performed in physiologically relevant conditions. The Zeiss Z1 was specifically 
designed for imaging of zebrafish (Reynaud et al., 2014b).  A method was developed building on 
established LSFM protocols to mount infected embryos, incubation conditions and imaging 
parameters in order to image living samples in toto for up to 44 hpi. A proposed model of the 
dynamics of S. aureus infection within zebrafish embryos is depicted in Figure 6.1. 
From previous results it was originally hypothesised that neutrophils were the  ‘weak link’ in the 
host response, where bacterial population expansion and subsequent escape would occur (Prajsnar 
et al., 2012). In my work, escape of S. aureus from fluorescently labelled neutrophils during long-
term imaging experiments was never observed. In my model neutrophils do not appear to be 
phagocytosing many bacteria early on during infection. This could be due to the naivety of 
neutrophils at 30 hpf when embryos are injected. Conversely, when long-term imaging of 
macrophages was performed phagocytosis was observed from 1 hpi. 
Also, there were macrophages recruited to the infection site and many of these had high bacterial 
burden, to the extent that it was not possible to count individual bacteria within the macrophage. 
An example of the relative number of neutrophils and macrophages and their bacterial burden at 
2.5 hpi is shown in Figure 6.2. Furthermore, there were often infection foci with extracellular 
bacteria and macrophages with a high bacterial load.  
It was thus hypothesised that macrophages are the initial nexus for infection. Using clodronate to 
deplete macrophages within the embryos, and infection with a mixed inoculum of strains with 
different antibiotic resistance markers, macrophages were found to be the niche for clonal bacterial 
population expansion within the host. It is the failure of the macrophages to contain the bacteria in 
this model which leads to overwhelming infection; a model for this is depicted in Figure 6.3. This 






Figure 6.1 Dynamics of systemic infection of S. aureus within a zebrafish embryo host 
Schematic to show infection progression within the zebrafish embryo host. After infection of the 
circulation with S. aureus, phagocytes are recruited. The bacteria are phagocytosed, subsequently 
bacteria are either killed within the phagocyte or survive within the host cell and replicate. This 
eventually leads to phagocyte lysis upon which the bacteria are either phagocytosed by more 
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Figure 6.2 MaxIP of embryo with labelled neutrophils and macrophages infected with 
mCherry S. aureus 
A) MaxIP of Tg(mpx:GFP, mpeg:mCherry xCAAX)I114,SH260 embryo (with GFP neutrophils and 
mCherry macrophages) infected with JE2-mCherry imaged by LSFM at 2.5 hpi. White ovals 
highlight faint neutrophils which contain 0-4 bacteria. At this timepoint, there are more 
macrophages than neutrophils within the circulation (~20 and ~8 respectively in this FOV). 
The macrophages present have high bacterial burden compared with neutrophils which have 
only phagocytosed a few bacteria. B)  Schematic of embryo in ventral orientation with purple 






liver, as the niche for bacterial expansion in a systemic murine model of S. aureus infection (Pollitt 
et al., 2018). Loss of clonal expansion after infection with a mixed inoculum occurred when mice 
are treated with clodronate (Pollitt et al., 2018). 
Often in LSFM experiments, after recruitment, macrophages with a high bacterial burden remain in 
the same region over many timepoints and this is true in the instances of phagocyte escape. S. 
aureus infection results in up-regulation of genes active in the innate immune response: TNF, IL-6, 
IL-12, IL-1β, CXCL8, CCL2 and CCL5, typically associated with associated with polarisation of 
macrophages to the M-1 subtype (Benoit et al., 2008). The integrin αDβ2 (CD11d/CD18) is a 
hallmark of M-1 polarised macrophages and increased expression of the αD subunit results in 
increased adherence to inflammatory ECM (which typically contains fibronectin, thrombospondin, 
fibrinogen) and retention of M-1 macropahges (Cui et al., 2018).  
Clonal expansion was identified in Kupffer cells, resident macrophages of the liver (Pollitt et al., 
2018) and it is possible that S. aureus is targeting an immune component that is associated with the 
retention of macrophages to the tissue. 
 Reporters of virulence determinants 
Differential expression of virulence factors is the response of the pathogen to its environment and 
this plasticity enables the pathogen to acquire nutrients and adapt to the host. During the initial 
stages of infection, expression of adhesins and immune evasion proteins occur (Geiger et al., 2008) 
,many of which are regulated by the saeRS TCS (Nygaard et al., 2010). The ability to track 
expression of virulence factors within the host, within different biological niches, in real time 
provides insight to their role during infection progression. 
 In this study, expression of the saeRS regulated nuc within a living host was examined and it was 
found that nuc mutants are attenuated in the systemic embryo infection model. This work has also 
demonstrated differential expression within a population of genetically identical bacteria in vivo, 
particularly within phagocytes. It was found that there was increasing signal from the reporter for 
nuc expression as infection progresses and nuc was expressed by a subset of bacteria within 
phagocytes (both neutrophils and macrophages). Interestingly expression of nuc within 
macrophages was identified and followed over time, with an increasing number of intracellular 
bacteria expressing nuc as infection progresses. Other studies investigating nuc expression have 
mainly focused on neutrophils and the extravasion of NETS (Berends et al., 2010; Kiedrowski et al., 
2014; Olson et al., 2013) and have not shown a role for nuc expression in macrophage escape or 
killing.  
Expression of nuc in the lesions which form within embryos has also been identified, likely due to 






Figure 6.3 Clonal expansion of S. aureus leading to overwhelming infection 
Upon systemic infection of embryos with isogenic strains, bacteria are initially phagocytosed. Once 
within macrophages a subset of bacteria replicates leading to the eventual cause of phagocyte lysis. 
After S. aureus has escaped the phagocyte, these bacteria go on to form lesions and cause 
overwhelming infection of the embryo. The lesion are derived from only a small number of the 






dissemination of bacteria from the aggregate to other niches within the host. Individual 
extracellular bacteria within the circulation both expressing and not expressing nuc has been found 
concomitantly with nuc expression in large aggregates. 
The nuc reporter used in this study is an indirect indicator of saeRS activity and it is likely that 
alongside the expression of nuc within macrophages and neutrophils, other saeRS regulated 
virulence factors are being expressed. The expression of nuc-GFP within macrophages from pCM20 
could be concomitant with activation of macrophage specific virulence factors also regulated by sae 
such as LukAB and PVL. In a macrophage culture model, there was no evidence for activation of sae 
within a macrophage, with the same level of sae expression in the inoculum as inside infected 
macrophages (Geiger et al., 2008). However, in my work extracellular bacteria were not expressing 
nuc directly after injection and nuc expression was not detected until 6 hpi, which is evidence of 
activation of sae. Shompole et al., (2003) have observed expression of AgrP3 within macrophages; it 
is possible that nuc expression within the phagocyte is due to the downstream activation of sae by 
agr and that in this instance the density of S. aureus within the phagocyte is responsible for the 
expression of nuc.  
In the later stages of infection, the expression of the nuc reporter in lesions may be indicative of 
production of virulence factors involved in the further perturbation of phagocytes. One study has 
exemplified this by treating isolated macrophages with bacterial culture supernatant where the sae 
regulated production LukAB was identified as a cause of macrophage dysfunction (Scherr et al., 
2015).  
A proposed model of virulence expression during systemic infection of embryos with S. aureus is 
depicted in Figure 6.4. Briefly, upon infection bacteria are phagocytosed and respond to 
environmental cues from the intracellular environment. This leads to the production of virulence 
determinants, such a toxins and enzymes, which aid escape from phagocytes by causing host cell 
lysis. The escaped bacteria are either subsequently phagocytosed or expand within the host. Upon 
formation of lesions within the circulation of embryos there is expression of proteins which have 
roles in biofilm maturation and also expression of virulence determinants which further perturb 
the immune response. 
 Limitations of this study 
The main limitation with the methodology used in this study to follow infection dynamics within a 
living host over extended time periods by LSFM, is throughput. The ability to only image one or two 
fish simultaneously limits the amount of quantitative analysis that can be performed on these data 
sets, but it remains a strong tool for gaining better insight to a hypothesis that can also be examined 






Figure 6.4 A model for virulence factor expression during infection 
Schematic depicting possible temporal expression of virulence factors during systemic infection of 
a zebrafish embryo that succumbs to infection. Bacteria are initially phagocytosed, and a subset 
respond to the intracellular environment by producing virulence factors which target host 
components and aid escape from the phagocyte. Bacteria then undergo expansion within the 
circulation and form lesions. In response to cell density in these aggregates bacteria begin to 
express virulence factors which leads to dissemination of bacteria to other niches within the host 











difficult to handle, the ability to image an entire bacterial population, within the host over time by 
LSFM is unparalleled. Another limitation was the lack of a third fluorescent label that could be used 
for long-term imaging of host pathogen interactions and as such the strains with constitutive 
smURFP production were developed. 
 Future directions 
6.5.1 Technical 
Recently, some researchers in the LSFM community have begun to inject α-bungarotoxin (a small 
immobilising protein from snake venom) or mRNA encoding the toxin. This works by irreversibly 
binding and inactivating acetylcholine receptors and has been found to impact development less 
than immersion in anesthetic (such as tricaine) (Swinburne et al., 2015). This method could be used 
to further improve the development of embryos during imaging and better mimic infection 
observed in the survival assay. 
6.5.2 Clonal expansion of S. aureus 
Creating a chromosomally encoded, constitutively expressed smURFP background would provide 
more tangible imaging of S. aureus within embryos with both neutrophils and macrophages 
labelled. It would also enable the ability to infect fish with a mixed inoculum and track the process 
of clonality after phagocytosis. The use of this background in combination with expression reporter 
could provide data that could be more rigorously analysed to dissect spatial and temporal 
expression of bacterial factors within phagocytes and/or lesions. 
To elucidate whether S. aureus are escaping from a subset of macrophages within the embryo, 
experiments following fluorescent bacteria in transgenic zebrafish lines which are currently being 
developed for labelled M-1 and M-2 macrophages, could be performed. 
6.5.3 Virulence factors 
The sae mutant is attenuated, but not completely, in the systemic model for S. aureus infection 
within zebrafish embryos (Prajsnar, 2009) probably due to the inability of the pathogen to produce 
pore-forming toxins required for phagocyte escape. Although this mutant might not go on to 
overwhelm the embryo, if nuc expression within the phagocyte from 6 hpi is from sae activity then 
transducing this reporter into a Δsae background and examining intra phagocyte expression would 
confirm this. Furthermore, to determine whether the increase in volume of nuc expressing bacteria 
within macrophages over time is due to quorum sensing by S. aureus within the phagocyte from 
constitutive AIP production, the pCM20 plasmid could be transduced into an agr mutant 






 Since finishing this study, a novel transgenic fish line developed by Isles, 2018 has reached 
maturity and can now be used for infection with S. aureus. This line, Tg(lyz:histone2a.mCherry, 
mpx:GFP) has mCherry labelled histones in the Tg(mpx:GFP) I114, background (GFP labelled 
neutrophils). In preliminary experiments NETs have been observed in this transgenic line after tail 
infection with Candida albicans (H. Isles, personal communication). Infection of 
Tg(lyz:histone2a.mCherry, mpx:GFP) embryos with JE2-smURFP pCM20 (constitutively expressing 
smURFP, GFP Nuc reporter) in combination with real-time LSFM during the initial stages of 
infection could be used to identify nuc expression by S. aureus to escape NETs. If this phenomenon 
occurs, escape could be compared with a fluorescent nuc mutant.  
It would be interesting to investigate the expression of virulence factors known to be involved in 
macrophage escape in vitro, using fluorescent reporters like the ones used in Chapter 5, starting 
with sae regulated pore-forming toxins such as LukAB, which has been shown to target the CD11b 
(α) subunit of αMβ2, Mac-1 (DuMont et al., 2013) or PVL which targets the C5aR and C5aL receptors. 
Such reporters could also be used to look at the interaction of phagocytes with formed lesions, as 
expression of LukAB and α-toxin from biofilm culture supernatant causes macrophage disfunction 
in macrophages in vitro (Scherr et al., 2015).  
6.5.4 Differential expression of genes implicated in biofilm maturation. 
An agr deficient strain could also be used to determine whether biofilm-like lesions form during 
infection with an agr mutant and if so confirm that expression of nuc in these large aggregates is 
controlled by agr. The reagent SYTOX© nucleic acid stain could be used in vivo in combination with 
live imaging to stain lesions for the extracellular DNA characteristic of biofilm. 
 Concluding remarks 
My study has developed a new approach to characterise the complex interaction between host and 
pathogen in vivo, in real time and at the cellular to whole organism level. This paves the way for 
future work to unravel the mechanisms that constitute the life or death struggle between a host and 
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 Codon optimised smURFP sequence 
The following sequence is the smURFP sequence codon optimised for expression in S. aureus. 
Optimisation was carried out by Mark Cooke and synthetic DNA was ordered from EuroFins. 
ATGGCGAAAACATCAGAGCAGCGAGTTAATATAGCAACGTTATTGACAGAAAACAAAAAAAAGATAGTGG
ATAAAGCAAGTCAAGACTTGTGGCGTCGACACCCTGACTTAATCGCACCGGGCGGAATTGCGTTTTCACAA
AGAGACAGAGCATTGTGTTTGAGAGATTATGGTTGGTTTTTGCACTTGATAACATTTTGTTTATTGGCGG
GAGACAAGGGTCCGATTGAATCTATCGGATTGATTAGTATAAGAGAAATGTATAACTCTTTGGGTGTGCC
GGTCCCAGCGATGATGGAGTCTATCCGATGTTTGAAAGAGGCGTCTTTATCATTGTTAGATGAAGAGGAT
GCTAACGAGACAGCTCCTTACTTTGACTATATCATAAAGGCTATGTCT 
 
 
